ML20126C508
| ML20126C508 | |
| Person / Time | |
|---|---|
| Site: | Clinton  |
| Issue date: | 04/30/1985 |
| From: | ILLINOIS POWER CO. |
| To: | |
| Shared Package | |
| ML20126C504 | List: |
| References | |
| PROC-850430, NUDOCS 8506140440 | |
| Download: ML20126C508 (117) | |
Text
- ,
CPS-0DCM
. '9 b
i.
-}
9
'l 1
4 ILLINOIS POWER COMPANY i~
1 CLINTON POWER STATION 0FFSITE DOSE CALCULATION MANUAL 1
l
-)
. Docket No. 50-461 i -
1 1
'i - -
'k t
l i
1 i
1
.I i
1 I
i i
i
't 1
}
~i .
l 8506140440 8506 j PDR ADOCK 0 p ,1 I
! CLINTON-I Rev.0-4/85
r CPS-ODCM i
(,
Illinois Power Company Clinton Power Station OFFSITE DOSE CALCULATION MANUAL Table of Contents Section Title Page 1.0 PREFACE . 1-1 4
! 2.0 LIQUID EFFLUENTS 2-1 2.1 Introduction 2-1 j
i 2.2 Liquid Radwaste Discharge Process Radiation 2-1 Monitoring (PRM) System
] ,
2.2.1 Method of Representative Sampling 2-1 2.3 10CFR20 Release Rate Limits 2-1 a 2.3.1 Liquid Radwaste Discharge PRM 2-2 Setpoints,
.'1 2.3.2 Plant Service Water Effluent PRM 2-8 Setpoints t
1 2.3.3 Shutdown Service Water Effluent 2-9 j PRM Satpoints 2.3.4 Fuel Pool Heat Exchanger Service 2-9 Water Effluent PRM Satpoints I
1 2.4 10CFR50, Appendix I Release Rate Limits 2-9 i
j 2.5 Compliance With CPS RETS 3.11.1.3/3.11.1.4 2-11 2.6 Doses From Liquid Effluent Pathways 2-20 1
4 3.0 GASEOUS EFFLUENTS 3-1 3.1 Introduction 3-1 3.2 Gaseous Effluent Release Point Monitoring 3-2 3.2.1 HVAC Stack Process Radiation 3-2 I
Monitoring (PRM) System CLINTON-I i Rev.0-4/85 l
=_- .
, CPS-0DCM t \
I Table of Contents
- Title Section Page, 3.0 3.2.2 SGTS Stack Process Radiation 3-2 Monitoring (PRM) System 3.3 Main Condenser Off-Gas Monitoring System 3-3 J
3.3.1 Pre-Treatment Air Ejector Off-Gas 3-3 PRM 3.3.2 Post-Treatment Air Ejector Off-Gas 3-4 PRM i -
q 3.4 10CFR20 Release Rate Limits 3-4 3.4.1 Dose Rate Due to Noble Gases 3-5 3
]3 3.4.2 Dose Rate Due to Radiciodines, 3-5 -
Particulates and Tritium l
.' i 3.5 10CFR50, Appendix I Release Rate Limits 3-13 f 3.5.1 Noble Gas Air Dose 3-13 l 3.5.2 Radiciodines, Particulates and 3-15
.)
4 Tritium Dose 1 3.6 Compliance With CPS RETS 3.11.2.4 3-23 3.7 Effluent Monitor Setpoint Calculations 3-24 l.
3.7.1 Total Body Dose Rate Setpoint 3-24
-! 3.7.2 Skin Dose Rate Setpoint 3-26
- j lj s', - 4.0 COMPLIANCE WITH 40CFR190 4-1
5.0 RADIOLOGICAL ENVIRONMENTAL MONITORING 5-1 l 6.0 ADJUSTMENT OF CPS RETS 6-1 i ,
i j CLINTON-I ' 11 Rev.0-4/85 4
6
, CPS-0DCM Tables Table Title Py 2.4-1 Adult Ingestion Dose Commitment Factors-At) 2-12 2.4-2 Bioaccumulation Factors-BF t 2-15 2.4-3 Adult Ingestion Dose Factors-DF g 2-16 2.6-1 Input Parameters For Calculating R,p) - 2-24 i
- j 3.4-1 Dose Factors For Noble Gases and Daughters 3-8 3.4-2 Pathway Dose Factors (Infant)-P .t 3-9 il
- 3.4-3 Distances to controlling Locations 3-11 l 3.4-4 Site Boundary Meteorological Dispersion Parameters 3 ~!
j 3.5-1 Inhalation Dose Factors For Infant-(DFAt ), 3-30 3.5-2 Inhalation Dose Factors For Child-(DFAt ), 3-33 i 3.5-3 Inhalation Dose Factors For Teen-(DFAt ), 3-36
'I -
3.5-4 3-39
- Inhalation Dose Factors For Adult-(DFAt ),
j 3.5-5 Ground Plane Dose Factors-DFG t -
3-42
] 3.5-6 Ingestion Dose Factors For Infant-(DFLt ), 3-44 3.5-7 Ingestion Dose Factors For Child-(DFLt ), 3-47 3.5-8 Ingestion Dose Factors For Teen-(DFLt ), 3-50 3.5-9 Ingestion Dose Factors For Adult-(DFLt ), 3-54 j 3.5-10 Input Parameters For Calculating R C
3-58 3.5-11 Input Parameters For Calculating R M 3-59 I
3.5-12 InputParametersForCalculatingRf 3-60 i
- CLINTON-I 111 Rev.0-4/85 I
CPS-0DCM
,'\
Tables i Table Title Page, 3.5-13 Pathway Dose Rate Factors For Infant-R g 3-61 3.5-14 Pathway Dose Rate Factors For Child-R g 3-64 3.5-15 Pathway Dose Rate Factors For Teen-R g 3-67 3.5-16 Pathway Dose Rate Factors For Adult-R g 3-70 4 5.0-1 CPS REMP Sampling Locations and Frequency 5-2 I
i I
I j
l i
s 1
1 ,
CLINTON-I iv Rev.0-4/85 e
CPS-ODCM
's Figures i Figure Title Pm l
2.1-1 Unrestricted Area Boundary For Liquid Effluents 2-7 i 2.5-1 Liquid Radwaste Treatment System 2-19 3.1-1 CPS Site Boundary For Gaseous Effluents 3-28 l
3.3-1 Main Condenser off-Gas Treatment System 3-29 5.0-1 REMP Locations Within 2 Miles of CPS 5-9 I]
I 5.0-2 REKP Locations Within 5 Miles of CPS 5-10 l
! 5.0-3 REMP Locations Within 50 Miles of CPS 5-11 i
s lii i ll
!)
l .'
)
I j
l lI l t CLINTON-I v Rev.0-4/85 l
l CPS-0DCM
- ,i
.. s i
List of Effective Panes
'. Pggg Revision Pm Revision P_ age, Revision P_
a age, Revision
'.1 0 2-23 0 3-27 0 3-58 0 i l
11 0 2-24 0 3-28 0 3-59 0 iii 0 2-25 0 3-29 0 3-60 0
! iv 0 3-30 0 3-61 0 3-1 3-31 3-62 v 0 0 0 0 t vi 0- 3-2 0 3-32 0 3-63 0 f 3-3 0 3-33 0 3-64 0 !
j 1-1 0 3-4 0 3-34 0 J-65 0 3-5 0 3-35 0 3-66 0 2-1 0 3-6 0 3-36 0 3-67 0 i
- 2-2 0 3-7 0 3-37 0, 3-68 0 2-3 0 3-8 0 3-38 0 3-69 0 t l 2-4 0 3-9 0 3-39 0 3-70 0
. 2-5 0 3-10 0 3-40 0 3-71 0 ;
l
, 2-6 0 3-11 0- 3-41 0 3-72 0 2-7 0 3-12 0 3-42 0 2-8 0 3-13 0 3-43 0 4-1 0 i 2-9 0 3-14 0 3-44 0 -
i 2-10 0 3-15 0 3-45 0 5-1 0 l 8 2-11 0 3-16 0 3-46 0 5-2 0 ,
I 2-12 0 3-17 0 3-47 0 5-3 0 f' 3 2-13 0 3-18 0 3-48 0- 5-4 0 2-14 0 3-19 0 3-49 0 5-5 0 2-15 0 3-20 0 3-50 0 5-6 0
+ 2-16 0 3-21 0 3-51 0 .5-7 0 l 2-17 0 3-22 0 3-52 0 5-8 0 !
2-18 0 3 0 3-53 0 5-9 0 2-19 0 3-24 0 3-54 0 5-10 0 t
.j 2-20 0 3-25 0 3-55 0 5-11 0
- 2-21 0 3-26 0 3-56 0 j 2-22 0 3-27 0 3-57 0 6-1 0 ,
I l 5
u i
I t
l- !
t l
f
- F CLINTON-I vi Rev 0-4/85 L t -
1
, s ., . . . . . -. .
CPS-0DCM 1.0 PREFACE The Clinton Power Station OFFSITE DOSE CALCULATION MANUAL (CPS-0DCM) provides the methodologies and parameters to be used by Illinois Power Company (IPC) to assure compliance with the dose limitations stated in the CPS Radiological Effluent Technical Specifications (CPS RETS). The RETS show compliance with 10CFR20, 10CFR50 Appendix A (CDC60 and 64), 10CFR50 Appendix I, and 40CFR190.
The CPS-0DCM was prepared based on guidance provided in NUREG-0133, PREPARATION OF RADIOLOGICAL EFFLUENT TECHNICAL SPECIFICATIONS FOR NUCLEAR POWER PLANTS (October 1978), and NUREG-0473, RADIOLOGICAL EFFLUENT TECHNICAL SPECIFICATIONS FOR BOILING t/ATER REACTORS (Draft 7" to Revision 3). This manual along with station ,_
procedures will be used by CPS personnel to demonstrate compliance with the CPS RETS. s Changes to the CPS-0DCM shall be provided in the SEMIANNUAL RADIOACTIVE EFFLUENT RELEASE REPORT.
l l
l l
l I
i t
CLINTON-1 11 Rev.0-4/85
CPS-0DCM 2.0 LIQUID EFFLUENTS 2.1 Introduction Liquid radwaste effluent released from CPS will meet 10CFR20
, concentration limits at the point of discharge to the unrestricted area shown in Figure 2.1-1. This design and operation objective will be achieved at all times. Actual discharges of liquid radwaste effluent will occur on a batch basis and the average .
concentration at the point of discharge will normally be only a small percentage of the allowed limits.
Cumulative quarterly dose contributions due to radioactive effluents released to the unrestricted area will be determined once every 31 days using NUREG-0133 and Regulatory Guide 1.109 methodology and parameters.
2.2 Liquid Radwaste Discharge Process Radiation Monitoring (PRM) System This monitoring subsystem measures liquid radwaste effluent radioactivity prior to the effluent joining plant service water and circulating water dilution streams. A high radioactivity signal from this gamma scintillation detector automatically terminates the liquid radwaste effluent release. The liquid radwaste effluent flow, variable from 10-60 GPM or 50-300 GPM, combines with plant service water flow (22,000 GPM minimum) and plant circulating water flow (0-567,00.0 GPM) in the Seal Well prior to entering the 3.4 mile discharge fiume to Lake Clinton.
2.2.1 Method of Representative Sampling To obtain a representative sample of the liquid radwaste tank to be discharged, the tank is recirculated a minimum of two tank volumes at which time a sample is obtained for isotopic analysis.
2.3 10CFR20 Release Rate Limits The requirements pertaining to discharge of liquid radwaste l effluent to the unrestricted area are specified in CPS RETS l
3.11.1.1:
CLINTON-I 2-1 Rev.0-4/85
CPS-0DCM
\.
4 1 "The concentration of radioactive material released in liquid j effluents to UNRESTRICTED AREAS shall be limited to the concentrations specified in 10CFR20, Appendix B, Table II,
- i. Column 2 for non-noble gas radionuclides. For dissolved or entrained noble gases, the concentration shall be limited to 2E-04flCi/ml total activity."
To comply with the above requirements, setpoints will be calculated to assure that Seal Well concentrations do not exceed 10CFR20, Appendix B, Table II, Column 2 values at any time.
2.3.1 Liquid Radwaste Discharge PRM Setpoints To achieve CPS RETS 3.11.1.1, and for the purpose of j implementation of CPS RETS 3.3.7.11, the alarm / trip setpoints i for. liquid effluent monitors and flow measurement devices are i
set to assure that the following equation is satisfied:
cf g CMPC II)
E+t
}
3 C = the affluent concentration limit I- MPC .
(CPS RETS 3.11.1.1) implementing
]i 10CFR20 for the site, corresponding to the specific mix of radionuclides in the affluent stream being considered, in) mci /ml c = the setpoint, inj2Ci/ml, of the radioactivity 3 monitor measuring the radioactivity j concentration in the effluent line prior to
't dilution and subsequent releases the setpoint,
]. which is inversely proportional to the
- volumetric flow of the effluent line and i proportional to the volumetric flow of the j dilution stream (s) i represents a value,plus the effluent if exceeded, stream, would result in concentrations exceeding the limits of
.1 10CFR20 in the unrestricted area
!i 4 F = the dilution water flow setpoint as determined
[ 4 at the Seal Well, in volume per unit time
] f = The flow setpoint as determined at the liquid radwaste discharge PRM location, in volume per unit time (same units as F) ilI1 b
J '
I j CLINTON-I .2-2 Rev.0-4/85 1
O
i l CPS-0DCM t i
- 7. .s The available dilution water flow (F) should be constant for a ,
given release, and the liquid radwaste tank discharge flow (f) and i monitor setpoint (c) are set to meet the condition of equation (1)
'. for a given effluent concentration (C The method by which this is accomplished is illustrated iW 9e)c. tions 2.3.1.1 through 2.3.1.5.
2.3.1.1 The isotopic concentration for a liquid radwaste tank to be discharged is obtained from the sum of the measured concentrations as determined by the analyses required in CPS RETS Table 4.11-1:
C t
- C+
g C,+hC,+(C+C,+C),pCi/ml T p 7 (2) where
[C = The sum of concentrations C of each 1
g 8 measured gamma emitter g obferved by gamma spectroscopy of the waste sample, pCi/ml.
[C a = The sum of Concentrations C of a alpha emitters (a)
- a in liquid radwaste as measufed in the MONTHLY
} compositesample,KCi/ml.
hCs = The sum of concentrations C of Sr-89/Sr-90 in e - liquid radwaste as observedsin the QUARTERLY j (, compositesample,pCi/ml. - I l C = The measured concentration of H-3 in liquid radwaste T as determined from analysis of the MONTHLY composite i sample,gCi/ml.
I C = The measured concentration of Fe-55 in liquid Fe radwaste as observed in the QUARTERLY composite 1
sample,pCi/ml.
C = The measured concentration of I-131 in the liquid 7
radwaste sample, pCi/ml I
h
) ,
1 CLINTON-I 2-3 Rev.0-4/85
- , , , , , ,v,__y _ _ . - . ,
CPS-0DCM !
9 2.3.1.2 The measured radionuclide concentrations are used to i
/'
~
calculated a DILUTION FACTOR (DF) which is the ratio of .
l total dilution flow rate to liquid radwaste tank effluent
. l
..". flow rate required to assure that the limiting concentrations of 10CFR20, Appendix B, Table II, Column 2 are met at the point of discharge to the unrestricted area.
C (3)
DF = SF i dimensionless 1 %
1 = SF C C, C, C T C, y C 7
I e
' g a s where -
C = The measured concentrations C , C , C , C ,
Cy ,, C7 asdefinedinequatioE(2f,jzei/mI.
i I MPC g = The limiting concentration of the MPC corresponding MPC , MPC radionuclide and MPC fromMPC 10CFE20,, MPClp,endiE,B, A
TabIeII,yfolumn2, 1/ml. For dissolved or i entrained-noble gas s, the concentration shall be limited to 2E-04jgCi/ml total activity.
SF = The conservative SAFETY FACTOR normally
/ applied to compensate for statistical i
(_ - fluctuations and measurement errors,
, dimensionless. ~
- 2.3.1.3 The maximum permissible liquid radwaste tank effluent flow
,' rate prior to dilution, f , is calculated 'oased on a fixed fractionoftheminimumdIlutionflowrate,Fd F Fd"** f d I
d :s Fd + fd av d : (4) p DF UT
. where
' 0.9 (Minimum Dilution Water Flow Rate), volume / time Fd=
DF = The., DILUTION FACTOR calculated by equation (3),
dimensionless Equation (4) is valid only for DF 2:1; for DF-el, the liquid i: radwaste tank effluent concentration meets the limits of
- 10CFR20 without dilution and'therefore f d may assume any value.
$ t CLINTON-I 2-4 Rev.0-4/85 f ll
- - ~ - _- .
.e,=~4-.. e. ..- ..
5
--w -
. . - - - ,,n .,m., -,.,,,---...,....,..,e ,. , , , . ~ . , - . . _ - , . .- . , , - - , - - - . - , .
I CPS-ODCM l
i 2.3.1.4 The dilution flow rate setpoint for minimum dilution flow rate, F, and the liquid radwaste tank. effluent flow rate setpoint for maximum liquid radwaste tank effluent flow rate, f, are calculated as follows:
F= F =0.9 (Minimum Dilution Water Flowrate), volume / time d (5) f= 0.9 (f )=0.9 a (Calculated Maximum Radwaste Tank ,
Effluent Flowrate), volume / time (6)
Accordingly, the radwaste discharge is automatically terminated if the dilution water flow rate falls below the assumed flow rate of 90 percent of the actual dilution flow or if the liquid radwaste tank effluent flow rate exceeds 90 percent of the calculated maximum flow rate.
2.3.1.5 The liquid radwaste discharge PRM setpoint may now be C (Eq.2), F(Eq.5) and specifiedbasedon.thevaluesof[hrbvidecompliancewiththe f(Eq.6) which were determined to limits of 10CFR20, Appendix B, Taile II, Column 2. The monitor response is primarily gamma response and the actual setpoint is therefore ~uased o C (Eq.2). The monitor setpoint, CPM, which correspon Eo the particular setpoint concentratien, 4 , is determined based on monitor calibration data or operatioHal data which correlates monitor response to sample analyses associated with the actual liquid radwaste to discharged. The second method is considered valid only if the integrity of laboratory methods of determination are proven more accurate than the monitor data.
The set point concentration, Cg , is obtained by the following equation:
C "
gC g, p i/ml (7)
M where f = The actual or maximum expected liquid radwaste a effluent flow rate, volume / time The other terms are as defined previously. If (f a /f value obtained for g is used to determine the moMit8r)fl, set oint above back .ound, CPM, from either of the two met ods described a ove. - In the case where (f /f ) =1, no release may be made and the alternativespreseNte8in sections 2.3.1.3 and 2.3.1.4 should be re-evaluated.
'CLINTON-I 2-5 . Rev.0-4/85
c-3 CPS-0DCM ss l
The setsoint concentration is conservative, even if fa is attaina' ale, since the calculated flow rate contains tMe SAFETY FACTOR, dilution flow rate and liquid radwaste tank
.'. effluent flow rate margins.
- 2.3.1.6 To prevent spurious alarms, revise the plant service water effluent PRM setpoint to coincide with the setpoint concentration, Cu , calculated by equation (7). This setpoint is vaTid only during periods of
, actual liquid radwaste discharges.
i i
.i i .
l
?I t
i 1 -
1 1
t
)
i
't i
4 i
1 1
1
.1
- 1 9
CLINTON-I , 2-6 Rev.0-4/85
r CPS-0DCM
- 1 i %
1 1
4
' Figure 2.1-1 UNRESTRICTED AREA BOUNDARY FOR LIQUID EFFLUENTS 4
380.004
, , , *--.9 .#W- ~ . , * 't...*_.' s *.s-M h s h' ( M **W
' . = - \ <, s.r ' ditairs, e ?-
" '..,:?s. f g'.' * . . y- -
c
- -y pn.c a . w.s- .
a -#, kQ' $$yg j & l '* ' 5 5.5 $ W~W$
. &r -- '.h-
),
.m~.
... ,. r y'0- MS/- -: ' J A: >- Div--y)+",..), ,) i i _\i mt .
.. %s. ,. q' .~ . . .
Ml
.p~i
-_ -[' ~
~#%n s
4,af If_ _
i
?
1 . '
- .q'L ;Y.- .
'*~
~& .-h'.Q.7.}%%"yf fJl f% g.! ' _' ]
. .> .Q ,. ,.)d
' _ ~.$ \
r ~;< .
.s. .
1 g,q .
+,-
'. r.;,, <
..__.%,.,..~.
A. -.. ~ n
.~
= :i. .
., I ~. e we . -
s.
~ - ' -
. h'~. p5 'f. , y',/
j W-xx7rIECpfg- p .< --
.()b)Ed!'..J
...., w
~
\ 7*
( ,
._ s ; _ . o . _ /~'
a ;,,c;,,,,, /
M'N' T. .
b.
2 ::1..:.r g '- - i . y..:Cc ..ff f. x .,i.h .- ; _ , .- g.;- l_ _ - =c ~ . .
.I .. n. ,. . .',.
. . , ~ < ,m., r. , . -
,c r .- -
.b.
.~ , , . ,
s g. _ .- u . !' .
}, u
-:t ] A,, _
. Le-w :, -Ou' . .? * ' ,ga _ k .
- ' _ ~~ '.'.~~"\ . ;,f ' -
I .&. . .- ,.s ~ i '. ,, mW..:
A # M - "
=,--...... AV ,,-
1 i m wa. ,..- . n. - r-C4M-#,.
- i
.r -
I m.-
c;;:;n...,a=s.sm,.g.,:a. ...- . ~' ,. ,/s/' ,,, ..rc, e --
_r...
_u .
m_ f ..-
l s_.w. p y.r-
. e.. s ,..
t, ,},
, + .
l,
, gJ.~+ . . e.c . . .s .
- .s,..o&w. . ,. .- ~
= - . ,., ..
r/.
.p.),
, * } ~ gi4 .,, . .
%..,,,' so , :. i.-
- _y * ,
g -A.
'g ~,
.. W i t p % e h %G-E..,N ( s'#'v/ - , - c ' . *?'.> '
.4
. m\
' . : ..:.-EL.s --:i_k, ~.. - g .. n . ,y'z./ ' .
. . . N.
_, w~/_. + -
,%p =n='.- l
- _ c "-
. - ._qj :1 .A e' 'N
,.-. ua ou "'.,:
. >.*:i.
.y.. .-- 3.
- 3_. y.41.
. ,,,/ y.:. , . ' -
- l. . l 1.. . *- 3' , ~ '; -. . .. ' t*g
..' ,c.s,,,.,
.(
- i.;,.-Q * ,
..; , ., t .'
. -t. a N'*
.'.. &,.y.y -"'._ 1 5
s
. t...
I..: '. . .
.s. *
.8 . . . , . .
- v. , -
- . . ~' t .3 . '
.y 1' .~.
.g
,,. . -L
-l -1 h
. i .s e.
%. @..y[~f3 (
+s .. . . , -5 g.' ' .
- s. . ,. .
s .,.,.s3.u. s_
y q..
- "C= =
. p. w. . ...
~
....m..~, .% :. . . . . = . - ~ ,-.-:.
m- . - e.-=- - -
.2. ; .. ..y
. f m'.(. . ..
.r._ ~< ..
~.
.- .n .
.,v_.s.- g ...- 4. . . .
f .. . . .
W;.
~
- 9.<, .i ,. ' - h:h n. @: .= *>,
, p. t s
i M, ';. . W ': ;\ ,.., .~. .8'N .
. .n
~
.~Q. _.CQ>
_" .a (L*% c,
-:?:.. . . --?%
.El._,;m.- . 4, f 's'. . .; s i & lI ?..; s.: - f *..:y.sll, k.a )
s:.
. .:- ; ,,s ;- .:
- f, .. ggg M. g R Ah A" yy ~
l r
1 l; CLINTON-I -
2-7 Rev.0-2/85
.t l6 I i i
1 1
CPS-0DCM 2.3.2 Plant Service Water Effluent PRM Setpoints Plant service water effluent continuously releases to the Seal Well where it mixes with circulating water effluent (if present) prior to entering Lcke Clinton via the 3.4 mile discharge flume. The plant service water effluent-is not considered a radioactive discharge pathway unless liquid
- . radwaste discharges are in progress or any service water cooling load heat exchanger has been detected as failed. To ensure that the plant service water contains no radioactivity, the following actions will be taken
- (a) grab sampling will be performed weekly and (b) the PRM setpoint !
should be. established at three (3)-times background. In no case shall the PRM setpoint exceed the corresponding MPC for the most limiting radionuclide (normally I-131) before-
- applying the safety and dilution factors.
In the event radioactivity is detected in the plant service water, daily grab sampling will be performed. The grab samples will be analyzed for those radionuclides and at the corresponding Lower Limit of Detection (LLD) specified in.
CPS-RETS Table 4.ll-1.A. The discharge through this pathway shall be assumed to cease when the measured radioactivity is below the more limiting LLD. PRM setpoints will then be determined following the methodology presented in section 2.3.1 as follows:
2.3.2.1 Perform section 2.3.1.2, solving equation (3) for DF using the approoriate vslues in the concentration term from the grab sample analysis.. If DF-ci, then perform section 2.3.1.5 to determine the PRM setpoint.
2.3.2.2 If DF El, a modified dilution factor, DF , must be determined so that available dilution flows may be Wpportioned among simultaneous discharge pathways.
The modified dilution ,
factor is defined as:
DF m
= DF (8) p-A r where F 3 is an administrative allocation factor which may be assigne8 any value between 0 and 1 under the condition that k (
(FA}n
, and where n = the number of liquid discharge pathways for which DF El and which are planned for simultaneous release.
For. simplicity, F3 may be assigned the value 1/n. Calculate fa in equation (47 by substituting the value of DF for DF aMd perform the calculation specified in sections f.3.1.4 and 2.3.1.5 to. determine flow rate and PRM setpoints.
ECLINTON-I 2-8 Rev.0-4/85
' CPS-0DCM 2.3.3 Shutdown Service Water (SX) Effluent PRM Setpoints Shutdown Service Water, when initiated, is a potential continuous radioactive discharge pathway to the Ultimate Heat Sink (UHS). The SX effluent is not considered a radioactive discharge pathway unless any SX cooling load heat exchanger has been detected as failed. To ensure that SX contains no radioactivity, the following actions will be taken: (a) grab sampling will be performed weekly and (b) the PRM setpoint should be established at three (3) times background. In no case shall the PRM setpoint exceed the corresponding MPC for the most limiting radionuclide (normally I-131) before applying the safety and dilution factors.
In the event radioactivity is detected in the SX system, daily sampling will be performed. The grab samples will be analyzed for those radionuclides and at the corresponding Lower Limit of Detection (LLD) specified in CPS-RETS Table 4.11-1.A. The discharge through this pathway shall be assumed to cease when the measured radioactivity is below the more limiting LLD. PRM setpoints will then be determined 4
following the methodology presented in sections 2.3.2.1 and 2.3.2.2 or section 2.3.1.
2.3.4 Fuel Pool Heat Exchanger Service Water Effluent PRM Setpoint The Fuel Pool Heat Exchanger Service Water effluent is considered a potential radioactive discharge pathway when Shutdown Service Water (SX) replaces Component Cooling Water (CC) as the heat sink for the fuel pool heat exchangers. To ensure that CC contains no radioactivity, the following actions will be taken: (a) grab sampling will be performed
, weekly and (b) the PRM setpoint should be established at three (3) times background. In no case shall the PRM setpoint exceed the corresponding MPC for the most limiting radionuclide (normally I-131) before applying the safety and dilution factors.
t In the event radioactivity is detected in the.CC system, daily CC grab sampling will be performed. The grab samples will lhe analyzed for those radionuclides and at the 1
. corresponding Lower Limit of Detection (LLD) s7ecified in CPS-RETS Table 4.11-1.A. The discharge through this pathway shall be assumed-to cease when the measured radioactivity is below the more limiting LLD. -The analysis data will then be used to determine the SX PRM setpoints (based on batch release of CC activity) following the methodology presented in sections 2.3.2.1 and 2.3.2.2 or section 2.3.1.
2.4 10CFR50, Appendix I Release Rate Limits CPS RETS 3.11.1.2 requires that the cumulative dose contributions to an individual from radioactive material in '
, liquid effluents released to the unrestricted area be.
- determined at least once per'31 days. The applicable dose limits are
CLINTON-I' 2-9 Rev.0-4/85
CPS-0DCM 51.5 mrem / calendar quarter - TOTAL BODY 55.0 mrem / calendar quarter - ANY ORGAN and 53 mrem / calendar year - TOTAL BODY 510 mrem / calendar year - ANY ORGAN The dose contribution to the maximum exposed individual from all radionuclides identified in liquid effluents released to the unrestr cted area is calculated as follows:
D j
=[ f ,y et y C gy F mrem (10) where D = The cumulative calendar quarter or. yearly dose to 3 any organ j from liquid effluent for the total release period, mrem .,
4t y = The length of the lth release time period over which.
C gy and F y are averaged for liquid releases, hours C gy = The average concentration of nuclide i in undiluted liquid effluent during release period 4ty ~for any liquid release,juCi/ml F = The near field average dilution factor for C 1 duringanyliquideffluentrelease,dimensiobkess.
Defined as the ratio of the average undiluted liquid radwaste flow during the release to the product of the average flow from the discharge structure to unrestricted receiving water and Z
= Average Undiluted Liquid Waste Flow (11)
(Average Discharge Structure Flow) Z Z = The applicable dilution factor for Lake Clinton, dimensionless
= 1.0 A = The composite ingestion dose commitment factor for fd the total body or critical organ of an adult for radionuclide i, mrem /hr perjuCi/ml
=K g Uw + UgBFt)DF g (12)
Dw where K = A units conversion factor, 1.14E+05 0
pCi-ml-yr/juCi-liter-hr
=-(1.0E+06 pCi/HC1)(1.0E+03 ml/ liter) ~
8760 hr/yr CLINTON-I 2-10 Rev.0-4/85 I
r
[_
CPS-0DCM U, = Annual water consumption by'the maximum adult, 10 -
liter /yr ,
D =-Dilution factor from the near field area to the
" nearest potable water intake, 1.0 U = Adult fish consumption rate, 21 kg/yr (Table E-5 of f
BF = Bioaccumulation factor for radionuclide i.in fish, f
pCi/k per pCi/ liter (Table 2.4-2 taken from Table A-1 o Regulatory Guide 1.109)
DF = Adult. ingestion dose conversion factor for f
radionuclide i, total body or critical or an,_
mrem /pCi (Table 2.4-3 taken from Table E- 1 of .
Table 2.4-1 contains values for A.3 1 as calculated by equation (12).
The quarterly limits referenced at the beginning of this section represent one-half of the annual design objective of Section-II.A of 10CFR50, Appendix 1. If either the calendar quarter or calendar year limits are exceeded, a special report pursuant to Section IV.A of 10CFR50, Appendix I shall be filed with the NRC.
~2.5 Compliance.With CPS RETS 3.11.1.3/3.11.1.4 The projected doses due to releases of liquid radwaste effluents will be calculated for each batch using equation (10). If the sum of the accumulated dose to date for the month and the projected dose for the remainder of the month exceeds CPS RETS 3.11.1.3 limits, then the liquid radwaste treatment system shall be used. This is to ensure compliance.
-with the OPERABILITY requirement of CPS RETS 3.11.1.3: Figure
-2.5-lishows the appropriate portions of the liquid radwaste treatment system which will be used.
The use of temporary liquid radwaste hold-up tanks may occur Lat CPS.
To comply with CPS RETS 3.11.1.4, the amount of liquid radwaste' stored in such tanks shall be limited to 10 curies, excluding tritium and dissolved or entrained noble gases. In lieu of the 10 curie limit, the methodology aresented in Apoendix B of NUREG-0133 (BWR-RATAFR code) will se used to establish the curie limit.
CLINTON-I 2-11 Rev.0-4/85
-CPS-0DCM TABLE 2.4-1 ADULT INGESTION DOSE COMMITMENT FACTORS - A q (mrem /hr per pCi/ml)
NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI H-3 NO DATA 3.46E-01 3.4 6E-01 3.46E-01 3.46E-01 3.46E-01 3.46E-01 C-14 3.13E+04* 6.26E+03 6.26E+03 6.26E+03 6.26E+03 6.26E+03 6.26E+03 NA-24 4.09E+02 4.09E+02 4.09E+02 4.09E+02 4.09E+02 4.09E+02 4.09E+02 P-32 4.62E+07 2.87E+06 1.78E+06 NO DATA NO DATA NO DATA 5.20E+06 CR-51 NO DATA NO DATA 1.28E+00 7.63E-01 2.81E-01 1.69E+00 3.21E+02 MN-54 NO DATA 4.38E+03 8.36E+02 NO DATA 1.30E+03 NO DATA 1.34E+04 s
MN-56 NO DATA 1.10E+02 1.96E+01 NO DATA 1.40E+02 NO DATA 3.52E+03 FE-55 6.61E+02 4.57E+02 1.07E+02 NO DATA NO DATA 2.55E+02 2.62E+02 FE-59 1.04E+03 2.45E+03 9.40E+02 NO DATA NO DATA 6.86E+02 8.18E+03 CO-58 NO DATA 9.00E+01 2.02E+02 NO DATA NO DATA NO DATA 1.82E+03 CO-60 NO DATA 2.58E+02 5.70E+02 NO DATA NO DATA NO DATA 4.86E+03 NI-63 3.13E+04 2.17E+03 1.05E+03 NO DATA NO DATA NO DATA 4.52E+02 NI-65 1.27E+02 1.65E+01 7.53E+00 NO DATA NO DATA NO DATA 4.18E+02 CU-64 NO DATA 1.01E+01 4.72E+00 NO DATA 2.54E+01 NO DATA 8.58E+02 ZN-65 2.32E+04 7.38E+04 3.33E+04 NO DATA 4.93E+04 NO DATA 4.64E+04 ZN-69 4.93E+01 9.43E+01 6.56E+00 NO DATA 6.13E+01 NO DATA 1.42E+01 BR-83 NO DATA NO DATA 4.05E+01 NO DATA NO DATA NO DATA 5.83E+01 BR-84 NO DATA NO DATA 5.24E+01 NO DATA NO DATA NO DATA 4.12E-04 BR-85 NO DATA NO DATA 2.15E+00 NO DATA NO DATA NO DATA LT E-15**
RB-86 NO DATA 1.01E+05 4.71E+04 NO DATA NO DATA NO DATA 1.99E+04 RB-88 NO DATA 2.90E+02 1.54E+02 NO DATA NO DATA NO DATA 4.00E-09 RB-89 NO DATA 1.92E+02 1.35E+02 NO DATA NO DATA NO DATA 1.11E-11 SR-89 2.25E+04 NO DATA 6.45E+02' NO DATA NO DATA NO DATA 3.60E+03 SR-90 5.53E+05 NO DATA 1.36E+05 NO DATA NO DATA NO DATA 1.60E+04 SR-91 4.14E+02 NO DATA 1.67E+01 NO DATA NO DATA NO DATA 1.97E+03 SR-92 1.57E+02 NO DATA 6.78E+00 NO DATA NO DATA NO DATA 3.11E+03 Y-90 5.87E-01 NO DATI. 1.57E-02 NO DATA NO DATA NO DATA 6.22E+03 CLINTON-I 2-12 Rev.0-4/85
CPS-ODCM
{
TABLE 2.4-1 (continued)
^DULT INGESTION DOSE COMMITMENT FACTORS - A 13 (mrem /hr per LCi/ml)
- NUCLIDE~ BONE LIVER T. BODY THYROID KIDNEY LUNG - CI-LLI Y-91m '5.54E-03 NO DATA 2.15E-04 NO DATA NO DATA NO DATA 1.63E-02 Y-91 8.60E+00 NO DATA 2.30E-01 NO DATA- NO DATA NO DATA 4.73E+03 Y-92 5.15E-02 NO DATA 1.51E-03 NO DATA NO DATA NO DATA 9.03E+02 Y-93 1.63E-01 NO DATA 4.51E-03 NO DATA NO DATA NO DATA Si18E+03 ZR-95 2.75E-01 8.81E-02 5.97E-02 NO DATA 1.38E-01 NO DATA '
2.79E+02
.ZR 1.52E-02 3.06E-03 1.40E-03 NO DATA , 4.63E-03 NO DATA 9.49E+02 NB-95 .4.47E+02 2.48E+02 1.34E+02 NO DATA 2.46E+02 NO DATA 1.51E+08 MO-99 NO DATA 1.08E+02 2.06E+01 NO DATA 2.45E+02 NO DATA 2.51E+02
' TC-99m-
.9.15E-03 2.59E-02 3.29E-01 NO DATA 3.93E-01 1.27E-02 1.53E+01 TC-101 9.41E-03. 1.36E-02 1.33E-01 NO DATA 2.44E-01 6.93E-03 4.08E-14 RU-103 4.64E+00 NO DATA 2.00E+00 NO DATA 1.77E+01 NO DATA 5.42E+02 RU-105 3.86E-01 NO DATA 1.52E-01 NO DATA 4.99E+00 NO DATA 2.36E+02 RU-106 6.90E+01 NO DATA 8.73E+00 NO DATA 1.33E+02 NO DATA 4.46E+03 AG-110m NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA
_TE-125m 2.57E+03 9.31E+02 3.44E+02 7.73E+02 1.04E+04 NO DATA 1.02E+04
-TE-127m 6.49E+03 2.32E+03 7.91E+02 1.66E+03 2.64E+04 NO DATA 2.18E+04 TE-127 1.05E+02 3.79E+01 2.28E+01 7.81E+01 4.30E+02 NO DATA 8.32E+03 TE-129m 1.10E+04 4.11E+03 1.74E+03 3.79E+03 4.60E+04 NO DATA 5.55E+04 TE-129 3.01E+01 1.13E+01 7.33E+00 2.31E+01 1.26E+02 NO DATA 2.27E+01 TE-131m. 1.66E+03 8.11E+02 6.76E+02 1.28E+03 8.22E+03 NO DATA 8.05E+04
, .TE-131 1.89E+01 7.89E+00 5.96E+00 1.55E+01 8.27E+01 NO DATA 2.67E+00
-TE-132 2.42E+03 1.56E+03 1.47E+03 1.72E+03 1.50E+04 NO DATA 7.39E+04 I-130 2.80E+01 8.26E+01 3.26E+01 7.00E+03 1.29E+02 NO DATA 7.11E+01 2
I-131 1.54E+02 .?.20E+02 1.26E+02 7.22E+04 3.78E+02 NO DATA 5.82E+01 I-132 7.52E+00 2.01E+01 7.04E+00 7.04E+02 3.20E+01 NO DATA 3.78E+00 1-133 5.26E+01 9.15E+01- 2.79E+01 1.34E+04 1.60E+02 NO DATA 8.22E+01
. I-134 3.93E+00 1.07E+01 3.82E+00 1.85E+02 1.70E+01 NO DATA 9.30E-03 i
- - CLINTON-I 2-13 Rev.0-4/85
- - - , - . - , . ,m.---. . - - - , - - - . , . -r...,,.o.r,ww..,.,-_,---v,
, ~~,-...,,w--,-c..w,. - , , ,
CPS-0DCM s TABLE'2.'4-1 (continued)
ADULT INGESTION DOSE COMMITMENT FACTORS - A..
1]
(mrem /hr per Wi/ml)
NUCLIDE' BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI I-135 1.64E+01' 4.30E+01 1.58E+01 2.83E+03 6.89E+01 NO DATA- 4.85E+01 CS-134 2.98E+05 7.09E+05 5.79E+05 NO DATA 2.29E+05 7.61E+04 1.24E+04 CS-136 3.12E+04 1.23E+05 8.86E+04 NO DATA 6.85E+04 9.39E+03 1.40E+04
'CS-137 3.82E+05 5.22E+05 3.42E+05 NO DATA 1.77E+05 5.89E+04 1.01E+04 CS-138 4.64E+02 5.22E+02 2.59E+02 NO DATA 3.84E+02 3.79E+01 2.23E-03 BA-139 1.04E+00 7.40E-04 3.04E-02 NO DATA 6.92E-04 4.20E-04 1.84E+00 BA-140 2.18E+02 2.73E-01 1.42E+01 NO DATA 9.29E-02 1.56E-01 4.48E+02 BA-141 5.05E-01 3.81E-04 1.70E-02 NO DATA 3.55E-04 2.16E-04 2.38E-10
'BA-142 2.28E-01 2.35E-04 1.44E-02 NO DATA 1.98E-04 1.33E-04 3.21E-19 LA-140 1.52E-01 7.68E-02 2.03E-02 NO DATA NO DATA NO DATA 5.64E+03
-LA-142 7.81E-03 3.55E-03 8.84E-04 NO DATA NO DATA NO DATA 2.59E+01 CE-141 3.31E-02 2.24E-02 2.54E-03 NO DATA 1.04E-02 NO DATA 8.55E+01 CE-143 5.83E-03 4.31E+00 4.77E-04 NO DATA 1.90E-03 NO DATA 1.61E+02
~CE-144 1.72E+00 7.21E-01 9.26E-02 NO DATA 4.28E-01 NO DATA 5.83E+02 PR-143 5. ( 1E-01 2.25E-01 2.78E-02 NO DATA 1.28E-01 NO DATA 2.44E+03 PR-144 1.14 E-03 7.62E-04 9.33E-05 NO DATA 4.30E-04 NO DATA 2.64E-10 ND-147 3.li4E-01 4.43E-01 2.65E-02 NO DATA 2.59E-01 NO DATA 2.13E+03 W-187 2.16E+02 2.47E+02 8.65E+01 NO DATA NO DATA NO DATA 8.10E+04 NP-239 2.98E-02 2.93E-03 1.62E-03 NO DATA 9.15E-03 NO DATA 6.02E+02 3.13 X 10
- -15 Less than 10
-CLINTON-I 2-14 Rev.0-4/85
-. . __ _ . . -=. -- .- . _ . -
, . CPS-0DCM
(
TABLE 2.4-2 BI0 ACCUMULATION FACTORS -BF i
(pC1/kg per pCi/ liter)
.i . . . . FISHWATER ELEMENT FISH H 9.0E-01
.).___...__...... -.
C 4.6E 03 NA 1.OE 02 P 1.0E 05 CR 2.0E 02 l MN 4.0E 02 j -
FE 1.0E 02 b;
CO 5.0E 01 NI 1.0E 02 a _. CU 5.0E 01
- ZN Z.0E 03
-- BR 4.2E 02 -
I RB 2.0E 03 SR ~ 3.0E 01 Y 2.5E 01 ZR 3.3E 00
- I NB 3.0E 04 1 MO 1.0E 01 TC 1.5E 01 '
RU l.0E 01 RH 1.0E 01 I, TE 4.0E 02 ,
1 I . 1.5E 01 i CS 2.0E 03
.: BA 4.0E 00 I LA Z.5E 01 j CE 1.0E 00 '
- j PR 2.5E 01
.1 ND 2.5E 01 i W l.2E 03 j NP 1.0E 01
'4 1
]
r i
. CLINTON-I 2-15 Rev.0-4/85 I
~
e
, , - - , _ , , , ----------,,,.w-. , - - , - - - - , . . - - - - - . - - - - - - -
,e - - - , - - - - - - , . - - , ,- - . . - , _ ,
~
l CPS-ODCM TABLE 2.4-3 ADULT INGESTION DOSE FACTORS -DF i (mrem /pCi ingested)
NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI H 3 NO DATA 1.05E-07 1.05E-07 1.05E-07 1.05E-07 1.05E-07 1.05E-07 C 14 2.84E-06* 5.68E-07 5.68E-07 5.68E-07 5.68E-07 5.68E-07 5.68E-07 NA 24 1.70E-06 1.70E-06 1.70E-06 1.70E-06 1.70E-06 1.70E-06 1.70E-06 P 32 1.93E-04 1.20E-05 7.46E-06 NO DATA NO DATA NO DATA 2.17E-05 CR 51 NO DATA NO DATA 2.66E-09 1.59E-09 5.86E-10 3.53E-09 6.69E-07 MN 54 NO DATA 4.57E-06 8.72E-07 NO DATA 1.36E-06 NO DATA 1.40E-05 MN 56 NO DATA 1.15E-07 2.04E-08 NO DATA 1.46E-07 NO DATA 3.67E-06 FE 55 2.75E-06 1.90E-06 4.43E-07 NO DATA NO DATA 1.06E-06 1.09E-06 FE 59 4.34E-06 1.02E-05 3.91E-06 NO DATA NO DATA 2.85E-06 3.40E-05 CO 58 NO DATA 7.45E-07 1.67E-06 NO DATA NO DATA NO DATA 1.51E-05 CO 60 NO DATA 2.14E-06 4.72E-06 NO DATA NO DATA NO DATA 4.02E-05 NI 63 1.30E-04 9.01E-06 4.36E-06 NO DATA NO DATA NO DATA 1.88E-06 NI 65 5.28E-07 6.86E-08 3.13E-08 NO DATA - NO DATA NO DATA 1.74E-06 CU 64 NO DATA 8.33E-08 3.91E-08 NO DATA 2.10E-07 NO DATA 7.10E-06 ZN 65 4.84E-06 1.54E-05 6.96E-06 NO DATA 1.03E-05 NO DATA 9.70E-06 ZN 69 1.03E-08 1.97E-08 1.37E-09 NO DATA 1.28E-08 NO DATA 2.96E-09 BR 83 NO DATA NO DATA 4.02E-08 NO DATA NO DATA NO DATA 5.79E-08 BR 84 NO DATA NO DATA 5.21E-08 NO DATA NO DATA NO DATA 4.09E-13 BR 85 NO DATA NO DATA 2.14E-09 NO DATA NO DATA NO DATA LT E-24**
RB 86 NO DATA 2.11E-05 9.83E-06 NO DATA NO DATA NO DATA 4.16E-06 RB 88 NO DATA 6.05E-08 3.21E-08 NO DATA NO DATA NO DATA 8.36E-19 RB 89 NO DATA 4.01E-08 2.82E-08 NO DATA NO DATA NO DATA 2.33E-21 SR 89 3.08E-04 NO DATA 8.84E-06 NO DATA NO DATA NO DATA 4.94E-05 SR 90 7.58E-03 NO DATA 1.86E-03 NO DATA NO DATA NO DATA 2.19E-04 SR 91 5.67E-05 NO DATA 2.29E-07 NO DATA NO DATA NO DATA 2.70E-05 SR 92 2.15E-06 NO DATA 9.30E-08 NO DATA NO DATA NO DATA 4.26E-05 Y 90 9.62E-09 NO DATA 2.58E-10 NO DATA NO DATA NO DATA 1.02E-04 CLINTON-I 2-16 Rev.0-4/85
CPS-ODCM
,\
TABLE 2.4-3 (continued)
' ADULT INGESTION DOSE FACTORS - DF i
, (mram/pci ingested)
NUCLIDE BONE LIVER T. BODY THTROID KIDNEY LUNG GI-LLI Y 91a 9.09E-11 NO DATA 3.52E-12 NO DATA NO DATA NO DATA 2.67E-10
- Y 91 1.41E-07 NO DATA 3.77E-09 NO DATA NO DATA NO DATA 7.76E-05 Y 92 8.45E-10 NO DATA 2.47E-11 NO DATA NO DATA NO DATA 1.48E-05 Y '93 2.68E-09 NO DATA 7.40E-11 NO DATA NO DATA . NO DATA 8.50E-05 ZR 95 3.04E-08 9.75E-09 6.60E-09 NO DATA 1.53E-08 NO DATA 3.09E-05
) 1.05E-04 4
j ZR 97 1.68E-09 3.39E-10 1.55E-10 'NO DATA 5.12E-10 NO DATA M
NB 95 6.22E-09 3.46E-09 1.86E-09 NO DATA 3.42E-09 NO DATA 2.10E-05 MO 99 NO DATA 4.31E-06 8.20E-07 NO DATA 9.76E-06 NO DATA 9.99E-06 TC 99m 2.47E-10 6.98E-10 8.89E-09 NO DATA 1.06E-08 3.42E-10 4.13E-07 j
1 -
'E TC101 2.54E-10 3.66E-10 3.59E-09 NO DATA 6.59E-09 1.87E-10 1.10E-21 RU103 1.85E-07 NO DATA 7.97E-08 NO DATA 7.06E-07 NO DATA 2.16E-05 RU105 1.54E-08 NO DATA 6.08E-09 NO DATA 1.99E-07 NO DATA 9.42E-06
, 14 j3 RU106 2.75E-06 NO DATA 3.48E-07 NO DATA 5.31E-06 NO DATA 1.78E-04 7 AG110m 1.60E-07 1.48E-07 8.79E-08 NO DATA 2.91E-07 NO DATA 6.04E-05 l TE125m 2.68E-06 9.71E-07 3.59E-07 8.06E-07 1.09E-0.5 NO DATA 1.07E-05 TE127a 6.77E-05 2.42E-06 8.25E-07 1.73E-06 2.75E-05 NO DATA 2.27E-05 TE127 1.10E-07 3.95E-08 2.38E-08 8.15E-08 4.48E-07 NO DATA 8.68E-06 i TE129m 1.15E-05 4.29E-05 1.82E-05 3.95E-06 4.80E-05 NO DATA 5.79E-05
,d TE129 3.14E-08 1.18E-08 7.65E-09 2.41E-08 1.32E-07 NO D.ATA 2.37E-08 1.73E-06 8.46E-07 7.05E-07 1.34E-06 8.57E-06 NO DATA 8.40Z-05 1 TE131m 6.22E-09 1.62E-08 8.63E-08 NO DATA 2.79E-09
- 'd TE131 1.97E-08 8.23E-09 TE132 2.52E-06 1.63E-06 1.53E-06 1.80E-06 1.57E-05 NO DATA 7.71E-05 I 130 7.56E-07 2.23E-06 8.80E-07 1.89E-04 3.48E-06 NO DATA 1.92E-06 7" 1.95E-03 1.02E-05 NO DATA 1.57E-06 t1 I 131 4.16E-06 5.95E-06 3.41E-06 u
, .}
I 132 2.03E-07 5.43E-07 1.90E-07 1.90E-05 8.65E-07 NO DATA 1.02E-07 f.j 2.47E-05 7.53E-07 3.63E-04 4.31E-06 NO DATA 2.22E-06
- I 133 1.42E-06
-I 134 1.06E-07 2.88E-07 1.03E-07 4.99E-06 4.58E-07 NO DATA 2.51E-10 t
CLINTON-I 2-17 Rev.0-4/85
--+i=,ww -w-- e---- -
y- .-
-ry-e-w- v,v m---w- - - - ' - --
,9 7 e'----v---C------iy
CPS-0DCM TABLE 2.4-3 (continued)
ADULT INGESTION DOSE FACTORS - DF i (mrem /pCi ingested)
I NUCLIDE BONE LIVER T. BODY THYROID KIDNET LUNG GI-LLI I 135 4.43E-07 1.16E-06 4.28E-07 7.65E-05 1.86E-06 NO DATA 1.31E-06
~~'~
CS134 6.22E-05 1.48E-04 1.21E-04 NO DATA 4.79E-05 1.59E-05 2.59E-06 CS136 6.51E-06 2.57E-05 1.85E-05 NO DATA 1.43E-05 1.96E-06 2.92E-06 CS137 7.97E-05 1.09E-04 7.14E-05 NO DATA 3.70E-05 1.23E-05 2.11E-06 CS138 5.52E-08 1.09E-07 5.40E-08 NO DATA 8.01E-08 7.91E-09 4.65E-13 BA139 9.70E-08 6.91E-11 2.85E-09 NO DATA 6.46E-11 3.92E-11 1.72E-07 BA140 2.03E-05 2.55E-08 1.33E-06 NO DATA 8.67E-09 1.46E-08 4.18E-05 BA141 4.71E-08 3.56E-11 1.59E-09 NO DATA 3.31E-11 2.02E-11 2.22E-17 BA142 2.13E-08 2.19E-11 1.34E-09 NO DATA 1.85E-11 1.24E-11 3.00E-26 LA140 2.50E-09 1.26E-09 3.33E-10 NO DATA NO DATA NO DATA 9.25E-05 ,
LA142 1.28E-10 5.82E-11 1.45E-11 NO DATA NO DATA NO DATA 4.25E-07 CE141 9.36E-09 6.33E-09 7.18E-10 NO DATA 2.94E-09 NO DATA 2.42E-05 J
CE143 1.65E-09 1.22E-06 1.35E-10 NO DATA 5.37E-10 NO DATA 4.56E-05 CE144 4.88E-07 2.04E-07 2.62E-08 NO DATA 1.21E-07 NO DATA 1.65E-04 PR143 9.20E-09 3.69E-09 4.56E-10 NO DATA 2.13E-09 NO DATA 4.03E-05 PR144 3.01E-11 1.25E-11 1.53E-12 NO DATA 7.05E-12 NO DATA 4.33E-18 ND147 6.29E-09 7.27E-09 4.35E-10 NO DATA 4.25E-09 NO DATA 3.49E-05 W 187 1.03E-07 8.61E-08 3.01E-08 NO DATA NO DATA NO DATA 2.82E-05 i
NP239 1.19E-09 1.17E-10 6.45E-11 NO DATA 3.65E-10 NO DATA 2.40E-05
- 2.84 X 10-06
- Less than 10-24 l
1 c
CLINTON-I . 2-18 Rev.0-4/85
CPS-0DCM
- i s
FIGURE 2.5-1
, LIQUID RADWASTE TREATMENT SYSTEM T
- i % 1 .
L # -
i m ), r.
4 E ___ e OLE -
E e .
s o "
x
~ ~' a -
,. f W
W.=ss c=so a
.t1, -
~~~~~
="
J -
. , , ,4 Q s g Y e on D'k"3
'i
- l 1
1WF01S Floor Drain OWZO1P Chem. Wst. 2WF04T Floor Drain OWE 02TA,B, and C Waste Evaporator Evap. Tank Pump Evaporator Tank Samp. Tk Pumps 2WF01S Floor Drain OWE 01FA,B, and C OWZO1T Chem. Waste OWE 01TA and B Excess Evcporator Waste Filters Evaporator Tank Water Tanks OW201S Chemical OWE 01DA,B, and C IWF04P Fir. Drn. 0WE01PA and B Excess W:ste Evaporator Waste Demins Evap. Tank Pump Water Tank Pumps 1WF04T Floor Drain OWE 02TA B. and C 2WF04P Fir. Drn. IPR 036 Service Evrporator Tank Waste Sample Tks. Evap. Tank Pump Water PRM IPR 040 Liquid RW Discharge PRM CLINTON-I 2-19 Rev.0-4/85
. . > ..e. e- ... -+ w- - . .--. ..
CPS-0DCM 2.6 Doses From Liquid Effluent Pathways Methods for calculating radiation doses from potable water, aquatic food, shoreline deposits and. irrigated food pathways are presented in Appendix A of Regulatory Guide 1.109.
Equations (13) through (17) describe how doses from these pathways will be calculated.
Potable Water
~
M P ap (13)
R,p) = 1100 Q D,fpjexp(-ktp), mrem /yr Aquatic Foods M ('14 )
R,p) = 1100 U,p p QB 1 gpD,1p)exp(-ht p), t mrem /yr Shoreline Deposits U ap p N R,p) = 110,000 QTD,fp)(exp(-htp)]
tf t
(1-exp(kt)],b mrem /yr (15)
Irrigated Foods (excluding tritium)
V (16)
R,p) = U 'p dexp(-kth)D t ,g p3 r(1 - exp(-h tEi e)3 + I BIgy[1-eh(-hf,t) b
. Yy kt ,
i ,
animal '
+ U,p F D iA ,gpj Qp gdexp(-kt) h r(1 - exp(-hEi t,)] + f $yty[1 - exp(-ht t3)]
Yv Mi ' ih,
. 1 _
+ Cg,QAw 4 ****/7' Tritium (irrigated foods)
C gyD,p) (17)
R,p) = U a ), mrem /yr
+ U,nimalD,pj F A(CtyQp+C AwSAw p
.' CLINTON-I 2-20 Rev.0-4/85 f
. . - CPS-0DCM l 't I
where
> B = The equilibrium bioaccumulation factor for nuclide i
. fP in pathway p, expressed as the ratio of the
. concentration in biota, pCi/kg, to the nuclide concentration in water, pCi/ liter, liter /kg
- B = The concentration factor for uptake of radionuclide iv i from soil by edible parts of crops, pCi/kg (wet) per pCi/kg (dry soil)
C iA"
= The concentration of radionuclide i in water
}__ consumed by animals, pCi/ liter -
j C ty = The concentration of radionuclide i in vegetation
- species v, pCi/kg -
'I D,gPJ
= The dose factor specific to a given age group a,
'l) radionuclide i, pathway p and organ J. Used to calculate the dose from an intake of a radionuclide,
! mrem /pC1, or from exposure to a given concentration -
J' of a radionuclide in sediment, mrem /hr per pCi/m 2.
4
- dg = The deposition rate of radionuclide i from fi irrigation water, pCi/m2 per hour F = The flow rate of the liquid effluent, ft 3 /sec i
i f 7
= The fraction of the year crops are irrigated, j dimensionless
'i - F = The stable element transfer coefficient that relates iA
! the daily intake rate by an animal to the
! concentration in an edible portion of animal j product, pCi/ liter (milk) per pCi/ day or pCi/kg g (animal product) per pCi/ day I
M = The mixing ratio (reciprocal of the dilution factor) j P at the point of exposure (or the point of withdraual j of drinking water or point of harvest of aquatic j food), dimensionless
>l P = The effective " surface density" for soil, kg (dry c) . 1 soil)/m2 (Table E-1, Regulatory Guide 1.109) 1 Qg, = The consumption rate of contaminated water by an j animal, liters / day Qp
= The consumption rate of contaminated feed or forage by an animal, kg/ day (wet weight) t t
-l CLINTON-I 2-21 Rev.0-4/85 I
a ~ --- a ,m,e- ,- - ,,-,,,,- , ,n ,-- , ,- -
, _ , _ . - w -- - - , , , - - - - - - - - - ,
. . CPS-0DCM i
- \
'l = The release rate of nuclide i, Ci/yr
.i Qt 3
r = The fraction of deposited activity retained on 4 crops, dimensionless (Table E-15, Regulatory Guide
. 1.109)
R,Pj = The total annual dose to organ j of individuals of age group (a) from all of the radionuclides in pathway p, mrem /yr t = The period of time for which sediment or soil is b
- exposed ~to contaminated water, hours (Table E-15, 1 Regulatory Guide 1.109) t, = The time period that crops are exposed to contamination during the growing season, hours i (Table E-15, Regulatory Guide 1.109) t = A holdup time that represents the time interval
~
h between harvest and consumption of the food, hour
- (Table E-15, Regulatory Guide 1.109) -
.j Tg = The radioactive half-life of nuclide i, days
]
] t = The average transit time required for nuclides to P reach the point of exposure. For internal dose, t
.1
- J is the total time elapsed between release of the P
> nuclides and ingestion of food or water, hours
]: (Table E-15, Regulatory Guide 1.109)
- ' U,P = A usage factor that specifies the exposure time or
- intake rate for an individual of age group (a) i associated with pathway p, hr/yr, 1/yr, or kg/yr j (Table E-5, Regulatory Guide 1.109)
) W = The shoreline width factor, dimensionless (Table j_ A-2, Regulatory Guide 1.109)
}
t3 Yy = The agricultural productivity (yield), kg (wet weight)/m2 (Table E-15, Regulatory Guide 1.109) kE i constant for radionuclide i; =Theeffectiveremovalrat\E i from crops, 1/hr, where radioactive decay constant, kn
+ h ,h is the 23 tHe removal 1.
rate constant for physical loss weathering j (Regulatory Guide 1.109, Table B-15) k = The radioactive decay constant of nuclide i, hr-1 1100 = The factor to convert from (Ci/yr)/(ft 2 /sec) to pCi/ liter I
l CLINTON-I 2-22 Rev.0-4/85 3
CPS-ODCM 110,000= The factor co convert from (Ci/;'r)/(ft /sec) 3 to pCi/ liter and to account for the proportionality ccustant used in the sediment radioactivity model
. Table 2.6-1 lists input parameters used to calculate R,p3 values.
CLINTON-I 2-23 Rev.0-4/85
l ,
CPS-ODCM i is 1.
Table 2.6-1
, INPUT PARAMETERS FOR CALCULATING R,p) l Potable Water Lake Dilution =
Lake Transit Time =
Water Treatment / Delivery Time =
- Usage Factors
- Adult = liter /yr Teen =
j Child - Infant =
1
- 1 L Aquatic Food Lake Dilution =
.t-i Time to Consumption = -
'i I Usage Factors : Adult = kg/yr Teen =
- j Child = Infant = 0 kg/yr i
4 Shoreline Deposits 1
- Lake Dilution =
. s j Width Factor = 0.3 l Usage Factors : Adult = hr/yr Teen =
. Child = Infant =
1 4
4 Irrigated Foods
) 1 Lake Dilution =
=
Lake Transit Time 9
l 1
l CLINTON-I 2-24 Rev.0-4/85
._.,.-n-. __ _ . . - . y, ._. - . --
CPS-ODCM l
,j i l'
TABLE 2.6-1 (continued)
INPUT PARAMETERS FOR CALCULATING R,g Irrigated Foods Vegetables Milk Meat Leafy Vegetables Food Delivery Time Usage Factors:
Adult I
. .) Teen .
Child
- f. Infant l'
1 Irrigation Rate -
Annual Yield .
Annual Growing Period
- 4 Annual 50 Mile Production i
l J.
1 b
a 1
3
.4 e
1 o .
CLINTON-I 2-25 Rev.0-4/85 1
i
CPS-0DCM 3.0 GASEOUS EFFLUENTS 3.1 Introduction Gaseous effluents from CPS are released on both a batch and continuous basis. Examples of batch releases are'drywell purge and main condenser mechanical vacuum pump discharge. Building ventilation and off-gas treatment system flow are examples of continuous releases. Gaseous releases considered are both short and long term as well at ground and mixed-mode levels.
There are two gaseous effluent release points to the environment: the Common Station HVAC Stack and_the Standby Gas Treatment System (SGTS) Stack. The SGTS is an. Engineered Safety Feature filter system utilized following an accident to reuuce iodine and particulate activity in gases leaking from the primary containment and which are potentially present in the secondary containment. The Common Station HVAC Stack ("HVAC Stack") receives process and ventilation exhaust from the following inputs:
- 1) Continuous Containment Purge (CCP)
- 2) Containment Building. Ventilation
- 3) Turbine Building Ventilation
- 4) Radwaste Building Ventilation
- 5) Auxiliary Building Ventilation
- 6) Fuel Building Ventilation
- 7) Auxiliary Building Refrigerant Purge
- 8) Laboratory Ventilation System
. 9) Counting / Equipment Decon Rooms Ventilation
- 10) Steam Packing Exhauster
- 11) Mechanical Vacuum Pump
- 12) Drywell Purge The effluent exiting the SGTS stack is monitored at the SGTS stack and the combined inputs to the HVAC stack are monitored at the HVAC stack. All the inputs to the HVAC Stack, with the exception of input nos 7 through 11, can be monitored prior to entering the stack.
Figure 3.1-1 delineates the CPS site boundary. There are no unrestricted areas located within the site boundary and all activities within the CPS site boundary are controlled by Illinois Power Company (IPC).
CLINTON-I 3-1 Rev.0-4/85
CPS-ODCM
- 3.21 ' Gaseous' Effluent Release Point Monitoring 3.2.1 HVAC Stack Process Radiation Monitoring (PRM)
-System The HVAC Stack inputs are monitored for radioactivity prior to discharge to the environment by the HVAC Stack PRM.- The PRM detector configuration provides effluent monitoring using seven (7) channels as
, follows:
- 1) Beta scintillator for particulates
- 2) Alpha surface barrier detector to account for the radon / thoron contribution to the beta particulate measurement
- 3) Gamma scintillator for iodine
- 4) Iodine background subtraction
- 5) Beta scintillator for low range noble gas
- 6) Energy-compensated Geiger-Mueller (G-M) detector for high range noble gas
- 7) Energy-compensated G-M detector for gamma area subtraction This monitor has no control function but annunciates in the Main Control Room and the Radiation Protection Office where proper response actions will be initiated in accordance with CPS procedures.
3.2.2 SGTS Stack Process Radiation Monitoring (PRM)
System As discussed in section 3.1, the SGTS is used to reduce post-accident concentrations of radioactivity in the primary and secondary containment via filter trains. The SGTS Stack PRM monitors the gaseous effluent of the filter trains at the SGTS Stack prior to release to the environment. The PRM detector' configuration utilizes nine (9) channels as follows:
- 1) Beta scintillator for particulates
-CLINTON-I 3-2 Rev.0-4/85 L
t.
, CPS-0DCM l
L
- 12) Gamma scintillator for low range iodine L
- 3) De-sensitized gamma scintillator for high range iodine I. 4) Iodine background subtraction (low range)
- 5) Iodine background subtraction (high range)
- 6) Beta scintillator for low range noble gas
- 7) Energy-compensated G-M detector for intermediate range noble gas
- 8) Energy-compensated G-M detector for high.
range noble gas
- 9) Energy-compensated G-M detector for gamma area subtraction l This monitor has no control function but I
annunciates in the Main Control Room and the Radiation Protection Office where proper response actions will be initiated in accordance with CPS procedures.
3.3 Main Condenser Off-Gas Monitoring System 3.3.1 Pre-Treatment Air Ejector Off-Gas Process Radiation Monitor (PRM)
The Pre-Treatment Off-Gas PRM monitors the discharge of either of the two steam jet air ejectors (SJAEs) or the H2/02 recombiners for gross noble gas radioactivity. This effluent is then routed to the charcoal adsorbers for eventual release to the environment via the station
, HVAC Stack. The PRM detector configuration consists of a single energy-compensated G-M detector mounted in a gas volume.
The monitor has no control function but annunciates in the Main Control Room and the Radiation Protection Office where proper response actions will be initiated in j accordance with CPS procedures.
i CLINTON-I 3-3 Rev.0-4/85 l
c.
CPS-0DCM 3.3.2 Post-Treatment Air-Ejector Off-Gas Process Radiation Monitor (PRM)
The Post-Treatment Off-Gas PRM monitors the gaseous radioactivity at upstream,
, intermediate or downstream sections of the charcoal adsorber beds prior to the effluent entering the station HVAC Stack for release to the environment. The PRM detector configuration is as described for the HVAC Stack PRM (section 3.2.1).
The monitor has two control functions.
Upon detection of noble gas activity in excess of the ALERT setpoint, the charcoal adsorber bypass valves shut (if in the charcoal bypass mode) and the off-gas is routed through the adsorbers.
Should noble gas activit'y exceed the HIGH setpoint, the off-gas system is automatically isolated from the HVAC Stack and a reactor {
scram subsequently occurs.
The Main Condenser Off-Gas Treatment System is shown in Figure 3.3-1.
3.4 10CFR20 Release Rate Limits Limits for release of airborne effluents to the j unrestricted area are stated in CPS RETS 3.11.2.1.
The dose rate in unrestricted areas due to radioactive materials released in gaseous effluents from the site shall be limited to the following values:
(a) Noble Gases - 2 500 mrem / year to the total body and 23000 mrem / year to the skin (b) aat ) iodines, di .Lculates anc' Tritium - 21500 mrem / year to any organ
~ *" CLINTON-I 3-4 Rev.0-4/85 r . i - -
CPS-ODCM
.\
3.4.1 Dose Rate Due To Noble Gases f
l In order to comply with CPS RETS 3.11.2.l(a),
.. % the dose rate at or beyond the site boundary i
due to noble gases shall be calculated as follows:
D t" Ei I(XIN)m9 im + IXIk)gS igI (l)
= total body dose rate at time of release, mrem / year j D, d (L g +1.IM g )g ((YTQ),Qg,+(M)gQgg )] (2)
.i = skin dose rate at time of j release, mram/ year The terms in the above equations are defined i; in section 3 . 4. . 2
.i 3.4.2 Dose Rate Due To Radiciodines, Particulates l4 and Tritium .
In order to comply with CPS RETS
- 3.ll.2.l(b), organ dose rates due to i radioiodines (I-131, I-133), partic~ulates 4 with half-lives =8 days and tritium shall i be calculated as follows:
D o =kP(Wk,+Wk) g ,t g tg (3) i = organ dose rate at time of
- j. rel, ease, mram/yr j t The terms used in equations (1) through (3) are defined as follows:
b
- K g- The total body dose factor due to
. gamma emissions for each identified noble gas radionuclide i, mrem /yr per KCi/m3
'l L g= The skin dose factor due to beta emissions for each identified noble gas radionuclide i, mrem /yr pergCi/m3 k Mg= The air dose factor due to gamma emissions for each identified noble gas radionuclide i, mrem /yr per#C1/m3 (1.1 mrem / mrad converts air dose to skin dose)
I i CLINTON-I 3-5 Rev.0-4/85 N
WM Gi'4 *h W.44D e- 6 w Je ..ee % we ap4.gge . -mg,
CPS-ODCM Pg= The dose factor for non-noble gas radionuclide i which includes pathway transport parameters, receptor usage. factors and the dosimetry of the exposure. The dose factors for inhalation, mrem /yr per 1/m3, and food / ground lane, m2-mrem /yr per fjCi/sec, pat ays are listed in Table 3.4-2 (infant). Dose factors are based on NUREG-0133, Section 5.2.1 assumptions unless otherwise stated.
Q im = The release rate of noble gas radionuclide i in gaseous effluent from mixed-mode release points,fjC1/sec Q = .The release rate of noble gas 18 radionuclide i in gaseous effluent from ground level releasepoints,pC1/sec Q ig = The release rate of non-noble gas radionuclide i in gaseous effluent from ground level releasepoints,pCi/sec Q,= The release rate of non-noble gas t radionuclide i in gaseous effluent from mixed-mode release points,pCi/sec
. (%7Q)* = The highest calculated annual average relative concentration for any area at or beyond the site boundary from mixed-mode releases, sec/m3 (K7Q)8 = average The highest calculated relative annual concentration for any area at or beyond the site boundary from ground level releases, sec/m3 CLINTON-I 3-6 Rev.0-4/85
CPS-0DCM i
W" = The controlling sector annual average dispersion parameter from ,
mixed-mode releases at the site '
boundary for the appropriate pathway ,
- X74, sec/m2, for inhalation I
- D74, m 2 , for food and ground -
plane W = The controlling sector annual i E average dispersion parameter from ground level ~ releases at the site boundary for the appropriate pathway.
=. Y7Q, sec/m3, for inhalation
- D74, m *, for food and ground plane ,
The factors K , L , and M relate the radionuclidekirbbrneconbentrationsto various dose rates assuming a semi-infinite cloud. These factors are listed Table 3.4-1 and were obtained from Table B-1 of Regulatory Guide 1.109 after mugtiplying the values 17 0 the conversion 10 pCi/jci.
The distances from CPS to controlling locations in the unrestricted area are listed in Table 3.4-3. The X/Q and D/Q values listed in Table 3.4-4 reflect acquired meteorological data for the period May 1972 through April 1977:
subsequent reports will utilize updated X/Q and D/Q averages.
CLINTON-I 3-7 Rev.0-4/85
~
, '_ s_. _~w -u 1. -
us.a:2_ a. ;. i.,, , x.: .~_w.w. uz ; . c.wu ~ '- -
L l.. -.
o*
-; u m. ?
h O-H M h b TABLE 3.4-1 H
!l DOSE FACTORS FOR NOBLE CASES AND DAUGHTERS
- Total Body Gamma Air Beta Air Dose Factor Skin Dose Factor Dose Factor Dose Factor Radionuclide i i i i (arem/yrpergCi/m') (area /yrperyC1/m') (mrad /yr pergCi/m') (arad/yrpergCi/m')
Kr-85m 1.17E+03 1.46E+03 1.23E+03 1.97E+03 Kr-85 1.61E+01 1.34E+03 1.72E+01 1.95E+03 Kr-87 5.92E+03 9.73E+03 6.17E+03 1.03E+04 Kr-88 1.47E+04 2.37E+03 ' 1.52E+04 2.93E+03 Kr-89 1.66E+04 1.01E+04 1.73E+04 1.06E+04 ta g Kr-90 1.56E+04 7.29E+03 1.63E+04 7.83E+03 Xe-131m 9.15E+01 4.76E+02 1.56E+02 1.llE+03 Xe-133m 2.51E+02 9.94E+02 3.27E+02 1.48E+03 Xe-133 2.94E+02 3.06E+02 3.53E+02 1.05E+03 Xe-135m 3.12E+03 7.llE+02 3.36E+03 7.39E+02 Xe-135 1.81E+03 1.86E+03 1.92E+03 2.46E+03 4
Xe-137 1.42E+03 1.22E+04 1.51E+03 1.27E+04
[ Xe-138 8.83E+03 4.13E+03 9.21E+03 4.75E+03 Ar-41 8.84E+03 2.69E+03 9.30E+03 3.28E+03
?
m t (J1
- The listed dose factors are for radionuclides that may be detected in gaseous effluents.
CPS-ODCM.
~
TABLE 3.4-2 PATHWAY DOSE FACTORS (INFANT) -P g Pf (Ground Plane)
Pg (Inhalation) (m2 mrem /yr per pCi/sec) P1/yr(Food)
Isotope (arem/yr per UC1/m3 ) Total Body Skin (m2 mrem per pCi/m3 )
sH-3. 6.47E+02 0.0 0.0 2.38E+03*
4 C-14 2.65E+04** 0.0 0.0 2.34E+09 NA-24~ 1.06E+04 1.71E+07 1.98E+07 1.56E+07 P-32; 2.03E+06 0.0 0.0 1.60E+11
, CR-51 1.28E+04 6.64E+06 7.85E+06 4.70E+06 MN-54 l'00E+06
. 1.10E+09 1.29E+09 3.90E+07 MN-56 .7.17E+04 1.29E+06 1.52E+06 2.86E+00 4 . FE-55 8.69E+04 - 0.0 0.0 1.35E+08 FE-59 '1.02E+06 3.88E+08 4.56E+08 3.92E+08 CO-58. 7.77E+05 5.27E+08 6.18E+08 6.06E+07 CO-60 4.51E+06 4.40E+09 5.17E+09 2.10E+08 NI-63 3.39E+05 0.0 0.0 3.50E+10 NI-65 5.01E+04 4.24E+05 4.93E+05 3.03E+01 CU-64 -1.50E+04 8.64E+05 8.64E+05 3.78E+06 ZN 6.47E+05 6.88E+08 7.91E+08 1.91E+10 ZN-69 1.32E+04 0.0 0.0 2.85E-09 BR-83 3.81E+02- 6.96E+03 1.01E+04 NO DATA BR-84 4.00E+02 2.90E+05 3.38E+05 NO DATA
- - BR-85 2.04E+01 0.0 0.0 NO DATA
, RB 1.90E+05 1.28E+07 1.47E+07 2.23E+10 RB-88 5.57E+02 4.72E+04 5.40E+04 1.88E-44 l
RB-89 3.21E+02 1.76E+05 2.11E+05 3.42E-52 SR-89 2.03E+06 3.06E+04 3.56E+04 1.26E+10 SR-90 4.09E+07 NO DATA N0' DATA 1.22E+11
-SR-91 7.34E+04 3.06E+06 3.58E+06 3.20E+05 SR-92 1.40E+05 1.11E+06 1.23E+06 5.06E+01 Y-90 2.69E+05 6.42E+03 7.59E+03 1.58E+06 Y-91m 2.79E+03 1.43E+05 1.66E+05 2.03E-15 1
i Y-91 2.4 5E+06 1.51E+06 1.70E+06 5.26E+06
'Y-92 1.27E+05 2.58E+05 3.06E+05 1.02E+01
, .Y-93 1.67E+05 2.61E+05 3.58E+05 1.69E+04 ZR-95 1.75E+06 3.44E+08 3.98E+08 8.27E-05 i ZR-97 1.4 0E+05 4.23E+06 4.92E+06 4.44E+04 NB-95 4.79E+05 5.42E+06 6.38E+06 4.70E+06 MO-99 1.35E+05 5.70E+06 6.60E+06 3.11E+08
, TC-99m 2.03E+03 2.63E+05 3.01E+05 1.64E+04 TC-101- 8.44E+02 2.90E+04 3.23E+04 4.89E-57 RU-103 5.52E+05 1.54E+08 1.80E+08 1.06E+05 RU-105 4.84E+04 9.08E+05 1.03E+06 3.18E+00 l' RU-106 1.16E+07 2.99E+08 3.59E+08 1.45E+06 l' AG-110m 3.67E+06 3.12E+09 3.64E+09 1.46E+10
~ TE-125m 4.47E+05 2.19E+06 3.01E+06 1.51E+08 r
5 CLINTON-I 3-9 Rev.0-4/85 4
e
.--~t . . - , e . . . ~ . - .-,-.-r ,,-_,--_,...+-.--,-.m . . - ,...- - , . _ , - . , -
CPS-0DCM TABLE 3.4-2 (continued)
PATHWAY DOSE FACTORS (INFANT) - Pi Pg (Ground Plane)
(m2 mrem /yr per pCi/sec) P (Food)
Isotope Pf (Inhalation)
(mrem /yr per ICi/m 3) Total Body Skin (m2 mrem /yr per uCi/m8 )
TE-127m 1.31E+06 1.18E+05 1.39E+05 4.22E+08 TE-127 2.44E+04 4.27E+03 4.70E+03 1.35E+05 TE-129n 1.68E+06 2.82E+07 3.30E+07 1.39E+09 TE-129 2.63E+04 3.77E+04 4.46E+04 2.59E-07 TE-131m 1.99E+05 1.15E+07 1.35E+07 2.29E+07 TE-131 8.22E+03 4.17E+04 4.93E+07 1.41E-30 TE-132 3.40E+05 6.05E+06 7.12E+06 6.55E+07 I-130 1.60E+06 7.86E+06 9.55E+06 8.72E+08 I-131 1.48E+07 2.46E+07 2.98E+07 1.05E+12 1-132 1.65E+05 1.78E+06 2.09E+06 1.36E+02 I-133 3.56E+06 3.50E+06 4.26E+06 9.60E-09 I-134 4.45E+04 6.37E+05 7.57E+05 7.88E+10 1-135 6.96E+05 3.61E+06 4.21E+06 2.02E+07 CS-134 7.03E+05 2.82E+09 3.28E+09 6.81E+10 CS-136 1.34E+05 2.15E+08 2.44E+08 5.82E+09 CS-137 6.12E+05 1.14E+09 1.34E+09 6.03E+10
'CS-138 8.76E+02 5.12E+05 5.86E+05 1.16E+08 BA-139 5.10E+04 1.51E+05 1.70E+05 2.72E-05 BA-140 1.60E+06 2.93E+07 3.35E+07 2.40E+08 BA-141 4.75E+03 5.96E+04 6.79E+04 5.08E-44 BA-142 1.55E+03 6.41E+04 7.30E+04 9.53E-79 LA-140 1.68E+05 2.74E+07 3.11E+07 1.88E+05 LA-142 5.95E+04 1.08E+06 1.30E+06 1.08E-05 CE-141 5.17E+05 1.95E+07 2.20E+07 1.37E+07 CE-143 1.16E+05 3.30E+06 3.76E+06 1.54E+06 CE-144 9.84E+06 5.85E+07 3.76E+07 1.34E+08 PR-143 4.33E+05 0.0 0.0 7.84E+05 PR-144 4.28E+03 2.62E+03 3.02E+03 1.13E-48 ND-147 3.22E+05 1.20E+07 1.44E+07 5.74E+05 W-187 3.96E+04 3.36E+06 3.90E+06 2.49E+06 NP-239 5.95E+04 2.44E+06 2.82E+06 9.43E+04 mrem /yr per LCi/m 2.65 X 10+04 CLINTON-I 3-10 Rev.0-4/85
. - . - - - - . . . - +
m CPS-ODCM TABLE 3.4-3 DISTANCES TO CONTROLLING LOCATIONS
- Location . Distance (mile / meter). Sector Comments
. Site Boundary - 0.66/1066 NE
-Inhalation pathway 0.66/1066 NE Food and Ground i .. -
Plane Exposure Pathway _ 0.5/805 E Grass-Cow-Milk 3.5/5633 SW Cows present but are not milke'd Grass-Coat-Milk- 2.0/3219 W Goats present but are not' milked Nearest Residence- - 0.76/1223 SW continually occupied Nearest Residence. 0.72/1159 NW IPC Visitor's Center
' Nearest Meat' Animal 1.0/1609 N Nearest Potential-
. Potable Water Pathway 3.4/5472 E Flume Discharge into lake Clinton f
Shoreline Recreation 2.2/3541 SE Mascoutin. Recreational Beach and Swimming J
V a
- As measured from the HVAC stack. Selection of location sector is based on the
' highest annual average X/Q values.
'CLINTON-I 3-11 Rev.0-4/85 O
- - - , - ,,-,,,n nr.-n,,,n--- . , - ~ ~ - - - .,--r-,--- - - - , - - - , , - , - - - , . - - - - - , . , , - ~ - - + - - , - ,
~
CPS-0DCM TABLE 3.4-4 SITE BOUNDARY METEOROLOGICAL DISPERSION PARAMETERS Sector Distance (mile / meter) %77 (sec/m3) D77 (m 2)
N 0.71/1142 8.4 E-6* 2.8 E-09 NNE 0.81/1303 8.3 E-6 2.6 E-09 NE 0.66/1062 1.1 E-5 3.3 E-09 ENE 0.73/1174 5.4 E-6 2.4 E-09
_E 0.71/1142 5.1 E-6 3.2 E-09 ESE 0.78/1255 3.5 E-6 2.9 E SE 0.66/1062 5.6 E-6 2.6 E-09 1
SSE 0.57/917 6.4 E-6 2.3 E-09 S 0.55/885 5.6 E-6 2.1 E-09 SSW 0.58/933 7.0 E-6 - 2.0 E-09 SW 0.67/1078 6.7 E-6 2.0 E-09 l
WSW 0.66/1062 9.8 E-6 1.4 E-09 W 0.66/1062 5.8 E-6 1.4 E-09 WNW 0.61/981 7.3 E-6 1.4 E-09 NW 0.61/981 7.2 E-6 1.7 E-09 NNW 0.61/981 7.9 E-6 2.4 E-09
- 8.4 X 10-06 CLINTON-I 3-12 Rev.0-4/85
CPS-0DCM 3.5 10CFR50, APPENDIX I RELEASE RATE LIMITS The requirements pertaining to 10CFR50 gaseous release rate limits are stated in CPS RETS 3.11.2.2 and 2.11.2.3. CPS RETS 3.11.2.2 requires that the air dose at or beyond the site boundary, due to noble gases, shall be limited to the following:
(a) During any calendar quarter, 55 mrad
.(gamma) and510 mrad (beta) and, (b) During any calendar year,210 mrad (gamma) and 220 mrad (beta).
CPS RETS 3.11.2.3 requires that the dose to an individual at or beyond the site boundary, due to radiciodines (I-131, I-133), tritium and all particulates with half-lives >8 days , shall be limited to the following:
(a) During any calendar quarter, 5 7.5 mrem to any organ and, (b) During any calendar year, 2 15 mrem to any organ.
3.5.1 Noble Gas Air Dose The air dose at or beyond the site boundary due to noble gases released in gaseous effluent will be determined using the following equations.
3.5.1.1 During any calendar quarter or calendar year, for gamma radiation:
D = 3.17 x 10-8 { My [(ITQ) ,Q 1 ,+
(4)
(x/q ,)qt,+ M Qg tg + (x/q)g 1g] q 3.5.1.2 During any calendar quarter or calendar year, for beta radiation:
D =3.17x10-8{Ng(M),Q,+ t (x/q) ,qt ,+ ( M )gQ tg + (x/q)gqfg] (5)
Where M
1
= The gamma air dose factor for each identified noble gas radionuclide i, mrad / year per yCi/m3 (M t values are listed in Table 3.4-1).
CLINTON-I 3-13 Rev.0-4/85
" ~
1 CPS-ODCM Ng= The beta air dose factor for each )
identified noble gas radionuclide l 1, mrad / year per mci /m3 (N g l values are listed in Table 3.4-1).
(K74)" = The highest calculated annual average relative concentration from mixed-mode release points for areas at or beyond the site boundary for long-term 0=500 hrs /yr) releases.
(x/q)* = The relative concentration from mixed-mode release points for areas at or beyond the site boundary for short-term (5500 hrs /yr) releases.
Qg, = The average release of noble gas radionuclide i for long-term releases from mixed-mode release points, UC1. Releases shall be cumulative over the calendar quarter or year, as appropriate.
qt*
= The average release of noble gas radionuclide i for short-term releases from mixed-mode release points, mci. Releases shall be cumulative over the calendar quarter or year, as appropriate.
(Z7Q)8 = average The highest calculated annual relative concentration
~
from ground level release points for areas at or beyond the site boundary for long-term 0-500 hr/yr) releases.
(x/q)8 - The relative concentration from ground level release points for areas at or beyond the site boundary for short-term c5500 hr/yr) releases.
CLINTON-I 3-14 Rev.0-4/85
1 CPS-ODCM if \
e ,? -
i i Q = The average release of noble gas
, l-_
t8 radionuclide i for long-term releases from ground level
.% release points,ptC1. Releases 4 -
shall be cumulative over the t calendar quarter or year, as appropriate.
l qf8
= The average release of noble gas radionuclide i for short-term
- releases from mixed-mode release ,
( points, $ 1. Releases shall be L1 .
cumulative over,the calendar j quarter or year, as appropriate.
i 4-
~ i- 3.17 x 10-8= The inverse of the number of seconds in a
{j year.
I F 3.5.2 Radiciodines, Particulates and Tritium Dose i *
,j -
The dose to an individual at or beyond the j site boundary due to radioiodines (I-131, -
- , I-133), tritium and particulates with i half-lives >8 days, will be determined j using the following equation
I j for any calendar quarter or calendar year, t
- j D p =3.17x10~81kRg(W,kg,+w,kg, (6) i + WQg ig + W qig}
4 g
j where
<a
Q*=i The releases of radionuclide i (I-131, I-133, tritium and particulates) for long-term (=500
) hrs /yr) releases from mixed-mode 1' release points,/JCi. Releases shall be cumulative over the
- j calendar quarter or year, as appropriate.
l .
1 qt* = The releases of radionuclide L
,i particulates) for short-term (5500 hrs /yr) releases from
', mixed-mode release points,4LCi.
'1 Releases shall be cumulative over i the calendar quarter or year, as ';
. appropriate.
il ,
i CLINTON-I 3-15 Rev.0-4/85 k
k s .m. --s- .- ~ . .ow-m . .... n, . . . .
m'wm---- -- y-+- - gr g-wr,giM-.-y-.w m.- y ,weg- - w e-p w_ _w9,-m.g vq q,- g-qm vig w w +< --g-N t wq,,.e,----e- w-- - , .
CPS-0DCM
]'g b .
Q = The releases of radionuclide i 18 (I-131, I-133, tritium and i
particulates) for long-term (>500 hrs /yr) releases from ground level release points, Lici.
Releases shall be cumdlative over the calendar quarter or year, as appropriate.
q18
= The release of radionuclide i j (I-131, I-133, tritium and
- j. particulates) for short-term j
c5500 hrs /yr) releass from ground t level release points, LIC1.
Releases shall be cumdlative over
]i the calendar quarter or year, as appropriate.
]
W* = The dispersion parameter for i estimating the dose to an individual at a controlling f location for long-term mixed-mode i releases.
i = (ITQ) , sec/m3, for the j .
inha19 tion pathway (F/Q) m , for the food and grounE, plane, pathways i
w
- The dispersion parameter for estimating the dose to an individual at a controlling j.
4 location for short-term i- mixed-mode releases.
}
= (x/q) ,
sec/m3, for the inhalftion pathway
= (D/q) m
- for the food and grounE, plane pathways W = The dispersion parameter for 8 estimating the dose to an individual at a controlling location for long-term ground level releases.
(%7Q) , sec/m 2 , for the inhalftion pathway
~2
=
(D7Q) m , for the food and ground, plane pathways
- 4 f 0 1
CLINTON-I 3-16 Rev.0-4/85
-CPS-0DCM
!k i
I w = The dispersion parameter for i ^ 8 estimating the dose to an individual at a controlling
.." location for short-term ground level releases.
= (x/q) , sec/m3 for the inhalItion pathway
= (D/q) m' , for the food and grounE, plane pathways 3.17 x 10-8 = The inverse of the number of seconds in a year.
- l. Rg = The dose factor for each
- identified radionuclide i, m2-mrem / year perf.ici/sec or mrem / year per pCi/m3 3.5.2.1 Dose Factor For Radionuclide 1 (R f)
The R val in
,! equatkon(uesusedtocalculateDare
- 6) determined separR
! each of the potential exposure pathways, i namely:
t I
}
("
- Inhalation (I)
- Ground Plane Contamination (G) i
- Grass-Cow / Goat-Milk (C) t
- Grass-Cow-Meat (M)
!
- Vegetation (V)
I i CPS RETS 3.11.2.3 is apslicable to the location at or beyond c2e site boundary l
- where the combination of existing pathways and receptor age groups indicates the maximum potential exposure. The
. inhalation and ground plane 'xposure
.l pathways exist at all loca -
3: other 1 pathways exist as determine by the most current land use census.
The R parameter is independent of the duratkonofgaseousreleasesandis calculated using the methodology discussed below.
o CLINTON-I 3-17 Rev.0-4/85 i
i
- e CPS-0DCM 3.5.2.1.1 Calculation of the Inhalation PathwayFactor,Rf Rf=K'(BR),(DFA),,t mrem /yearperpC1/m3 where K' = A units conversion constant, 10 6 pCi/pCi The breathing rate of the (BR) a= receptor age group (a), m3/ year.
= 1400 (infant)
= 3700 (child)
= 8000 (teen and adult)
Values for (BR),obtained from NUREG-0133, p.32.
(DFAt )a= The maximum organ inhalation dose factor for receptor of age group (a) for radionuclide i, mrem /pC1.
The total body is considered as an organ in the selection of (DFA Values for (DFA ) were obtakn)IdfromTablesE-7bhfough E-10 of Regulatory Guide 1.109
. and are presented in Tables 3.5-1 through 3.5-4 of this Manual.
3.5.2.1.2 Calculation of the Ground Plane Pathway Factor, RO U
Rf = . K'K" (SF) (DFG4 ) (1-e-ki)/ht(,8) m2-mrem /yearparpCi/sec where i 6
K' = A units conversion constant, 10 pCi/yCi K" = A units conversion constant, 8760 hour0.101 days <br />2.433 hours <br />0.0145 weeks <br />0.00333 months <br /> / year SF = The shielding factor, dimensionless
= 0.7 as suggested in Table E-15 of Regulatory Guide 1.109 CLINTON-I 3-18 Rev.0-4/85 d
\
CPS-0DCM DFGt= The ground plane dose conversion factor for radionuclide 1, mrem / hour per pC1/m2 Values for DFG were obtained from Table E-6 of kegulatory Guide 1.109 and are presented in Table 3.5-5 of this Manual.
k= The decay constant fgr radionuclide i, see t= The exposure time, sec
= 4.73 x 10 8 see (15 years) 3.5.2.1.3 Calculation of The Grass-Cow / Goat-Milk Pathway Factor. R C IU so (9)
Rf=K'9F F ,(r) (DFLt ),
,. Ai + Aw -
ff s+(1-f,f,)e-kt h e kCf,
~
p Y Y,
.p _
m2-mrem /yr perf,4Ci/sec ;
where ,
K' = A units conversion constant, 10 0 PCi/pci Q=F ne cow / goat feed consumption rate, kg(wet)/ day U
ap
= The receptor's milk consumption rate for age group (a),
liters / year Y = The agricultural productivity by P unit area of pasture feed grass, kg/m2 F" = The stable element transfer coefficients, days /litar r= Fraction of deposited activity retained on feed grass, dimensionless CLINTON-I 3-19 Rev.0-4/85
CPS-0DCM
! (DFL t ),= The maximum organ ingestion dose factor for radionuclide i and the receptor in age group (a),
mrem /pC1. Values for (DFL wereobtainedfromTablesb)fl -
through E-14 of Regulatory Guide 1.109 and are presented in Table 3.5-6 through 3.5-9 of this Manual.
k=g The deca constant f radionuc ide i, sec~gr h" = The decay constant for removal of activity on leaf and plant _y surfaces by weathering, sec
5.73 x 10~7 sec ~1 (corresponding to a 14-day ha~1f-time) t
f The transp' ort time from pasture to animal, to milk, to receptor, see th= The transport time from pasture to harvest, to animal, to receptor, sec f = Fraction of the year that the P cow / goat is on pasture, dimensionless f = Fraction of the cow / goat feed a that is pasture grass while the cow / goat is on pasture, dimensionless The input pargmeters for calculating R are listed in Table 3.5-10.1 Tritium The concentration of tritium in milk is based on its airborne concentration rather than the deposition.
Rh= K'K"F,Qp U ,p(DFL t ),[0.75(0.5/H)],
mrem /yrperf.4Ci/m3 (10) l CLINTON-I 3-20 Rev.0-4/85 l
l
CPS-0DCM e
where i K" = A units conversion constant, 10 3 gm/kg L
H = The absolute atmospheric
- f. :
humidity f
= 8 gm/m3 (NUREG-0133, p. 34)
(_ 0 . '7 5 = The fraction of total feed'that
'- is water, dimensionless 0.5 = The ratio of the specific activity of the feed grass water to the atmospheric water, dimensionless 1.
I The other paramegers are as defined in the calculation of R t.
l 3.5.2.1.4 Calculation of The Grass-Cow-Meat Pathway Factor. R Rf=K_'SIUap)
F Ff (r)(DFLt ), + (1~fpsf ) e
~
h I
Ai %w
- p s (e~kUf],m2-mrem"/yrperKCf./sec (11) l where t
l K' =
A gnits conversion constant, 10 pCi/yCi l
U = tion ap The ratereceptor's meat consump/
for age group (a), kg year l Ff= The stable element transfer
! coefficient, days /kg L
cf= The transport time from pasture to receptor, seconds th- The transport time from crop field to receptor, seconds l.
I CLINTON-I 3-21 Rev.0-4/85 l
l
CPS-0DCM
. (DFL t ),= The maximum organ ingestion dose factor for radionuclide i and the receptor in age group (a), mrem per pCi. Values are tabulated in Table 3.5-6 through 3.5-9 of this Manual.
The input par eters necessary for calculating are listed in Table 3.5-11.
All other te s are as defined for equations (9) and (10).
Tritium:
The concentration of tritium in meat is based on its airborne concentration rather than the deposition.
Ry = K'K"Ft QpU ,p(DFL t ), (0.75(0.5/H)] , mrem /yr per pCi/m3 (12)
The terms in equation (12) are as defined in equations -
(10) and (11).
3.5.2.1.5 CalculationoftheVegetationPathwayFactor,RY b
R{=K' I")
(DFLt )* U,fe-kiL+U,fe~kih g
U S 8
t l Yy k +hy) ~ ~
(13)
' ~
m2-mrem /yrperpCi/sec where K' = A gnits conversion constant, 10 pCi/gCi U=b The consumption rate of fresh a leafy vegetation by the receptor in age group (a), kg/yr U S= The consumption rate of stored a the receptor.in age vegetation group (a), kg by/yr fg = The fraction of the annual intake of fresh leafy vegetation grown locally, dimensionless f= The fraction of the annual intake 8 of stored vegetation grown l
locally, dimensionless CLINTON-I 3-22 Rev.0-4/85 l
L
JCPS-0DCM tg= The average time between harvest of leafy vegetation and its consumption, seconds t=
h The average time between harvest of stored vegetation and its consumption, seconds Y
V
= The vegetation areal density, kg/m2 (DFLg )a= The maximum organ ingestion dose factor for radionuclide i and the receptor in age group (a), mrem per pCi. Values are tabulated in Table 3.5-6 through 3.5-9 of this Manual.
The input par eters necessary fer calculating R are listed in Table 3.5-12.
All other ce s are as defined for equations (9) through (12).
Tritium:
The concentration of tritium in vegetation is based on its airborne concentration rather than the deposition.
L 8 Rf=K'K"(U,fL + Ua fg) (DFLg ),(0.75(0.5/H)] , mrem /yr perjuC1/m3 (14) <
The terms in equation (14) are as defined for equations (10) and (13).
N Y The pathway dose rate factors (R I
, GR , R C
, R , R ), by agegroup,arelistedinTable3f5-1fthfougk3.$-16.
3.6 Compliance With CPS-RETS 3.11.2.4 CPS RETS 3.11.2.4 requires that the Offgas Treatment System shall not be used in the charcoal bypass mode unless the Post-Treatment Air Ejector Offgas radiation monitor is operable per CPS RETS 3.3.7.12. Prior to alacing the Offgas Treatment System in the charcoal sylass mode, the alarm setpoints for the Station HVAC Ex2aust and the Post-Treatment Offgas radiation monitors shall be calculated to account for the increased fractions of short-lived noble gases. The noble gas release fractions shall be based either on actual measured values or on design basis noble gas concentration fractions (at t = 30 min) in the primary coolant offgas.
l
! CLINTON-I 3-23 Rev.0-4/85 i
CPS-ODCM i
4 o
3.7 Effluent Monitor Setpoint Calculations Gaseous effluent Process Radiation Monitor (PRM) alarm setpoints shall be calculated to ensure that the dose '
4 rate in unrestricted areas due to noble gases released do not exceed 500 mrem / year to the total body and 3000
!. mrem / year to the skin. The initial setpoints will be calculated using the BWR-GALE code radionuclide mix obtained for CPS: once CPS becomes operational,.the actual radionuclide mix will be used.- The PRM setpoints are based on the instantaneous noble gas dose rates and are applied at the point of which the
- effluent leaves the site boundary into an unrestricted area. Further, the bases for each setpoint consider the type of release at the PRM location (long or.short term using the appropriate atmospheric dispersion >
conditions).
Both total body and skin dose setpoints will be calculated and the more restrictive limit applied to the respective PRM. The actual setpoint used may be lower than the restrictive limit since the two release points will be partitioned such that their sum does not exceed 100 percent of the restrictive limit. The percentages used to partition the release points could vary at plant discretion to accommodate plant i'
4 operational conditions. In no case will the combined releases due to variations in the PRM setpoints result in RETS limits being exceeded.
3.7.1 Total Body Dose Rate Setpoint i ,
l The fraction of the total gaseous radioactivity in each gaseous effluent release path-j for each noble gas a i radionuclide i shall be determined,using the following relationship:
C ij
, dimensionless f)=
t (ij l where C
ij
= The measured concentration of identified noble gas radionuclide i in gaseous effluent release
. path j , QCi/cc The maximum acceptable release rate of all noble gases in release path j to comply with CPS RETS 3.11.2.1 is calculated by using the equation:
Fj l Q 500 ,pCi/sec 1 Tj=(X/Q)j{(Kgt))
F i
!- CLINTON-I 3-24 Rev.0-4/85
CPS-0DCM where '
Q = The maximum acceptable release Td rate of all noble gases in releasepathj,gCi/sec F Total dose rate allocation factor 3= assigned to release path j (varying between 0.0 and 1.0),
dimensionless 500 - Total body dose rate limit specified in CPS RETS 3.11.2.la, mrem / year The highest relative (X/Q))= concentration of release path j at the site boundary
=
(I7Q) (x/q)y, (%74)n or (x/q)$,dependTngontypeand duration of release, sec/m3 (ref. section 3.5.1)
Kg = The total body dose factor due to gamma emissions of noble gas radionuclide i as listed in Table B-1 of Regulatory Guide *l.109 and Table 3.4-1 of this Manual, mrem /yrperpCi/m3 f = The fraction as defined by fd equation (15), dimensionless The total maximum acceptable concentration of noble gas radionuclides in release path j is calculated using the following equation:
C ,gCi/cc (17)
Tj = 9[J where C = The total maximum acceptable T3 concentration of all noble gases in release path j , gC1/cc Q = The maximum acceptable release T3 rate of all noble gases in release path j determined from equation (16), gC1/sec CLINTON-I 3-25 Rev.0-4/85
.. CPS-0DCM
- t %
A :
.l R The effluent release rate of
/'
3= release point j , cc/see h The maximum acceptable concentration of l
noble gas radionuclide i in the gaseous effluent pathway j for each individual noblegasintheeffluentpathwayj,Cf3 will be determined as follows:
f tj Tj C ' mci /cc (18)
Cf3=
where the terms f are defined in equations (15)anb3(andC17). Tj
- 1 The gaseous effluent PRM noble gas channel alarm setpoint can now be calculated using
- the equation below:
- CAS j = [1 Cfjt), E cpm (19)
- )
where:
CASy= The channel alarm setpoint above background for gaseous release pathway j , cpm The maximum acceptable
}
/
Cf3 = concentration of noble gas
' radionuclide i in the gaseous release pathway j (determined by equation (18)), gCi/cc l3 E Detection efficiency of the PRM tj = monitoring gaseous release pathway j for noble gas 4 radionuclide 1, cpm per pCi/cc 3.7.2 Skin Dose Rate Setpoint To ensure compliance with the CPS RETS 3.11.2.la skin dose rate limit, PRM setpoints shall be calculated using the methodology presented in the previous section 3.7.1 and by substituting the following equation for equation (16):
Fj Q 3000 , Ci/sec (20)
Tj=(X/Q)j3(Lc1.1M)f i t ij 9
CLINTON-I 3-26 Rev.0-4/85 i
l CPS-0DCM where Q = The maximum acceptable release T3 rate of all noble gases in release path j, gCi/sec F = Total dose rate allocation factor d assigned to release path j (varying between 0.0 and 1.0), dimensionless 3000= Skin dose rate limit specified in CPS RETS 3.11.2.la, mram/ year (X/Q)d = concentration The highest relative of release path j at the site boundary
= (x/q) or (x/q)
(KM) 51ng on Yy,pe(XM)ganddurationO depen release, sec/m3 (ref. section 3.5.1)
Lg= The skin dose factor due to gamma emissions for each identified noble gas radionuclide i, mrad /yr peryC1/m3, as listed in Table 3.4-1 of this Manual.
1.1 = An air dose to skin . dose equivalent conversion factor, mram/ mrad Mg = The air dose factor due to gamma emissions'for each identified noble gas radionuclide i, mrad /yr pergC1/m3, as listed in Table 3.4-1 of this Manual f = The fraction defined by equation f3 (15)
The calculated total body and skin dose rate channel alarm setpoints shall be compared and the more restrictive setpoint used. A safety factor may also be applied to the setpoint calculated by equation (19) to compensate for statistical fluctuations and measurement errors.
CLINTON-I 3-27 Rev.0-4/85
CPS-0DCM i
Figure 3.1-1 CPS SITE BOUNDARY FOR GASEOUS EFFLUENTS a
e psee.ee.
= .. sa ew _ s.
- ' ~ __. '
~
g --; . a
\ ,. 2 -- -
. g .: 6 W - Qe%.... 1f. 7.v 1 1.e .
. . . . . _ j .-. g' 9 e..- ,"- (
s.
,...i.. ,a ,.qja,f:
6, a . j,.,g* : g n. -
.I
_ i t
- c g :. . ,l $.k . - .s.-
.- 3 -
28",; a; 9- .
[{r i s.
a ;,g 9- 4' ,-. . ,,
< * ,;mj . . . .. v --
- 4 L .~ . . ,, , . -
. g
, , . - ...- s. t ..v, , , sc . . . -
n, . ..,, - . .
w 4 1 ....
-re, _ %- -4i.= . i, -
. - /, u. m ,_. y ,~ ' ,- - i
. . m. . m. .
.a . .:.p;;%.y... -w! .c.,,.
. a..,..,s. .
M-h.g..,Q.74i$..t .:
,p . .+ ;,, .s ,- w annu sioes .
"," 1 J,- L . .a_. ' ::
~'
. a s. .D. . . .
. W r M.f ,, g%\.
s y: - _-
.._Q ,g %'y/gf
^
3
,,, ],,,._ ." .atni-= - -
'..I
. . , .,k '-
. . , ,s
-r
-g- ,.A e, ,
1
.,,,.....,g,.,,... ,_ ,,;,
s .
~ 9 . g,>' s', . .. , . . .
e.* .%
h .m %'.,,,,,
I'x.
~
b .*
,I 8 ma
~ ,/
.,;I.i-enunguan ~
' v*-
~
l 4,' -
.. \,,. t, , .- . .
.r
\ '% ~ , L- -
3 p ~. #- 9 s ~'.e L...
l ..a.= _k+r .-~,7, . ..Ar.,.hy %g
. n ...e>..e. .A.
,p y l sf*-Q.
v :. ; . -
p -
t . t ,j '
g .rm ,c .
Wv s
.i a . - t.
i ** * * -
7 yA. i. $, "
'[
...), I '.. ... '
!-, h .. s q q.gl*?: g&,' '&.5Q C,w+, i,f ' .b' ,,5( f ^ Q (n = = id C k i .' i^. \
.?
, ., . ".: .-:qJ ~t .,(\ V_ x -/ M , , _ . .
- m. l ,.: - -
f'
-l.~. * . '.
.c,.e d N .**'-
"E
!? .} ';?' ,8 'iq .'.. x A l' "e s ' " - - - * = -
> ., \ opst. ' ,
.'Q;,. s .
,l
.e .
,, g'
- u. .
-+ %. ,
, - ! . : .?
g.
p l.-
{ .
+..t,_-
I i.
J l
- ~
P- -f If 's , %'$ . ? , ., '13 h '.
- .. .,j . ..s . . %;..- .
. . . u . . , .,
g
.j ! .' ~.I. , . . [.g :.,u g- 4. . '..
. .y., w
%_- '.q,.,.,,....'\
,e, . E :f . ., * (, '. ',i f.. f I .,a
. q ;. .. ... ,. r t- *- ,3(;
,- .b .y
-(..
. , . 7 ., . , . , . .
.,, .. : . .cQ:.i .*,'jf ,',i.t I..c. -k.gr. .eN.O- 5 :,,'N i
.n
~
e r,* , g ,.: ,g*g.
. s. ... .
...- a; .
- w. y.
.* W - E . ? N
{ ,
.~g" : . 4 . ,. - } e - -l
,:. ,$R - .
, n. . s , %e..,f.*.- yl.> ;,,a .. ..g . '.
. v. . -.. .
Y;; y@
M9. u.
3 2:.%;,dNaf A o
CLINTON-I 3-28 Rev.0-4/85
1
- CPS-0DCM
\
FIGURE 3.3-1 MAIN CONDENSER OFF-GAS TREATMENT SYSTEM imm w ess 146E005A - _.,
tmws .
I bg_ _
- "3 w m
/ ] ,mg sw
,i ,
,, /=== _ _ 2 2
'\
l a
lQ g l imam .
m y1
, I l
W M.ws: = L.L
_ J '""
u ma
{.m..
T .anan m otAotta -
'^
,j f m A
'l
?
4 1CD01A Main ,0CA01TA CV 1N66B010B Cooler 1N66D013 1PR35S Off-cas Candenser Separator Tank A Condenser B Charcoal Adsorber Post Treatment PRM ICA01AA Steam Jet OCA01TB CV IN66 ZOO 3A IN66D016 HEPA 1PR41S Off-Gas Air Ejector A Separator Tank B Dessicant Dryer A Filter Post Treatment PRM 1CA01AB Steam Jet 1N66D005A IN66 ZOO 3B OPROIS HVAC Air Ejector B Recombiner A Dessicane Dryer B Stack PRM #1 OCA01PA Condenser IN66D005B 1N66B011 Cas OPR02S HVAC V:cuum (CV) Pump A Recombiner B Cooler Stack PRM #2 OCA01PB CV Pump B IN66B010A Cooler IN66D012 1PR34S Off-Gas
' Condenser A Charcoal Adsorber Pretreatment PRM CLINTON-I 3,29 Rev.0-4/85
--- , .--g-,,_.-e ---e - ,-w,-w-- , y,-- - - - - - = -----e.- <e
,_.e , - , , - - - - - - - - - - - -
CPS-0DCM Table 3.5-1 INHALATION DOSE FACTORS FOR INFANT - (DFA g ),
(mrem per pCi inhaled)
NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG CI-LLI H 3 NO DATA 4.62E-07 4.62E-07 4.62E-07 4.62E-07 4.62E-07 4.62E-07 C 14 1.89E-05* 3.79E-06 3.79E-06 3.79E-06 3.79E-06 3.79E-06 3.79E-06 NA 24 7.54E-06 7.54E-06 7.54E-06 7.54E-06 7.54E-06 7.54E-06 7.54E-06 P 32 1.45E-05 8.03E-05 5.53E-05 NO DATA NO DATA NO DATA 1.15E-05 CR 51 NO DATA NO DATA 6.39E-08 4.11E-08 9.45E-09 9.17E-06 2.55E-07 MN 54 NO DATA 1.81E-05 3.56E-06 NO DATA 3.56E-06 7.14E-04 5.04E-06 MN 56 NO DATA 1.10E-09 1.58E-10 NO DATA 7.86E-10 8.95E-06 5.12E-05 -
FE 55 1.41E-05 8.39E-06
- 2.38E-06 NO DATA NO DATA 6.21E-05 7.82E-07 FE 59 9.69E-06 1.68E-05 6.77E-06 NO DATA NO DATA 7.25E-04 1.77E-05 CO 58 NO DATA 8.71E-07 1.30E-06 NO DATA NO DATA 5.55E-04 7.95E-06 CO 60 NO DATA 5.73E-06 8.41E-06 NO DATA NO DATA 3.22E-03 2.28E-05 NI 63 2.42E-04 1.46E-05 8.29E-06 NO DATA NO DATA 1.49E-04 1.73E-06 NI 65 1.71E-09 2.03E-10 8.79E-11 NO DATA NO DATA 5.80E-06 3.58E-05 CU 64 NO DATA 1.34E-09 5.53E-10 NO DATA 2.84E-09 6.64E-06 1.07E-05 2N 65 1.38E-05 4.47E-05 2.22E-05 NO DATA 2.32E-05 4.62E-04 3.67E-05 ZN 69 3.85E-11 6.91E-11 5.13E-12 NO DATA 2.87E-11 1.05E-06 9.44E-06 BR 83 NO DATA NO DATA 2.72E-07 NO DATA NO DATA NO DATA LT E-24**
BR 84 NO DATA NO DATA 2.86E-07 NO DATA NO DATA NO DATA LT E-24 BR 85 NO DATA NO DATA 1.46E-08 NO DATA NO DATA NO DATA LT E-24 RB 86 NO DATA 1.36E-04 6.30E-05 NO DATA NO DATA NO DATA 2.17E-06 RB 88 NO DATA 3.98E-07 2.0$E-07 NO DATA NO DATA NO DATA 2.42E-07 RB 89 NO DATA 2.29E-07 1.47E-07 NO DATA NO DATA NO DATA 4.87E-08 SR 89 2.84E-04 NO DATA 8.15E-06 NO DATA NO DATA 1.45E-03 4.57E-05 SR 90 2.92E-02 NO DATA 1.85E-03 NO DATA NO DATA 8.03E-03 9.36E-05 SR 91 6.83E-08 NO DATA 2.47E-09 NO DATA NO DATA 3.76E-05 5.24E-05 SR 92 7.50E-09 NO DATA 2.79E-10 NO DATA NO DATA. 1.70E-05 1.00E-04 Y 90 2.35E-06 NO DATA 6.30E-08 NO DATA NO DATA 1.92E-04 7.43E-05 CLINTON-I 3-30 Rev.0-4/85
CPS-0DCM Table 3.5-1 (continued)
INHALATION DOSE FACTORS FOR INFANT - (DFA g ),
(mrem per pCi inhaled)
NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI Y 91m 2.91E-10 NO DATA 9.90E-12 NO DATA NO DATA 1.99E-06 1.68E-06 Y 91 4.20E-04 NO DATA 1.12E-05 NO DATA NO DATA 1.75E-03 5.02E-05 Y 92 1.17E-08 NO DATA 3.29E-10 NO DATA NO DATA 1.75E-05 9.04E-05 Y 93 1.07E-07 NO DATA 2.91E-09 NO DATA NO DATA 5.46E-05 1.19E-04 ZR 95 8.24E-05 1.99E-05 1.45E-05 NO DATA 2.22E-05 1.25E-05 1.55E-05 ZR 97 1.07E-07 1.83E-08 8.36E-09 NO DATA 1.85E-08 7.88E-05 1.00E-04 NB 95 1.12E-05 4.59E-06 2.70E-06 NO DATA 3.37E-06 3.42E-04 9.05E-06 MO 99 NO DATA 1.18E-07 2.31E-08 NO DATA 1.89E-07 9.63E-05 3.48E-05 TC 99m 9.98E-13 2.06E-12 2.66E-11 NO DATA 2.22E-11 5.79E-07 1.45E-06 TC101 4.65E-14 5.88E-14 5.80E-13 NO DATA 6.99E-13 4.17E-07 6.03E-07 RU103 1.44E-06 NO DATA 4.85E-07 NO DATA 3.03E-06 3.94 E-04 1.15E-05 RU105 8.74E-10 NO DATA 2.93E-10 NO DATA 6.42E-10 1.12E-05 3.46E-05 RU106 ,6.20E-05 NO DATA 7.77E-06 NO DATA 7.61E-05 8.26E-03 1.f7E-04 AG110m 7.13E-06 5.16E-06 3.57E-06 NO DATA 7.80E-06 2.62E-03 2.36E-05 TE125m 3.40E-06 1.42E-06 4.70E-07 1.16E-06 NO DATA 3.19E-04 9.22E-06 TE127m 1.19E-05 4.93E-06 1.48E-06 3.48E-06 2.68E-05 9.37E-04 1.93E-05 TE127 1.59E-09 6.81E-10 3.49E-10 1.32E-09 3.47E-09 7.29E-06 1.74E-05 TE129m 1.01E-05 4.35E-06 1.595-06 3.91E-06 2.27E-05 1.20E-03 4.93E-05 TE129 5.63E-11 2.48E-11 1.34E-11 4.82E-11 1.25E-10 2.14E-06 1.88E-05 TE131m 7.62E-08 3.93E-08 2.59E-08 6.38E-08 1.89E-07 1.42E-04 8.51E-05 TE131 1.24E-11 5.87E-12 3.57E-12 1.13E-11 2.85E-11 1.47E-06 5.87E-06 TE132 2.66E-07 1.69E-07 1.26E-07 1.99E-07 7.39E-07 2.43E-04 3.15E-05 I 130 4.54E-06 9.91E-06 3.98E-06 1.14E-03 1.09E-05 NO DATA 1.42E-06 I 131 2.71E-05 3.17E-05 1.40E-05 1.06E-02 3.70E-05 NO DATA 7.56E-07 I 132 1.21E-06 2.53E-06 8.99E-07 1.21E-04 2.82E-06 NO DATA 1.36E-06 I 133 9.46E-06 1.87E-05 4.00E-06 2.54E-03 1.60E-05 NO DATA 1.54E-06 I 134 6.58E-07 1.34E-06 4.75E-07 3.18E-05 1.49E-06 NO DATA 9.21E-07 CLINTON-I 3-31 Rev.0-4/85
CPS-0DCM
- Table 3.5-1 (continued)
INHALATION DOSE FACTORS FOR INFANT - (DFA g ),
.(mrem per pCi inhaled)
NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI m,
'I 135 2.76E-06 5.43E-06 1.98E-06 4. 97E-04 6.05E-06 NO DATA 1.31E-06 CS134 _ 2.83E-04 5.02E-04 5.32E-05 NO DATA 1.36E-04 5.69E-05 9.53E-07 CS136 3.45E-05 9.61E-05 3.78E-05 NO DATA 4.03E-05 8.40E-06 1.02E-06 CS13*/ 3.92E-04 4.37E-05 3.25E-05 NO DATA 1.23E-04 5.09E-05 9.53E-07 CS130 3.61E-07 5.58E-07 2.84E-07 NO DATA 2.93E-07 4.67E-08 6.26F-07 BA1393 - 1.06E-09 7.03E-13 3.07E-11 NO DATA 4.73E-13 4.25E-06 3.64E .
A BA140 4.00E-05 4.00E-08 2.07E-06 NO DATA 9.59E-09 1.14E-03 2.74E-05 BA141 1.12E-10 7.70E-14 3.55E-12 NO DATA 4.64E-14 2.12E-06 3.39E-06 f BA142 2.84E-11 < 2.36E-14 1.40E-12 NO DATA 1.36E-14 1.11E-06 4.95E-07 i
LA140 3.61E-07 1.43E-07 3.68E-08 NO DATA NO DATA 1.20E-04 6.06E-05 LA142 7.36E-10 2.69E-10 6.46E-11 NO DATA NO DATA 5.87E-06 4.25E-05 CE141 1.98E-05 1.19E-05 1.42E-06 NO DATA 3.75E-06 3.69E-04 1.54E-05 CE143 2.09E-07 1.38E-07 1.58E-08 NO DATA 4.03E-08 8.30E-05 3.55E-05
' CE144 2.28E-03 8.65E-04 1.26E-04 NO DATA 3.84E-04 7.03E-03 1.06E-04
PR143 1.00E-05 3.74E-06 4.99E-07 NO DATA 1.41E-06 3.09E-04 2.66E-05 l
l
- PR144 3.42E-11 ~ 1.32E-11 1.72E-12 NO DATA 4.80E-12 1.15E-06 3.06E-06 2.25E-06 2.30E-04 2.23E-05 ND147 5.67E-06 5.81E-06 3.57E-07 NO DATA W 187 9.26E-09 6.44E-09 2.23E-09 NO DATA NO DATA 2.83E-05 2.54E-05 NP239 , 2.65E-07 2.37E-08 1.34E-08 NO DATA 4.73E-08 4.25E-05 1.78E-05 l-l l
- 1.89 X 10-05
- Less than 10-24 l
CLINTON-I 3-32 Rev.0-4/85
l CPS-ODCM Table 3.5-2 INHALATION DOSE FACTORS FOR CHILD - (DFA g ),
(mrem per pCi inhaled)
NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI H 3 NO DATA 3.04E-07 3.04E-07 3.04E-07 3.04E-07 3.04E-07 3.04E-07 C 14 9.70E-06* 1.82E-06 1.82E-06 1.82E-06 1.82E-06 1.82E-06 1.82E-06 NA 24 4.35E-06 4.35E-06 4.35E-06 4.35E-06 4.35E-06 4.35E-06 4.35E-06 P 32 7.04E-04 3.09E-05 2.67E-05 NO DATA NO DATA NO DATA 1.14E-05 CR 51 NO DATA NO DATA 4.17E-08 2.81E-08 6.57E-09 4.59E-06 2.93E-07
- MN 54 NO DATA 1.16E-05 2.57E-06 NO DATA 2.71E-06 4.26E-04 6.19E-06 MN 56 NO DATA 4.48E-10 8.43E-11 NO DATA 4.52E-10 3.55E-06 3.33E-05 FE 55 1.28E-05 6.80E-06 2.10E-06 NO DATA NO DATA 3.00E-05 7.75E-07 FE 59 5.59E-06 9.04E-06 4.51E-06 NO DATA NO DATA 3.43E-04 1.91E-05 CO 58 NO DATA 4.79E-07 8.55E-07 NO DATA NO DATA 2.99E-04 9.29E-06 CO 60 NO DATA 3.55E-06 6.12E-06 NO DATA NO DATA 1.91E-03 2.60E-05 NI 63 2.22E-04 1.25E-05 7.56E-06 NO DATA NO DATA 7.43E-05 1.71E-06 NI 65 8.08E-10 7.99E-11 4.44E-11 NO DATA NO DATA 2.21E-06 2.27E-05 CU 64 NO DATA 5.39E-10 2.90E-10 NO DATA 1.63E-09 2.59E-06 9.92E-06 ZN 65 1.15E-05 3.06E-05 1.90E-05 NO DATA 1.93E-05 2.69E-04 4.41E-06 ZN 69 1.81E-11 2.61E-11 2.41E-12 NO DATA 1.58E-11 3.84E-07 2.75E-06 BR 83 NO DATA NO DATA 1.28E-07 NO DATA NO DATA NO DATA LT E-24**
BR 84 NO DATA NO DATA 1.48E-07 NO DATA NO DATA NO DATA LT E-24 BR 85 NO DATA NO DATA 6.84E-09 NO DATA NO DATA NO DATA LT E-24 RB 86 NO DATA 5.36E-05 3.09E-05 NO DATA NO DATA NO DATA 2.16E-06 RB 88 NO DATA 1.52E-07 9.90E-08 NO DATA NO DATA NO DATA 4.66E-09 RB 89 NO DATA 9.33E-08 7.83E-08 NO DATA NO DATA NO DATA 5.11E-10 SR 89 1.62E-04 NO DATA 4.66E-06 NO DATA NO DATA 5.83E-04 4.52E-05 SR 90 2.73E-02 NO DATA 1.74E-03 NO DATA NO DATA 3.99E-03 9.28E-05 CLINTON-I 3-33 Rev.0-4/85
CPS-ODCM
! \
Table 3.5-2 (continued)
INHALATION DOSE FACTORS FOR CHILD - (DFA g ),
. (mrem per pCi inhaled)
NUCLIDE BONE LIVER T. BODY THYROID KIDNEY Li!NG GI-LLI
': SR 91 3.28E-08 NO DATA 1.24E-09 NO DATA NO DATA 1.44E-05 4.70E-05 SR 92 3.54E-09 NO DATA 1.42E-10 NO DATA NO DATA 6.49E-06 6.55E-05
,J 2.99E-08 NO DATA 7.07E-05 7.24E-05 Y 90 1.11E-06 NO DATA NO DATA
- l. .
Y 91m 1.37E-10 NO DATA 4.98E-12 NO DATA NO DATA 7.60E-07 4.64E-07
- q Y 91 2.47E-04 NO DATA 6.59E-06 NO DATA NO DATA 7.10E-04 4.97E-05 j Y 92 5.50E-09 NO DATA 1.57E-10 NO DATA NO DATA 6.46E-06 6.46E-05
'l4
'! Y 93 5.04E-08 NO DATA 1.38E-09 NO DATA NO DATA 2.01E-05 1.05E-04
-l ZR 95 5.13E-05 1.13E-05 1.00E-05 NO DATA 1.61E-05 6.03E-04 1.65E-05 3.06E-05 9.49E-05 j ZR 97 5.07E-08 7.34E-09 4.32E-09 NO DATA 1.05E-08 ,.
j l
NB 95 6.35E-06 2.48E-06 1.77E-06 NO DATA 2.33E-06 1.66E-04 1.00E-05 j MO 99 NO DATA 4.66E-08 1.15E-08 NO DATA 1.06E-07 3.66E-05 3.42E-05 TC 993 4.81E-13 9.41E-13 1.56E-11 NO DATA 1.37E-11 2.57E-07 1.30E-06
'l i TC101 2.19E-14 2.30E-14 2.91E-13 NO DATA 3.92E-13 1.58E-07 4.41E-09
,; RU103 7.55E-07 NO DATA 2.90E-07 NO DATA 1.90E-06 1.79E-04 1.21E-05 RU105 4.13E-10 NO DATA 1.50E-10 NO DATA 3.63E-10 4.30E-06 2.69E-05
(
4
$ RU106 3.68E-05 NO DATA 4.57E-06 NO DATA 4.97E-05 3.87E-03 1.16E-04 i AC110m 4.56E-06 3.08E-06 2.47E-06 NO DATA 5.74E-06 1.48E-03 2.71E-05 TE125m
- 1.82E-06 6.29E-07 2.47E-07 5.20E-07 NO DATA 1.29E-04 9.13E-06
[Ii l TE127m 6.72E-06 2.31E-06 8.18E-07 1.64E-06 1.72E-05 1.91E-09 4.00E-04 2.71E-06 1.93E-05 1.52E-05 l TE127 7.49E-10 2.57E-10 1.65E-10 5.30E-10 1.36E-05 4.76E-04 4.91E-05
] TE129m 5.19E-06 1.85E-06 8.22E-07 1.71E-06 j
TE129 2.64E-11 9.45E-12 6.44E-12 1.93E-11 6.94E-11 7.93E-07 6.89E-06 4 TE131m 3.63E-08 1.60E-08 1.37E-08 2.64E-08 1.08E-07 5.56E-05 8.32E-05 I~
TE131 5.87E-12 2.28E-12 1.78E-12 4.59E-12 1.59E-11 5.55E-07 3.60E-07 TE132 1.30E-07 7.36E-08 7.12E-08 8.58E-08 4.79E-07 1.02E-04 3.72E-05
^
I 130 2.21E-06 4.43E-06 2.28E-06 4.99E-04 6.61E-06 NO DATA 1.38E-06 I. I 131 1.30E-05 1.30E-05 7.37E-06 4.39E-03 2.13E-05 NO DATA 7.68E-07
.I 1
i CLINTON-I 3-34 Rev.0-4/85 c
m,,-,,- . - - - - - - e- ----- v
CPS-0DCM Table 3.5-2 (continued)
INHALATION DOSE FACTORS FOR CHILD - (DFA g ),
(mrem per pCi inhaled)
NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG OI-LLI I 132 5.72E-07 1.10E-06 5.07E-07 5.23E-05 1.69E-06 NO DATA 8.65E-07 I 133 4.48E-06 5.49E 2.08E-06 1.04E-03 9.13E-06 NO DATA 1.48E-06 I 134 3.17E-07 5.84E 2.69E-07 1.37E-05 8.92E-07 . NO DATA 2.58E-07 I 135 1.33E -96 2.36E-06 1.12E-06 2.14E-04 3.62E-06 NO DATA 1.20E-06 CS134 1.76E-04 2.74E-04 6.07E-05 NO DATA 8.93E-05 3.27E-05 1.04E-06 CS136 1.76E-05 4.62E-05 3.14E-05 NO DATA 2.58E-05 3.93E-06 1.13E-06 CS137" 2.45E-04 2.23E-04 3.47E-05 NO DATA 7.63E-05 2.81E-05 9.78E-07 CS138 1.71E-07 2.27E-07 1.50E-07 NO DATA 1.68E-07 1.84E-08 7.29E-08 BA139 4.98E-10 2.66E-13 1.45E-11 NO DATA 2.33E-13 1.56E-06 1.56E-05 BA140 2.00E-05 1.75E-08 1.17E-06 NO DATA 5.71E-09 4.71E-04 2.75E-05 BA141 5.29E-11 2.95E-14 1.72E-12 NO DATA 2.56E-14 7.89E-07 7.44E-08 BA142 1.35E-11 9.73E-15 7.54E-13 NO DATA 7.87E-15 4.44E-07 7.41E-10 LA140 1.74E-07 6.08E-08 2.04E-08 NO DATA NO DATA 4.94E-05 6.10E-05 LA142 3.50E-10 1.11E-10 3.49E-11 NO DATA NO DATA 2.35E-06 2.05E-05 CE141 1.06E-05 5.28E-06 7.83E-07 NO DATA 2.31E-06 1.47E-04 1.53E-05 CE143 9.89E-08 5.37E 7.77E-09 NO DATA 2.26E-08 3.12E-05 3.44E-05 CE144 1.83E-03 5.72E-04 9.77E-05 NO DATA 3.17E-04 3.23E-03 1.05E-04 4.99E-06 1.50E-06 2.47E-07 NO DATA 8.11E-07 1.17E-04 2.63E-05 PR143 PR144 1.61E-11 4.99E-12 8.10E-13 NO DATA 2.64E-12 4.23E-07 5.32E-08 2.92E-06 2.36E-06 1.84E-07 NO DATA 1.30E-06 8.87E-05 2.22E-05 ND147 W 187 4.41E-09 2.61E-09 1.17E-09 NO DATA NO DATA 1.11E-05 2.46E-05 1.26E-07 9.04E-09 6.35E-09 NO DATA 2.63E-08 1.57E-05 1.73E-05 NP239
- 9.70 X 10 -06
- Less than 10-24 CLINTON-I 3-35 Rev.0-4/85
CPS-0DCM Table 3.5-3 INHALATION DOSE FACTORS FOR TEEN - (DFA g ),
(mrem per pCi inhaled)
NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI H 3 NO DATA 1.59E-07 1.59E-07 1.59E-07 1.59E-07 1.59E-07 1.59E-07 C 14 3.25E-06* 6.09E-07 6.09E-07 6.09E-07 6.09E-07 6.09E-07 6.09E-07 NA 24 1.72E-06 1.72E-06 1.72E-06 1.72E-06 1.72E-06 1.72E-06 1.72E-06 P 32 2.36E-04 1.37E-05 8.95E-06 NO DATA NO DATA NO DATA 1.16E-05 CR 51 NO DATA NO DATA 1.69E-08 9.37E-09 3.84E-09 2.62E-06 3.75E-07 MN 54 NO DATA 6.39E-06 1.05E-06 NO DATA 1.59E-06 2.48E-04 8.35E-06 MN 36 NO DATA 2.12E-10 3.15E-11 NO DATA 2.24E-10 1.90E-06 7.18E-06 FE 55 4.18E-06 2.98E-06 6.93E-07 NO DATA NO DATA 1.55E-05 7.99E-07 FE 59 1.99E-06 4.62E-06 1.79E-06 NO DATA NO DATA 1.91E-04 2.23E-05 CO 58 NO DATA 2.59E-07 3.47E-07 NO DATA NO DATA 1.68E-04 1.19E-05 CO 60 NO DATA 1.89E-06 2.48E-06 NO DATA NO DATA 1.09E-03 3.24E-05 NI 63 7.25E-05 5.43E-06 2.47E-06 NO DATA NO DATA 3.84E-05 1.77E-06 4.59E-06
~
NI 65 2.73E-10 3.66E-11 1.59E-11 NO DATA
- NO DATA 1.17E-06 CU 64 NO DATA 2.54E-10 1.06E-10 NO DATA 8.01E-10 1.39E-06 7.68E-06 ZN 65 4.82E-06 1.67E-05 7.80E-06 NO DATA 1.08E-05 1.55E-04 5.83E-06 ZN 69 6.04E-12 1.15E-11 8.07E-13 NO DATA 7.53E-12 1.98E-07 3.56E-08 BR 83 NO DATA NO DATA 4.30E-08 NO DATA NO DATA NO DATA LT E-24**
BR 84 NO DATA- NO DATA 5.41E-08 NO DATA NO DATA NO DATA LT E-24 BR 85 NO DATA NO DATA 2.29E-09 NO DATA NO DATA NO DATA LT E-24 RB 86 NO DATA 2.38E-05 1.05E-05 NO DATA NO DATA NO DATA 2.21E-06 RB 88 NO DATA 6.82E-08 3.40E-08 NO DATA NO DATA NO DATA 3.65E-15 RB 89 NO DATA 4.40E-08 2.91E-08 NO DATA NO DATA NO DATA 4.22E-17 SR 89 5.43E-05 NO DATA 1.56E-06 NO DATA NO DATA 3.02E-04 4.64E-05 SR 90 1.35E-02 NO DATA 8.35E-04 NO DATA NO DATA 2.06E-03 9.56E-05 CLINTON-I 3-36 Rev.0-4/85
. , CPS-0DCM
,\
Table 3.5-3 (continued)
I INHALATION DOSE FACTORS FOE TEEN - (DFA g ),
(mrem per pCi inhsled)
NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI
~
~^ SR 91 1.10E-08 NO DATA 4.39E-10 NO DATA NO DATA 7.59E-06 3.24E-05 SR 92 1.19E-09 N0 DATA 5.08E-11 NO DATA NO DATA 3.43E-06 1.49E-05 Y 90 3.73E-07 NO DATA 1.00E-08 NO DATA NO DATA 3.66E-05 6.99E-05 3
., Y 91m 4'.63E-11 NO DATA 1.77E-12 NO DATA NO DATA 4.00E-07 3.77E-09 s
Y 91 8.26E-05 NO DATA 2.21E-06 NO DATA NQ DATA 3.67E-04 5.11E-05 Y 92 1.84E-09 NO DATA 5.36E-11 NO DATA NO DATA 3.35E-06 2.06E-05 Y 93 1.69E-08 NO DATA 4.65E-10 NO DATA NO DATA 1.04E-05 7.24E-05 ZR 95 1.82E-05 5.73E-06 3.94E-06 NO DATA 8.42E-06 J.36E-04 1.86E-05 i ZR 97 1.72E-08 3.40E-09 1.57E-09 NO DATA 5.15E-09 1.42E-05 7.88E-05 -
il i NB 95 2.32E-06 1.29E-06 7.08E-07 NO DATA 1.25E-06 9.35E-05 1.21E-05
] MO 99 NO DATA 2.11E-08 4.03E-09 NO DATA 5.14E-08 L.92E-05 3.36E-05 TC 99m 1.73E-13 4.83E-13 6.24E-12 NO DATA 7.20E-12 1.44E-07 7.66E-07 i
l TC101 7.40E-15 1.05E-14 1.03E-13 NO DATA 1.90E-13 8.34E-08 1.09E-16 RU103 2.63E-07 NO DATA 1.12E-07 NO DATA 9.29E-07 9.79E-05 -1.36E-05
'RU105 1.40E-10 NO DATA 5.42E-11 NO DATA 1.76E-10 2.27E-06 1.13E-05 RU106 1.23E-05 NO DATA 1.55E-06 NO DATA 2.38E-05 2.01E-03 1.20E-04 l AC110m 1.73E-06 1.64E-06 9.99E-07 NO DATA 3.13E-06 8.44E-04 3.41E-05 j .
TE125m 6.10E-07 2.80E-07 8.34E-08 1.75E-07 NO DATA 6.70E-05 9.38Z-06 i
TE127m 2.25E-06 1.02E-06 2.73E-07 5.48E-07 8.17E-06 2.07E-04 1.99E-05 i TE127 2.51E-10 1.14E-10 5.52E-11 1.77E-10 9.10E-10 1.40E-06 1.01E-05 TE129m 1.74E-06 8.23E-07 2.81E-07 5.72E-07 6.49E-06 2.47E-04 5.06E-05
-] ._
- TE129 8.87E-12 4.22E-12 2.20E-12 6.48E-12 3.32E-11 4.12E-07 2.02E-07 TE131m 1.23E-08 7.51E-09 5.03E-09 9.06E-09 5.49E-08 2.97E-05 7.76E-05 TE131 1.97E-12 1.04E-12 6.30E-13 1.55E-12 7.72E-12 2.92E-07 1.89E-09
')
y j
I
- 3 e l CLINTON-I 3-37 Rev.0-4/85
._._y__- - - . - - - - - - - - - , . - , --.w--,_. -
_ a _ -c - g we.- ,-..i. g-. - + -
CPS-0DCM Table 3.5-3 (continued)
INHALATION DOSE FACTORS FOR TEEN - (DFA f ),
(mrem per pCi inhaled)
NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LIJ _
TE132 4.50E-08 3.63E-08 2.74E-08 3.07E-08 2.44E-07 5.61E-05 5.79E-05 I 130 7.80E-07 2.24E-06 8.96E-07 1.86E-04 3.44E-06 NO DATA 1.14E-06
. I 131 4.43E-06 6.14E-06 3.30E-06 1.83E-03 1.05E-05 NO DATA 8.11E-07 I 132 1.99E-07 5.47E-07 1.97E-07 1.89E-05 d.65E-07 NO DATA 1.59E-07 I 133 1.52E-06 2.56E-06 7.78E-07 3.65E-04 4.49E-06 NO DATA 1.29E-06 I 134 1.11E-07 2.90E-07 1.05E-07 4.94E-06 4.58E-07 NO DATA 2.55E-09 I 135 4.62E-07 1.18E-06 4.36E-07 7.76E-05 1.86E-06 NO DATA 8.69E-07 CS134 6.28E-05 1.41E-04 6.86E-05 NO DATA 4.69E-05 1.83E-05 1.22E-06 CS136 6.44E-06 2.42E-05 1.71E-05 NO DATA 1.38E-05 2.22E-06 1.36E-06 CS137 8.38E-05 1.06E-04 3.89E-05 NO DATA 3.80E-05 1.51E-05 1.06E-06 CS138 5.82E-08 1.07E-07 5.58E-08 NO DATA 8.28E-08 9.84E-09 3.38E-11 BA139 1.67E-10 1.18E-13 4.87E-12 NO DATA 1.11E-13 8.08E-07 8.06E-07 BA140 6.84E-06 8.38E-09 4.40E-07 NO DATA 2.85E-09 2.54E-04 2.86E-05 BA141 1.78E-11 1.32E-14 5.93E-13 NO DATA 1.23E-14 4.11E-07 9.33E-14 BA142 4.62E-12 4.63E-15 2.84E-13 NO DATA 3.92E-15 2.39E-07 5.99E-20 LA140 5.99E-08 2.95E-08 7.82E-09 NO DATA NO DATA 2.68E-05 6.09E-05 LA142 1.20E-10 5.31E-11 1.32E-11 NO DATA NO DATA 1.27E-05 1.50E-06 CE141 3.55E-06 2.37E-06 2.71E-07 NO DATA 1.11E-06 7.67E-05 1.58E-05 CE143 3.32E-08 2.42E-08 2.70E-09 NO DATA 1.08E-08 1.63E-05 3.19E-05 CE144 6.11E-04 2.53E-04 3.28E-05 NO DATA 1.51E-04 1.67E-03 1.08E-04 PR143 1.67E-06 6.64E-07 8.28E-08 NO DATA 3.86E-07 6.04E-05 2.67E-05 PR144 5.37E-12 2.20E-12 2.72E-13 NO DATA 1.26E-12 2.19E-07 2.94E-14 ND147 9.83E-07 1.07E-06 6.51E-08 NO DATA 6.28E-07 4.65E-05 2.28E-05 W 187 1.50E-09 1.22E-09 4.29E-10 NO DATA NO DATA 5.92E-06 2.21E-05 NP239 4.23E-08 3.99E-09 2.21E-09 NO DATA 1.25E-08 8.11E-06 1.65E-05
- 3.52 X 10-06
- Less than 10-24 CLINTON-I 3-38 Rev.0-4/85
._. _._. _ n :._ . '._ _ ._
. ' CPS-ODCM
. .:..9 ;z v.. .n '
p,? m.1 3-t . 4 ,' , uw
.. At. . :(,
Table 3.5-4 1 1
iv.. . INHALATION DOSE FACTORS FOR ADULT - (DFAi )a 1,$!U{.A1..Ng;b,;.)gl$".%
J j'
(mrem per pCi intaled) l
$!Me:f.cf.GA*a
.d.;
,. ,me.*p;d;i
,m _ ~
? u --
r.:1 .
s :
i t;- 'NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI DfGwNs.;*s.cm - - !
ic_ 2 NO DATA 1.58E-07 1.58E-07 1.58E-07 1.58E-07 1.58E-07 1.58E-07 6 ;,,yR . C114?',';. 3 y,1 2.27E-06* 4.26E-07 4.26E-07 4.26E-07 4.26E-07 4.26E-07 4.26E-07 C 1.28E-06 1.28E-06 1.28E-06 1.28E-06 1.28E-06 1.28E-06 l
'(fqtMW%i% 7N F24V'*' '1.28E-06 *
&!.6 lr - .
jf}>![P!t 32 : .1.65E-04 9.64E-06 6.26E-06 NO DATA NO DATA NO DATA 1.08E-05
..p!
. ..r flaCR 512,' NO DATA NO DATA 1.2SE-08 7.44E-09 2.85E-09 1.80E-06 4.15E-07 l
~ f.#b;NN 54 '" - NO DATA 4.95E-06 7.87E-07 NO DATA 1.23E-06 1.75E-04 9.67E-06 paymm - ,
ir VCM ~,
&f..e#' 5 NO DATA 1.55E-10 2.29E-11 NO DATA 1.63E-10 1.18E-06 2.53E-06
'IlHN,5621 FE"55 3.07E-06' 2.12E-06 4.93E-07 NO DATA NO DATA 9.01E-06 7.54E-07 I$ FE"59.- 1.47E-06 3.47E-06 1.32E-06 NO DATA NO DATA 1.27E-04 2.35E-05
,', q . , .
. * . g. g.-
Q V ~ . .W.V p . .
- ,;, c NO DATA 1.98E-07 2.59E-07 NO DATA NO DATA 1.16E-04 1.33E-05
$4/,i,(CO,58 C0 60 7 g.NIf63b,p.NODATA.
5.40E-05 1.44E-06 3.93E - 1.81E-06 1.85E-06 NO DATA NO DATA NO DATA NO DATA 7.46E-04 2.23E-05 3.56E-05 1.67E-06 3r%"3g:/3;.$40 ht, 'N
'G?% ;w.:n449 .
f.i/.., [,NI;.65y;g ,,'. 1.92E-10 2.62E-11 1.14E-11 NO DATA NO DATA 7.00E-07 1.54E-06 eJ.D.,CU 64 NO DATA 1.83E-10 7.69E-11 NO DATA 5.78E-10 8.48E-07 6.12E-06 P T ZN 655" .: 4 05E-06' 1.29E-05 5.82E-06 NO DATA 8.62E-06 1.08E-04 6.68E-06 h d'h s]m W&Q::,..e ,,z ,.ma, D If ZN 69 ' 4 23E-12 8.14E-12 5.65E-13 NO DATA 5.27E-12 NO DATA 2.04E-09 if, , BR 83 ' NO DATA 3.01E-08 NO DATA NO DATA NO DATA 2.90E-08
[NODATA
/ 84 1 NO DATA NO DATA 3.91E-08 NO DATA JO DATA NO DATA 2.05E-13 i'. ,$f. 'BRo %V s.
N4,@.a. c : ,
e f ' 'BR 85 .NO DATA NO DATA 1.60E-09 NO DATA NO DATA NO DATA LT E-24**
'RB 86' NO DATA 1.69E-05 7.37E-06 NO DATA NO DATA NO DATA 2.08E-06
'J RB 8 NO DATA 4.84E-08 2.41E-08 NO DATA NO DATA NO DATA 4.18E-19
- b m ge
- y,,8.y
.g v .3 .w ,
1 RB 89, NO DATA 3.20E-08 2.12E-08 NO DATA NO DATA NO DATA 1.16E-21
.. .. ..SR,891 3.80E-05 NO DATA 1.09E-06 NO DATA NO DATA 1.75E-04 4.37E-05 f/
7 e,,'90 E SR 1.24E-02 NO DATA 7.62E-04 NO DATA NO DATA 1.20E-03 9.02E-05 3 7
' *E, i .
i CLINTON-I 3-39 Rev.0-4/85
CPS-0DCM
\
,.. Table 3.5-4 (continued) i l
INHALATION DOSE FACTORS FOR ADULT - (DFA g ),
1
~
(mrem per pCi inhaled) l l
i NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI SR 91 7.74E-09 NO DATA 3.13E-10 NO DATA NO DATA 4.56E-06 2.39E-05
- SR 92 8.43E-10 NO DATA 3.64E-11 NO DATA NO DATA 2.06E-06 5.38E-06 i Y 90 2.61E-07 NO DATA 7.01E-09 NO DATA NO DATA 2.12E-05 6.32E-05 i Y 91m 3.26E-11 NO DATA 1.27E-12 NO DATA NO DATA 2.40E-07 1.66E-10 J' Y 91 5.78E-05 NO DATA 1.55E-06 NO DATA NO DATA 2.13E-04 4.81E-05 Y 92 1.29E-09 NO DATA 3.77E-11 NO DATA N0' DATA 1.96E-06 9.19E-06 1 Y 93 1.18E-08 NO DATA 3.26E-10 NO DATA NO DATA 6.06E-06 5.27E-05 ZR 95 1.34E-05 4.30E-06 2.91E-06 NO DATA 6.77E-06 2.21E-04 1.88E-05
, ZR 97 1.21E-08 2.45E-09 1.13E-09 NO DATA 3.71E-09 9.84E-06 6.54E-05 -
d NB 95 1.76E-06 9.77E-07 5.26E-07 NO DATA 9.67E-07 6.31E-05 1.30E-05 f MO 99 NO DATA 1.51E-08 2.87E-09 NO DATA 3.64E-08 1.14E-05 3.10E-05 1
TC 99m 1.29E-13 3.64E-13 4.63E-12 NO DATA 5.52E-12 9.55E-08 5.20E-07 TC101 5.22E-15 7.52E-15 7.38E-14 NO DATA 1.35E-13 4.99E-08 1.36E-21 1 RU103 1.91E-07 NO DATA 8.23E-38 NO DATA 7.29E-07 6.31E-05 1.38E-05 i RU105 9.88E-11 NO DATA 3.89E-11 NO DATA 1.27E-10 1.37E-06 6.02E-06 1
RU106 8.64E-06 NO DATA 1.09E-06 NO DATA 1.67E-05 1.17E-03 1.14E-04 AG110m 1.35E-06 1.25E-06 7.43E-07 NO DATA 2.46E-06 5.79E-04 3.78E-05
,. TE125m 4.27E-07 1.98E-07 5.84E-08 1.31E-07 1.55E-06 3.92E-05 8.83E-06 l
TE127m 1.58E-06 7.21E-07 1.96E-07 4.11E-07 5.72E-06 1.20E-04 1.87E-05 TE127 1.75E-10 8.03E-11 3.87E-11 1.32E-10 6.37E-10 8.14E-07 7.17E-06
.)
a TE129m 1.22E-06 5.84E-07 1.98E-07 4.30E-07 4.57E-06 1.45E-04 4.79E-05 s
.i .
TE129 6.22E-12 2.99E-12 1.55E-12 4.87E-12 2.34E-11 2.42E-07 1.96E-08 TE131m 8.74E-09 5'45E-09 3.63E-09 6.88E-09 3.86E-08 1.82E-05 6.95E-05 TE131 1.39E-12 7.44E-13 4.49E-13 1.17E-12 5.46E-12 1.74E-07 2.30E-09 4,
i TE132 3.25E-08 2.69E-08 2.02E-08 2.37E-08 1.82E-07 3.60E-05 6.37E-05 i 2.61E-06 9.61E-07 I 130 5.72E-07 1.68E-06 6.60E-07 1.42E-04 NO DATA I 131 3.15E-06 4.47E-06 2.56E-06 1.49E-03 7.66E-06 NO DATA 7.85E-07 9
] i CLINTON-I 3-40 Rev.0-4/85
--.n - - - . - - - -
I er _ _ _ --,-.-m.-,~ - - - - - . . _ . , - , .-w- ----,ir wr - - - - - -g ---r- -
CPS-0DCM Table 3.5-4 (continued)
INHALATION DOSE FACTORS FOR ADULT - (DFA g ),
(mrem per pCi inhaled)
NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI I 132 1.45E-07 4.07E-07 1.45E-07 1.43E-05 6.48E-07 NO DATA 5.08E-08 I 133 1.08E-06 1.85E-06 5.65E-07 2.69E-04 3.23E-06 NC DATA 1.11E-06 I 134 8.05E-08 2.16E-07 7.69E-08 3.73E-06 3.44E-07 NO DATA 1.26E-10 1 135 3.35E-07 8.73E-07 3.21E-07 5.60E-05 1.39E-06 NO DATA 6.56E-07 CS134 4.66E-05 '1.06E-04 9.10E-05 NO DATA 3.59E-05 1.22E-05 1.30E-06 CS136 4.88E-06 1.83E-05 1.38E-05 ~ NO DATA 1.07E-05 1.50E-06 1.46E-06 CS137 5.98E-05 7.76E-05 5.35E-05 NO DATA 2.78E-05 9.40E-06 1.05E-06 CS138 4.14E-08 7.76E-08 4.05E-08 NO DATA 6.00E-08 6.07E-09 2.33E-13 BA139 1.17E-10 8.32E-14 3.42E-12 NO DATA 7.78E-14 4.70E-07 1.12E-07 BA140 4.88E-06 6.13E-09 3.21E-07 NO DATA 2.09E-09 1.59E-04 2.73F-05 BA141 1.25E-11 9.41E-15 4.20E-13 NO DATA 8.75E-15 2.42E-07 1.4 5E-17 BA142 3.29E-12 3.38E-15 2.07E-13 NO DATA 2.86E-15 1.49E-07 1.96E-26 LA140 4.30E-08 2.17E-08 5.73E-09 NO DATA NO DATA 1.70E-05 5.73E-05 LA142 8.54E-11 3.88E-11 9.65E-12 NO DATA NO DATA 7.91E-07 2.64E-07 CE141 2.49E-06 1.69E-06 1.91E-07 NO DATA 7.83E-07 4.52E-05 1.50E-05
~CE143 2.33E-08 1.72E-08 1.91E-09 NO DATA 7.60E-09 9.97E-06 2.83E-05 CE144 4.20E-04 1.79E-04 2.30E-05 NO DATA 1.06E-04 9.72E-04 1.02E-04 PR143 1.17E-06 4.69E-07 5.80E-08 NO DATA 2.70E-07 3.51E-05 2.50E-05 PR144 3.76E-12 1.56E-12 1.91E-13 NO DATA 8.81E-13 1.27E-07 2.69E-18 ND147 6.59E-07 7.62E-07 4.56E-08 NO DATA 4.45E-07 2.76E-05 2.16E-05 W 187 1.06E-09 8.85E-10 3.10E-10 NO DATA NO DATA 3.63E-06 1.94E-05 2.87E-08 2.82E-09 1.55E-09 NO DATA 8.75E-09 4.70E-06 1.49E-05 NP239
- 2.27 X 10-06
- Less than 10-24 CLINTON-I 3-41 Rev.0-4/85
CPS-0DCM TABLE 3.5-5 GROUND PLANE DOSE FACTORS - DFG g (mrem /hr per pCi/m2)
"- -- ELEMENT TOTAL BODY SKIN H-3 0.0 0.0 C-14 0.0 0.0
-KA-24 -- 4 2.50E-08* 2.90E-08 P-32 0.0 0.0 CR-51 2.20E-08 2.60E-10 MN-54 5.80E-09 6.80E-09 MN-56. 1.10E-08 1.30E-08 FE-55 0.0 0.0 FE-59 8.00E-09 9.40E-09 CO-58 7.00E-09 8.20E-09 CO-6 1.70E-08 2.00E-08 NI-63 0.0 0.0 NI-65 3.70E-09 4.30E-09 CU-64 1.50E-09 1.70E-09 ZN-65 4.00E-09 4.60E-09 ZN-69 0.0 0.0 BR-83 6.40E-11 9.30E-11 BR-84 1.20E-08 1.40E-08 -
BR-85 0.0 0.0 RB-86 6.30E-10 7.20E-10 RB-88 3.50E-09 4.00E-09 RB-89 1.50E-08 1.80E-08
.- -SR-89 5.60E-13 6.50E-13 SR-91 7.10E-09 8.30E-09 SR-92 9.00E-09 1.00E-08 Y-90 2.20E-12 2.60E-12 Y-91m 3.80E-09 4.40E-09 Y-91 2.40E-11 2.70E-11 Y-92 1.60E-09 1.90E-09 Y-93 5.70E-10 7.80E-10 ZR-95 5.00E-09 5.80E-09 2R-97 5.50E-09 6.40E-09
'NB-95 5.10L-09 6.00E-09 MD-99 1.90E-09 2.20E-09 TC-99m 9.60E-10 1.10E-09
.TC-101 2.70E-09 3.00E-09 RU-103 3.60E-09 4.20E-09 RU-105 4.50E-09 5.10E-09 RU-106. 1.50E-09 1.80E-09 AG-110m 1.80E-08 2.10E-08 CLINTON-I 3-42 Rev.0-4/85 l-
- r. - . _..._ . . . . _ _ _ . . .
CPS-ODCM Table 3.5-5 (Continued)
GROUND PLANE DOSE FACTORS - DFG t
(mrem /hr per pCi/m2)
, _ _ - ELEMENT TOTAL BODY SKIN TE-125m 3.50E-11 4.80E-11 TE-127m 1.10E-12 1.30E-12
-TE-127 1.00E-11 1.10E-11
. . _ _ . .. TE-129m 7.70E-10 9.00E-10 TE-129 7.10E-10 8.40E-10 TE-131m 8.40E-09 9.90E-09 TE-131 2.20E-09 2.00E-09 I-130 1.40E-08 1.70E-08
. -- - _ .I-131 2.80E-09 3 . 4 0 E - 0 ",
I-132 1.70E-08 2.00E-Oo I-133 3.70E-09 4.50E-09 I-134 1.60E-08 1.90E-08 I-135 1.20E-08 1.40E-08
.; ; CS-134. 1.20E-08 1.40E-08 CS-136 1.50E-08 1.70E-08 CS-137 4.20E-09 4.90E-09 CS-138 2.10E-08 2.40E-08 BA-139 2.40E-09 2.70E-09
-. . . _ BA-140 2.10E-09 2.40E-09 BA-141 - 4.30E-09 4.90E-09 BA-142 7.90E-09 9.00E-09 LA-140 1.50E-08 1.70E-08 LA-142 1.50E-08 1.80E-08 CE-141 5.50E-10 6.20E-10 CE-143 2.20E-09 2.50E-09 CE-144 3.20E-10 3.70E-10 PR-143 0.0 0.0 PR-144 2.00E-10 2.30E-10 ND-147 1.00E-09 1.20E-09 W-187 3.10E-09 3.60E-09 NP-239 9.50E-10 1.10E-09
-~ - .
- 2.50 X 10-08 CLINTON-I- 3-43 Rev.0-4/85
l CPS-0DCM i
l TABLE 3.5-6 !
INGESTION DOSE FACTORS FOR INFANT - (DFLg )g (mrem per pCi ingested)
NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI H 3 NO DATA 3.08E-07 3.08E-07 3.08E-07 3.08E-07 3.08E-07 3.08E-07 C 14 2.37E-05* 5.06E-06 5.06E-06 5.06E-06 5.06E-06 5.06E-06 5.06E-06 NA 24 1.01E-05. 1.01E-05 1.01E-05 1.01E-05 1.01E-05 1.01E-05 1.01E-05 P 32 1.70E-03 1.00E-04 6.59E-05 NO DATA NO DATA NO DATA 2.30E-05 CR 51 NO DATA NO DATA 1.41E-08 9.20E-09 2.01E-09 1.79E-08 4.11E-07 MN 54 NO DATA 1.99E-05 4.51E-06 NO DATA 4.41E-06 NO DATA 7.31E-06 4
MN 56 NO DATA 8.18E-07 1.41E-07 NO DATA 7.03E-07 NO DATA 7.43E-05 FE 55 1.39E-05 8.98E-06 2.40E-06 NO DATA NO DATA 4.39E-06 1.14E-06
- FE 59 3.08E-05 5.38E-05 2.12E-05 NO DATA NO DATA 1.59E-05 2.57E-05 CO 58 NO DATA 3.60E-06 8.98E-06 NO DATA NO DATA NO DATA 8.97E-06 CO 60 NO DATA 1.08E-05 2.55E-05 NO DATA NO DATA NO DATA 2.57E-05 N1 03 6.34E-04 3.92E-05 2.20E-05 NO DATA NO DATA NO DATA 1.95E-06 N1 65 4.70E-06 5.32E-07 2.42E-07 NO DATA NO DATA NO DATA 4.05E-05 CU 64 ~.0 DATA 6.09E-07 2.82E-07 NO DATA 1.03E-06 NO DATA 1.25E-05 ZN 65 1.84E-05 6.31E-05 2.91E-05 NO DATA 3.06E-05 NO DATA 5.33E-05 ZN 69 9.33E-08 1.68E-07 1.25E-08 NO DATA 6.98E-08 NO DATA 1.37E-05 BR 83 NO DATA NO DATA 3.63E-07 NO DATA NO DATA NO DATA LT E-24**
- BR 84 NO DATA NO DATA 3.82E-07 NO DATA NO DATA NO DATA LT E-24 BR 85 NO DATA NO DATA- 1.94E-08 NO DATA NO DATA NO DATA LT E-24 RB 86 NO DATA 1.70E-04 8.40E-05 NO DATA NO DATA NO DATA 4.34E-06 RB 88 NO DATA 4.98E-07 2.73E-07 NO DATA NO DATA NO DATA 4.85E-07 RB 89 NO DATA 2.86E-07 1.97E-07 NO DATA NO DATA NO DATA 9.74E-08 SR 89 2.51E-03 NO DATA 7.20E-05 NO DATA 'NO DATA NO DATA 5.16E-05 SR 90 1.85E-02 NO DATA 4.71E-03 NO DATA NO DATA NO DATA 2.31E-04 SR 91 5.00E-05 NO DATA 1.81E-06 NO DATA NO DATA NO DATA 5.92E-05 SR 92 1.92E-05 NO DATA 7.13E-07 NO DATA NO DATA NO DATA 2.07E-04 Y 90 8.69E-08 NO DATA 2.33E-09 NO DATA NO DATA NO DATA 1.20E-04 CLINTON-I 3-44 -
Rev.0-4/85
CPS-0DCM
'f, k J
TABLE 3.5-6 (continued) f .
INGESTION DOSE FACTORS FOR INFANT - (DFL g ),
(mrem per pCi ingested)
,N_UCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI Y 91m 8.10E-10 NO DATA 2.76E-11 NO DATA NO DATA NO DATA 2.70E-06 4
Y 91 1.13E-06' NO DATA 3.01E-08 NO DATA NO DATA NO DATA 8.10E-05 4 Y 92 7.65E-09 NO DATA 2.15E-10 NO DATA NO DATA . NO DATA 1.46E-04 Y 93 2.43E-08 NO DATA 6.62E-10 NO DATA NO DATA NO DATA 1.92E-04 j ZR 95 2.06E-07 5.02E-08 3.56E-08 NO DATA 5.41E-08 NO DATA 2.50E-05 j ZR 97 1.48E-08 2.54E-09 1.16E-09 NO DATA 2.56E-09 NO DATA 1.62E-04
- j. _
d NB 95 4.20E-08 1.73E-08 1.00E-08 NO DATA 1.24E-08 NO DATA 1.46E-05 MO 99 NO DATA 3.40E-05 6.63E-06 NO DATA
. NO DATA 1.12E n]
.i
- TC 993 1.92E-09 3.96E-09 5.10E-08 NO DATA 4.26E-08 2.07E-09 1.15E-06 i
l i TC101 2.27E-09 2.86E-09 2.83E-08 NO DATA 3.40E-08 1.56E-09 4.86E-07 j- RU103 1.48E-06 NO DATA 4.95E-07 NO DATA 3.08E-06 NO DATA 1.80E-05 i RU105 1.36E-07 NO DATA 4.58E-08 NO DATA 1.00E-06 NO DATA 5.41E-05 RU106 2.41E-05 NO DATA 3.01E-06 NO DATA 2.85E-05 NO DATA 1.83E-04 i
AG110m 9.96E-07 7.27E-07 4.81E-07 NO DATA 1.04E-06 NO DATA 3.77E-05 l TE125m 2.33E-05 7.79E-06 3.15E-06 7.84E-06 NO DATA , NO DATA 1.11E-05 k
l TE127m 5.85E-05 1.94E-05 7.08E-06 1.69E-05 1.44E-04 NO DATA 2.36E-05 TE127 1.00E-06 3.35E-07 2.15E-07 8.14E-07 2.44E-06 NO DATA 2.10E-05 1 TE129m 1.00E-04 3.43E-05 1.54E-05 3.84E-05 2.50E-04 NO DATA 5.97E-05 0
TE129 2.84E-07 9.79E-08 6.63E-08 2.38E-07 7.07E-07 NO DATA 2.27E-05 TE131m 1.52E-05 6.12E-06 5.05E-06 1.24E-05 4.21E-05 NO DATA 1.03E-04 TE131 1.76E-07 6.50E-08 4.94E-08 1.57E-07 4.50E-07 NO DATA 7.11E-06 i TE132 2.08E-05 1.03E-05 9.61E-06 1.52E-05 6.44E-05 NO DATA 3.81E-05 I 130 6.00E-06 1.32E-05 5.30E-06 1.48E-03 1.45E-05 NO DATA 2.83E-06 I 131 3.59E-05 4.23E-05 1.86E-05 1.39E-02 4.94E-05 NO DATA 1.51E-06 l
j I 132 1.66E-06 3.37E-06 1.20E-06 1.58E-04 3.76E-06 NO DATA 2,73E-06
]- I 133 1.25E-05 1.82E-05 5.33E-06 3.31E-03 2.14E-05 NO DATA 3.08E-06
- I 134 8.69E-07 1.78E-06 6.33E-07 4.15E-05 1.99E-06 NO DATA 1.84E-06 F
1 j CLINTON-I 3-45 Rev.0-4/85
CPS-0DCM TABLE 3.5-6 (continued)
INGESTION DCSE FACTORS FOR INFANT - (DFL g ),
(mrem per pCi ingested)
NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI I 135 3.64E-06 7.24E-06 2.64E-06 6.49E-04 8.07E-06 NO DATA 2.62E-06 CS134 3.77E-04 7.03E-04 7.10E-05 NO DATA 1.81E-04 7.42E-05 1.91E-06
-CS136 4.59E-05 1.35E-04 5.04E-05 NO DATA 5.38E-05 1.10E-05 2.05E-06 CS137 5.22E-04 6.11E-04 4.33E-05 NO DATA 1.64E-04 6.64E-05 1.91E-06 CS138 4.81E-07 7.82E-07 3.79E-07 NO DATA 3.90E-07 6.09E-08 1.25E-06 BA139 8.81E-07 5.84E-10 2.55E-08 NO DATA 3.51E-10 3.54E-10 5.58E-05 BA140 1.71E-04 1.71E-07 8.81E-06 NO DATA 4.06E-08 1.05E-07 4.20E-05 BA141 4.25E-07 2.91E-10 1.34E-08 NO DATA 1.75E-10 1.77E-10 5.19E-06 BA142 1.84E-07 1.53E-10 9.06E-09 NO DATA 8.81E-11 9.26E-11 7.59E-07 LA140 2.11E-08 8.32E-09 2.14E-09 NO DATA NO DATA NO DATA 9.77E-05 LA142 1.10E-09 4.04E-10 9.67E-11 NO DATA NO DATA NO DATA 6.86E-05 CE141 7.87E-08 4.80E-08 5.65E-09 NO DATA 1.48E-08 NO DATA 2.48E-05 CE143 1.48E-08 9.82E-06 1.12E-09 NO DATA 2.86E-09 NO DATA 5.73E-05 CE144 2.98E-06 1.22E-06 1.67E-07 NO DATA 4.93E-07 NO DATA 1.71E-04 PR143 8.13E-08 3.04E-08 4.03E-09 NO DATA 1.13E-08 NO DATA 4.29E-05 PR144 2.74E-10 1.06E-10 1.38E-11 NO DATA 3.84E-11 NO DATA 4.93E-06 ND147 5.53E-08 5.68E-08 3.48E-09 NO DATA 2.19E-08 NO DATA 3.60E-05 W 187 9.03E-07 6.28E-07 2.17E-07 NO DATA NO DATA NO DATA 3.69E-05 l
NP239 1.11E-08 9.93E-10 5.61E-10 NO DATA 1.98E-09 NO DATA 2.87E-05 l
- 2.37 X'10-05 l ** Less than 10-24 l
l CLINTON-I 3-46 Rev 0-4/85
CPS-ODCM TABLE 3.5-7 INGESTION DOSE FACTORS FOR CHILD - (DFL g ),
(mrem per pCi ingested)
NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI
'H 3 NO DATA 2.03E-07 2.03E-07 2.03E-07 2.03E-07 2.03E-07 2.03E-07 C 14 1.21E-05* 2.42E-06 2.42E-06 2.42E-06 2.4 2E-06 2.4 2E-06 2.4 2E-06 NA 24 5.80E-06 5.80R-06 5.80E-06 5.80E-06 5.80E-06 5.80E-06 5.80E-06 P 32^ 8.25E-06 3.86E-05 3.18E-05 NO DATA NO DATA NO DATA 2.28E-05 CR 51 NO DATA NO DATA. 8.90E-09 4.94E-09 1.35E-09 9.02E-09 4.72E-07 MN 54 NO DATA 1.07E-05 2.85E-06 NO DATA 3.00E-06 NO DATA 8.98E-06 MN 56 NO DATA 3.34E-07 7.54E-08 NO DATA 4.04E-07 NO DATA 4.84E-05 FE 55 1.15E-05 6.10E-06 1.89E-06 NO DATA NO DATA 3.45E-06 1.13E-06 FE 59 1.65E-05 2.67E-05 1.33E-05 NO DATA NO DATA 7.74E-06 2.78E-05 CO 58 NO DATA 1.80E-06 5.51E-06 NO DATA NO DATA NO DATA 1.05E-05 CO 60 NO DATA 5.29E-06 1.56E-05 NO DATA NO DATA NO DATA 2.93E-05 NI 63 5.38E-04 2.88E-05 1.83E-05 NO DATA NO DATA NO DATA 1.94E-06 NI 65 2.22E-06 2.09E-07 1.22E-07 NO DATA NO DATA NO DATA 2.56E-05 CU 64 NO DATA 2.45E-07 1.48E-07 NO DATA 5.92E-07 NO DATA 1.15E-05 ZN 65 1.37E-05 3.65E-05 2.27E-05 NO DATA 2.30E-05 140 DATA 6.41E-06 ZN 69 4.38E-08 6.33E-08 5.85E-09 NO DATA 3.84E-08 NO DATA 3.99E-06 BR 83 NO DATA NO DATA 1.71E-07 NO DATA NO DATA NO DATA LT E-24**
BR 84 NO DATA NO DATA 1.98E-07 NO DATA NO DATA NO DATA LT E-24 BR 85 NO DATA NO DATA 9.12E-09 NO DATA NO DATA NO DATA LT E-24 RB 86 NO DATA 6.70E-05 4.12E-05 NO DATA NO DATA NO DATA 4.31E-06 RB 88 NO DATA 1.90E-07 1.32E-07 NO DATA NO DATA NO DATA 9.32E-09 l
RB 89 NO DATA 1.17E-07 1.04E-07 NO DATA NO DATA NO DATA 1.02E-09 SR 89 1.32E-03 NO DATA 3.77E-05 NO DATA NO DATA NO DATA 5.11E-05 SR 90 1.70E-02 NO DATA 4.31E-03 NO DATA NO DATA NO DATA 2.29E-04 CLINTON-I 3-47 Rev.0-4/85
. CPS-0DCM i S. i l i j TABLE 3.5-7 (continued)
INGESTION DOSE FACTORS FOR CHILD - (DFL g ),
, (mram per pCi ingested)
).
NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI SR 91 2.40E-05 NO DATA 9.06E-07 NO DATA NO DATA NO DATA 5.30E-05 SR 92 9.03E-06 NO DATA 3.62E-07 NO DATA NO DATA NO DATA 1.71E-04
,I 4.11E-08
' Y 90 NO DATA 1.10E-09 NO DATA NO DATA NO DATA 1.17E-04
] .
"f~ Y91m -- 3.82E-10 Y 91 6.02E-07 NO DATA NO DATA 1.30E -11 1.61E-08 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 7.48E-07 8.02E-05 l
, Y 92 3.60E-09 NO DATA 1.03E-10 NO DATA NO DATA NO DATA 1.04E-04 3
'W- Y 93 1.14E-08 NO DATA 3.13E-10 NO DATA NO DATA NO DATA 1.70E-04
-} ZR 95 1.16E-07 2.55E-08 2.27E-08 NO DATA 3.65E-08 NO DATA 2.66E-05 i ZR 97 6.99E-09 1.01E-09 5.96E-10 NO DATA 1.45E-09 NO DATA 1.53E 1
_ ~ _ . _
NB 95 2.25E-08 8.76E-09 6.26E-09 NO DATA 8.23E-09 NO DATA 1.62E-05
'l MO 99 NO DATA 1.33E-05 3.29E-06 NO DATA 2.84E-05 NO DATA 1.10E-05 TC 99 9.23E-10 1.81E-09 3.00E-08 NO DATA 2.63E-08 9.19E-10 1.03E-06 i
TC101 1.07E-09 1.12E-09 1.42E-08 NO DATA 1.91E-08 5.92E-10 3.56E-09
- RU103 7.31E-07 NO DATA 2.81E-07 NO DATA 1.84E-06 NO DATA 1.89E-05 RU105 6.45E-08 NO DATA 2.34E-08 NO DATA 5.67E-07 NO DATA 4.21E-05 e
..j .
[ RU106 1.17E-05 NO DATA 1.46E-06 NO DATA 1.58E-05 NO DATA 1.82E-04
!! -AG110m 5.39E-07 3.64E-07 2.91E-07 NO DATA 6.7bE-07 NO DATA 4.33E-05 l TE125m 1.14E-05 3.09E-06 1.52E-06 3.20E-06 NO DATA NO DATA 1.10E-05 4
.: p -
d TE127m 2.89E-05 7.78E-06 3.43E-06 6.91E-06 8.24E-05 NO DATA 2.34E-05 TE127 4.71E-07 1.27E-07 1.01E-07 3.26E-07 1.34E-04 NO DATA 1.84E-05
] TE129a 4.87E-05 1.36E-05 7.56E-06 1.57E-05 1.43E-04 NO DATA 5.94E-05 i
_ q _. - ,
TE129 1.34E-07 3.74E-08 3.18E-08 9.56E-08 3.92E-07 NO DATA 8.34E-06 TE131a 7.20E-06 2.49E-06 2.65E-06 5.12E-06 2.41E-05 NO DATA 1.01E-04 TE131 8.30E-08 2.53E-08 2.47E-08 6.35E-08 2.51E-07 NO DATA 4.36E-07
, o 2
CLINTON-I 3-48 Rev.0-4/85
CPS-0DCM TABLE 3.5-7 (continued)
INGESTION DOSE FACTORS FOR CHILD - (DFLg ) ,
(mrem per pCi ingested)
NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI TE132 1.01E-05 4.47E-06 5.40E-06 6.51E-06 4.15E-05 NO DATA 4.50E-05 I 130 2.92E-06 5.90E-06 3.04E-06 6.50E-04 8.82E-06 NO DATA 2.76E-06 I 131 1.72E-05 1.73E-05 9.83E-06 5.72E-03 2.84E-05 NO DATA 1.54E-06 I 132 8.00E-07 1.47E-06 6.76E-07 6.82E-05 2.25E-06 NO DATA 1.73E-06 I 133 5.92E-06 7.32E-06 2.77E-06 1.36E-03 1.22E-05 NO DATA 2.95E-06 I 134 4.19E-07 7.78E-07 3.58E-07 1.79E-05 1.19E-06 NO DATA 5.16E-07 I 135 1.75E-06 3.15E-06 1.49E-06 2.79E-04 4.83E-06 NO DATA 2.40E-06 CS134 2.34E-04 3.84E-04 8.10E-05 NO DATA 1.19E-04 4.27E-05 2.07E-06 CS136 2.35E-05 6.46E-05 4.18E-05 NO DATA 3.44E-05 5.13E-06 2.27E-06
' CS137 3.27E-04 3.13E-04 4.62E-05 NO DATA 1.02E-04 3.67E-05 1.96E-06 ,
CS138 2.28E-07 3.17E-07 2.01E-07 NO DATA 2.23E-07 2.40E-08 1.46E-07 BA139~ 4.14E-07 2.21E-10 1.20E-08 NO DATA 1.93E-10 1.30E-10 2.39E-05 BA140 8.31E-05 7.28E-08 4.85E-06 NO DATA 2.37E-08 4.34E-08 4.21E-05 BA141 2.00E-07 1.12E-10 6.51E-09 NO DATA 9.69E-11 6.58E-10 1.14E-07 BA142 8.74E-08 6.29E-11 4.88E-09 NO DATA 5.09E-11 3.70E-11 1.14E-09 LA140 1.01E-08 3.53E-09 1.10E-09 NO DATA NO DATA NO DATA 9.84E-05 LA142- 5.24E-10 1.67E-10 5.23E-11 NO DATA NO DATA NO DATA 3.31E-05 CE141 8.97E-08 1.98E-08 2.94E-09 NO DATA 8.68E-09 NO DATA 2.47E-05 CE143 6.99E-09 3.79E-06 5.49E-10 NO DATA 1.59E-09 NO DATA 5.55E-05 CE144 2.08E-06 6.52E-07 1.11E-07 NO DATA 3.61E-07 NO DATA 1.70E-04 PR143 3.93E-08 1.18E-08 1.95E-09 NO DATA 6.39E-09 NO DATA 4.24E-05 PR144 1.29E-10 3.99E-11 6.49E-12 NO DATA 2.11E-11 NO DATA 8.59E-08 ND147 2.79E-08 2.26E-08 1.75E-09 NO DATA 1.24E-08 NO DATA 3.58E-05 W 187 4.29E-07 2.54E-07 1.14E-07 NO DATA NO DATA .NO DATA 3.57E-05 NP239 5.25E-09 3.77E-10 2.65E-10 NO DATA 1.09E-09 NO DATA 2.79E-05
- 1.21 X 10-05
- Less than 10-24 CLINTON-I 3-49 Rev.0-4/85
CPS-0DCM TABLE 3.5-8 INGESTION DOSE FACTORS FOR TEEN - (DFL g ),
(mrem per pCi ingested)
NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI H 3 NO DATA 1.06E-07 1.06E-07 1.06E-07 1.06E-07 1.06E-07 1.06E-07 C 14 4.06E-06* 8.12E-07 8.12E-07 8.12E-07 8.12E-07 8.12E-07 8.12E-07 NA 24 2.30E-06 2.30E-06 2.30E-06 2.30E-06 2.30E-06 2.30E-06 2.30E-06 u
P 32 2.76E-04 1.71E-05 1.07E-05 NO DATA NO DATA NO DATA 2.32E-05 CR 51 NO DATA NO DATA 3.60E-09 2.00E-09 7.89E-10 5.14E-09 6.05E-07 MN 54 NO DATA 5.90E-06 1.17E-06 NO DATA 1.76E-06 NO DATA 1.21E-05 MN 56 NO DATA 1.58E-07 2.81E-08 NO DATA 2.00E-07 NO DATA 1.04E-05 FE 55 3.78E-06 2.68E-06 6.25E-07 NO DATA NO DATA 1.70E-06 1.16E-06 FE 59 5.87E-06 1.37E-05 5.29E-06 NO DATA NO DATA 4.32E-06 3.24E-05 1
CO 58 NO DATA 9.72E-07 2.24E-06 NO DATA NO DATA NO DATA 1.34E-05 CO 60 NO DATA 2.81E-06 6.33E-06 NO DATA NO DATA NO DATA 3.66E-05 NI 63 1.77E-04 1.25E-05 6.00E-06 NO DATA NO DATA NO DATA 1.99E-06 i
NI 65 7.49E-07 9.57E-08 4.36E-08 NO DATA NO DATA NO DATA 5.19E-06 CU 64 NO DATA 1.15E-07 5.41E-08 NO DATA 2.91E-07 NO DATA 8.92E-06 4 ZN 65 5.76E-06 2.00E-05 9.33E-06 NO DATA 1.28E-05 NO DATA 8.47E-06 ZN 69 1.47E-08 2.80E-08 1.96E-09 NO DATA 1.83E-08 NO DATA 5.16E-08
. BR 83 NO DATA NO DATA 5.74E-08 NO DATA NO DATA NO DATA LT E-24**
BR 84 NO DATA NO DATA 7.22E-08 NO DATA NO DATA NO DATA LT E-24 BR 85 NO DATA NO DATA 3.05E-09 NO DATA NO DATA NO DATA LT E-24 RB 86 NO DATA 2.98E-05 1.40E-05 NO DATA NO DATA NO DATA 4.41E-06 RB 88 NO DATA 8.52E-08 4.54E-08 NO DATA NO DATA NO DATA 7.30E-15 i
CLINTON-I 3-50 Rev.0-4/85 1
CPS-ODCM !
! \ l TABLE 3.5-8 (continued)
INGESTION DOSE FACTORS FOR TEEN - (DFL g ),
(mrem per pCi ingested) i
-NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI RB 89 NO DATA 5.50E-08 3.89E-08 NO DATA NO DATA NO DATA 8.43F-17 SR 89 4.40E-04 NO DATA 1.26E-05 NO DATA NO DATA NO DATA 5.24E-05 SR 90 8.30E-03 NO DATA 2.05E-03 NO DATA NO DATA NO DATA 2.33E-04 SR 91 8.07E-06 NO DATA 3.21E-07 NO DATA NO DATA NO DATA 3.66E-05 3 SR 92 3.05E-06 NO DATA 1.30E-07 NO DATA NO DATA NO DATA 7.77E-05 j Y 90 1.37E-08 NO DATA 3.69E-10 NO DATA NO DATA NO DATA 1.13E-04, l' Y 91m 1.29E-10 NO DATA -
4.93E-12 NO DATA NO DATA NO DATA 6.09E-09 j Y 91 2.01E-07 NO DATA 5.39E-09 NO DATA NO DATA NO DATA 8.24E-05
, Y 92 1.21E-09 NO DATA 3.50E-11 NO DATA NO DATA NO DATA 3.32E-05 I
j Y 93 3.83E-09 NO DATA 1.05E-10 NO DATA NO DATA NO DATA 1.17E-04
! ZR 95 4.12E-08 1.80E-08 8.94E-09 NO DATA 1.91E-08 NO DATA 3.00E-05 l ZR 97 2.37E-09 4.69E-10 2.16E-10 NO DATA 7.11E-10 NO DATA 1.27E-04 I
j NB 95 8.22E-09 4.56E-09 2.51E-09 NO DATA 4.42E-09 NO DATA 1.95E-05 4 MO 99 NO DATA 6.03E-06 1.15E-06 NO DATA 1.38E-05 NO DATA 1.08E-05 TC 99m 3.32E-10 9.26E-10 1.20E-08 NO DATA 1.38E-08 5.14E-10 6.08E-07 i
v_.
- I TC101 3.60E-10 5.12E-10 5.03E-09 NO DATA 9.26E-09 3.12E-10 8.75E-17
'I RU103 2.55E-07 NO DATA 1.09E-07 NO DATA 8.99E-07 NO DATA 2.13E-05 RU105 2.18E-08 NO DATA 8.46E-09 NO DATA 2.75E-07 NO DATA 1.76E-05
]
4 j RU106 3.92E-06 NO DATA 4.94E-07 NO DATA 7.56E-06 NO DATA 1.88E-04 i AG110m 2.05E-07 1.94E-07 1.18E-07 NO DATA 3.70E-07 NO DATA 5.45E-05
.j TE125m 3.83E-06 1.38E-06 5.12E-07 1.07E-06 NO DATA NO DATA 1.13E-05 t
e i
0 CLINTON-I 3-51 Rev.0-4/85 4 e - - e. 4r e .d ..4 wo u g *, m e e . ,e ..e . . . . . _.y.go , .e e+
$, ~
CPS-ODCM
- -(
- , TABLE 3.5-8 (continued)
J INGESTION DOSE FACTORS FOR TEEN - (DFL t ),
. (mrem per pCi ingested)
(
J l NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI TE127a 9.67E-06 3.43E-06 1.15E-06 2.30E-06 3.92E-05 NO DATA 2.41E-05 TE127 1.58E-07 5.60E-08 3.40E-08 1.09E-07 6.4-E-07 NO DATA 1.22E-05 TE129s 1.63E-05 6.05E-06 2.58E-06 5.26E-06 6.82E-05 NO DATA 6.12E-05
((j TE129 4.48E-08 1.67E-08 1.09E-08 3.20E-08 1.88E-07 NO DATA 2.45E-07 TE131m 2.44E-06 1.17E-06 9.76E-07 1.76E-06 1 22E-05 NO DATA 9.39E-05 j TE131 2.79E-08 1.15E-08 8.72E-09 2.15E-08 1.22E-07 NO DATA 2.29E-09 d
TE132 3.49E-06 2.21E-06 2.08E-06 2.33E-06 2.12E-05 NO DATA 7.00E-05 I 130 1.03E-06 2.98E-06 1.19E-06 2.43E-04 4.59E-06 NO DATA 2.29E-06 q I 131 5.85E-06 8.19E-06 4.40E-06 2.39E-03 1.41E-05 NO DATA 1.62E-06 I 132 2.79E-07 7.30E-07 2.62E-07 2.46E-05 1.15E-06 NO DATA 3.18E-07 I 133 2.01E-06 3.41E-06 1.04E-06 4.76E-04 5.98E-06 NO DATA 2.58E-06
} I 134 1.46E-07 3.87E-07 1.39E-07 6.45E-06 6.10E-07 NO DATA 5.10E-09
))
I 135 6.10E-07 1.57E-06 5.82E-07 1.01E-04 2.48E-06 NO DATA 1.74E-06 CS134 8.37E-05 1.97E-04 9.14E-05 NO DATA 6.26E-05 2.39E-05 2.45E-06
~; CS136 8.59E-06 3.38E-05 2.27E-05 NO DATA 1.84E-05 2.90E-06 2.72E-06 l
- CS137 1.12E-04 1.49E-04 5.19E-05 NO DATA 5.07E-05 1.97E-05 2.12E-06 s -j CS138 7.76E-08 1.49E-07 7.45E-08 NO DATA 1.10E-07 1.28E-08 6.76E-11
=1 BA139 1.39E-07 9.78E-11 4.05E-09 NO DATA 9.22E-11 6.74E-11 1.24E-06 1
BA140 2.84E-05 3.48E-08 1.83E-06 NO DATA 1.18E-08 2.34E-08 4.38E-05
.I BA141 6.71E-08 5.01E-11 2.24E-09 NO DATA 4.65E-11 3.43E-11 1.43E-13 BA142 2.99E-08 2.99E-11 1.84E-09 NO DATA 2.53E-11 1.99E-11 9.18E-20
.J
,j 1
e
<]
q II '
CLINTON-I 3-52 Rev.0-4/85 I
A w- -- -- -- - *,w--y r- - ---w--3---,w-_,.w= +---.+w g-n-m- - - -, ,-we- * - - - - w-w ---g---we,. w,ewv" e we -us-we ur e== aww--- ,-g*-ww---re-w--w---m-v~'-mww--
CPS-ODCM )
TABLE 3.5-8 (continued)
INGESTION DOSE FACTORS FOR TEEN - (DFL g ),
(mrem per pCi ingested)
NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI LA140 3.48E-09 1.71E-09 4.55E-10 NO DATA NO DATA NO DATA 9.82E-05 LA142 1.79E-10 7.95E-11 1.98E-11 NO DATA NO DATA NO DATA 2.42E-06 CE141 1.33E-08 8.88E-09 1.02E-09 NO DATA 4.18E-09 NO DATA 2.54E-05 CE143 2.35E-09 1.71E-06 1.91E-10 NO DATA 7.67E-10 NO DATA 5.14E-05 CE144 6.96E-07 2.88E-07 3.74E-08 NO DATA 1.72E-07 NO DATA 1.75E-04 PR143 1.31E-08 5.23E-09 6.52E-10 NO DATA 3.04E-09 NO DATA 4.31E-05 PR144 4.30F-11 1.76E-11 2.18E-12 NO DATA 1.01E-11 NO DATA 4.74E-14 ND147 9.38E-09 1.02E-08 6.11E-10 NO DATA 5.99E-09 NO DATA 3.68E-05 W'187 1.46E-07 1.19E-07 4.17E-08 NO DATA NO DATA NO DATA 3.22E-05 NP239 1.76E-09 1.66E-10 9.22E-11 NO DATA 5.21E-10 NO DATA 2.67E-05
- 4.06 X 10-06
- Less than 10-24 CLINTON-I 3-53 Rev.0-4/85
CPS-0DCM TABLE 3.5-9 INGESTION DOSE FACTORS FOR ADULT - (DFL t ),
(mrem per pCi ingested) e a -NUCLIDE -- BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ;
H 3 NO DATA 1.05E-07 1.05E-07 1.05E-07 1.05E-07 1.05E-07 1.05E-07 C 14 2.84E-06* 5.68E-07 5.68E-07 5.68E-07 5.68E-07 5.68E-07 5.68E-07 NA 24 1.70E-06 1.70E-06 1.70E-06 1.70E-06 1.70E-06 1.70E-06 1.70E-06 P 32 1.93E-04 1.20E-05 7.46E-06 NO DATA NO DATA NO DATA 2.17E-05 CR 51 NO DATA NO DATA 2.66E-09 1.59E-09 5.86E-10 3.53E-09 6.69E-07 MN 54 NO DATA 4.57E-06 8.72E-07 NO DATA 1.36E-06 NO DATA 1.40E-05 NN 56 NO DATA 1.15E-07 2.04E-08 NO DATA 1.46E-07 NO DATA 3.67E-06 FE 55 2.75E-06 1.90E-06 4.43E-07 NO DATA NO DATA 1.06E-06 1.09E-06 FE 59 4.34E-06 1.02E-05 3.91E-06 NO DATA NO DATA 2.85E-06 3.40E-05 CO 58 NO DATA 7.45E-07 1.67E-06 NO DATA NO DATA NO DATA 1.51E-05 CO 60 NO DATA 2.14E-06 4.72E-06 NO DATA NO DATA NO DATA 4.02E-05 NI-63 1.30E-04 9.01E-06 4.36E-06 NO DATA NO DATA NO DATA 1.88E-06 NI 65 5.28E-07 6.86E-08 3.13E-08 ' NO DATA NO DATA NO DATA 1.74E-06 CU 64 NO DATA 8.33E-08 3.91E-08 NO DATA 2.10E-07 NO DATA 7.10E-06 ZN 65 4.84E-06 1.54E-05 6.96E-06 NO DATA 1.03E-05 NO DATA 9.70E-06 ZN 69 1.03E-08 1.97E-08 1.37E-09 NO DATA 1.28E-08 NO DATA 2.96E-09 BR 83 NO DATA NO DATA 4.02E-08 NO DATA NO DATA NO DATA 5.79E-08
- BR 84 NO DATA NO DATA 5.21E-08 NO DATA NO DATA NO DATA 4.09E-13 BR 85 NO DATA NO DATA 2.14E-09 NO DATA NO DATA NO DATA LT E-24**
RB 86 NO DATA 2.11E-05 9.83E-06 NO DATA NO DATA NO DATA 4.16E-06 RB 88 NO DATA 6.05E-08 3.21E-08 NO DATA NO DATA NO DATA 8.36E-19 i
CLINTON-I 3-54 Rev.0-4/85
CPS-0DCM 1 Si (
l TABLE 3.5-9 (continued)
INGESTION DOSE FACTORS FOR ADULT - (DFL g ),
(mrem per pCi ingested)
.' NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI s
RB 89 NO DATA 4.01E-08 2.82E-08 NO DATA NO DATA NO DATA 2.33E-21 SR 89 3.08E-04 NO DATA 8.84E-06 NO DATA NO DATA NO DATA 4.94E-05 SR 90 7.58E-03 NO DATA 1.86E-03 NO DATA NO DATA NO DATA 2.19E-04
.. 1 - . .
. SR 91 5.67E-06 NO DATA 2.29E-07 NO DATA NO DATA NO DATA 2.70E-05 i SR 92 2.15E-06 NO DATA 9.30E-08 NO DATA NO DATA NO DATA 4.26E-05 1 2.58E-10 1.02E-04 Y 90 9.62E-09 NO DATA NO DATA NO DATA NO DATA 0 ._._ _.
j Y 91m 9.09E-11 NO DATA 3.52E-12 NO DATA NO DATA NO DATA 2.67E-10
, ! Y 91 1.41E-07 NO DATA 3.77E-09 NO DATA NO DATA NO DATA 7.76E-05 Y 92 8.45E-10 NO DATA 2.47E-11 NO DATA NO DATA NO DATA 1.48E-05 -
! Y 93 2.68E-09 NO DATA 6.40E-11 NO DATA NO DATA NO DATA 8.50E-05 1 ZR 95 3.04E-08 9.75E-09 6.60E-09 NO DATA 1.53E-08 NO DATA 3.09E-05 l ZR 97 1.68E-09 3.39E-10 1.55E-10 NO DATA 5.12E-10 NO DATA 1.05E-04 1 .
g NB 95 6.22E-09 3.46E-09 1.86E-09 NO DATA 3.42E-09 NO DATA 2.10E-05 MO 99 NO DATA 4.31E-06 8.20E-07 NO DATA 9.76E-06 NO DATA 9.99E-06
, TC 99m 2.47E-10 6.98E-10 8.89E-09 NO DATA 1.06E-08 3.42E-10 4.13E-07
.' i -
TC101 2.54E-10 3.66E-10 3.59E-09 NO DATA 6.59E-09 1.87E-10 1.10E-21 4
RU103 1.85E-07 NO DATA 7.97E-08 NO DATA 7.06E-07 NO DATA 2.16E-05 RU105 1.54E-08 NO DATA 6.08E-09 NO DATA 1.99E-07 NO DATA 9.42E-06
- 1
'i
.j RU106 2.75E-06 NO DATA 3.48E-07 NO DATA 5.31E-06 NO DATA 1.78E-04
- .j' AG110m 1.60E-07 1.48E-07 8.79E-08 NO DATA 2.91E-07 NO DATA 6.04E-05 3
TE125m 2.68E-06 9.71E-07 3.59E-07 8.06E-07 1.09E-05 NO DATA 1.07E-05
,i.
1 1
? ,1 t
CLINTON-I 3-55 Rev.0-4/85 i
I t
CPS-0DCM
- 6. 1 g.
TABLE 3.5-9 (continued)
INGESTkONDOSEFACTORSFORADULT-(DFL), g
[ (mrem per pCi ingested)
NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI TE127m 6.77E-06 2.42E-06 8.25E-07 1.73E-06 2.75E-05 NO DATA 2.27E-05
. TE127 1.10E-07 3.95E-08 2.38E-08 8.15E-08 4.48E-07 NO DATA 8.68E-06 TE129m 1.15E-05 4.29E-06 1.82E-06 3.95E-06 4.80E-05 NO DATA 5.79E-05
]
1 r
TE129 3.14E-08 1.18E-08 7.65E-09 2.41E-08 1.32E-07 NO DATA 2.37E-08
! TE131a 1.73E-06 8.46E-07 7.05E-07 1.34ELO6 8.57E-06 NO DATA 8.40E-05
-l TE131 1.97E-08 8.23E-09 6.22E-09 1.62E-08 8.'63E-08 NO DATA 2.79E-09 i TE132 2.52E-06 1.63E-06 1.53E-06 1.80E-06 1.57E-05 NO DATA 7.71E-05 1 I 130 7.56E-07 2.23E-06 8.80E-07 1.89E-04 3.48E-06 NO DATA 1.92E-06 j I 131 4.16E-06 5.95E-06 3.41E-06 1.95E-03 1.02E-05 NO DATA 1.57E ,
I 132 2.03E-07 5.43E-07 1.90E-07 1.90E-05 8.65E-07 NO DATA 1.02E-07 I 133 1.42E-06 2.47E-06 7.53E-07 3.63E-04 4.31E-06 NO DATA 2.22E-06 I 134 1.06E-07 2.88E-07 1.03E-07 4.99E-06 4.58E-07 NO DATA 2.51E-10 i
i' I 135 4.43E-07 1.16E-06 4.28E-07 7.65E-05 1.86E-06 NO DATA 1.31E-06 CS134 6.22E-05 1.48E-04 1.21E-04 NO DATA 4.79E-05 1.59E-05 2.59E-06 CS136 6.51E-06 2.57E-05 1.85E-05 NO DATA 1.43E-05 1.96E-06 2.92E-06 CS137 7.97E-05 1.09E-04 7.14E-05 NO DATA 3.70E-05 1.23E-05 2.11E-06
- CS138 5.52E-08 1.09E-07 5.40E-08 NO DATA 8.01E-08 7.91E-09 4.65E-13
{ BA139 9.70E-08 6.91E-11 2.84E-09 NO DATA 6.46E-11 3.92E-11 1.72E-07 l
,1 1 BA140 2.03E-05 2.55E-08 1.33E-06 NO DATA 8.67E-09 1.46E-08 4.18E-05 BA141 4.71E-08 3.56E-11 1.59E-09 NO DATA 3.31E-11 2.02E-11 2.22E-17 i
BA142 2.13E-08 2.19E-11 1.34E-09 NO DATA 1.85E-11 1.24E-11 3.00E-26 j .
i l
i i
4 i
l e t
i CLINTON-I 3-56 Rev 0-4/85
- ebge= me wag -e. e ee -etN e sum m eegam *h =~ w - * -e
CPS-0DCM TABLE 3.5-9 (continued)
INGESTION DOSE FACTORS FOR ADULT - (DFL g ),
(mrem per pCi ingested)
. NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI LA140 2.50E-09 1.26E-09 3.33E-10 NO DATA NO DATA NO DATA 9.25E-05 LA142 1.28E-10 5.82E-11 1.45E-11 NO DATA NO DATA NO DATA 4.25E-07 CE141 -9.36E-09 6.33E-09 7.18E-10 NO DATA 2.94E-09 NO DATA 2.42E-05 CE143 1.65E-09 1.22E-06 1.35E-10 NO DATA 5.37E-10 NO DTA 4.56E-05 CE144 4.88E-07 2.04E-07 2.62E-08 NO DATA 1.21E-07 NO DATA 1.65E-04 PR143 9.20E-09 3.69E-09 4.56E-10 NO DATA 2.13E-09 NO DATA 4.03E-05 PR144 3.01E-11 1.25E-11 1.53E-12 NO DATA 7.05E-12 NO DATA 4.33E-18 ND147 6.29E-09 7.27E-09 4.35E-10 NO DATA 4.25E-09 NO DATA 3.49E-05 W 187 1.03E-07 8.61E-08 3.01E-08 NO DATA NO DATA NO DATA 2.82E-05 NP239 1.19E-09 1.17E-10 6.45E-11 NO DATA 3.65E-10 NO DATA 2.40E-05
- 2.84 X 10-06
- Less than 10-24 CLINTON-I 3-57 Rev.0-4/85
CPS-0DCM l\
TABLE 3.5-10
- j C
INPUT PARAMETERS FOR CALCULATING R t
Parameter Value Table
- Q p.(kg/ day) 50 for cow E-3 4 6 for goat .
E-3 Uap (liters /yr) -- Infant 330 E-5 Child 330 E-5
~ - Teen 400
- E-5
, [__ . . . .. . _ . _ . . . ~
- Adult 310 E-5 j Yp 0.7 E-15 (kg/m2)
Ys_(kg/m2) 2.0 E-15 q-a F,(days / liter) . Each stable element for cow E-1.
j . Each stable element for goat E-2
~;
i r (dimensionless) 1.0 for radioiodine E-15
- r --
0.2 for particulates E-15 e 1.73 x 105 (2 days) E-15 f (seconds) j 7.78 x 106 (90 days) E-15 h Iseconds) t
,.t--~- _
f, (dimensionless) 1.0 for cow NUREG
- 1.0 for goat -0133 Section o ,
5.3.1.3
.u l 1.0 for cow NUREG
- fP (dimensionless) 1.0 for goat -0133 i Section j 5.3.1.3 t-l
.l.. , _ .
.I 4
I i
- of Regulatory Guide 1.109 unless atherwise stated 4 r l
i CLINTON-I 3-58 Rev.0-4/85 1
i
CPS-ODCM a ',
, 's i
j TABLE 3.5-11
'l - M INPUT PARAMETERS FOR CALCULATING R t
i Parameter Value Table *
~.
U 8P-(kg/yr) - Infant 0 E-5
- Child 41 E-5
-Teen 65 E-5
- Adult 110 E-5
F f
-(days /kg) Each stable . E-1 element
{ cf (seconds) 1.73 x 10 6 E-15 j (20 days)
-! t h (seconds) 7.78 X 10 E-15
- (90 days)
Y p (kg/m2)_ 0.7 E-15 -
l Y, (kg/m2) 2.0 E-15
] r (dimensionless) 1.0 for radiciodine E-15 1 0.2 for particulates E-15
-y. .
- - Qf (kg/ day) 50 ,
E-3 i, .
1
-q -
i I
1 i
3.
,, "of Regulatory Guide 1.109 e
1 1
- CLINTON-I 3-59 Rev.0-4/85
CPS-0DCM /
q; ( 0 TABLE 3.5-12 V q INPUT PARAMETERS FOR CALCULATING R
. .a, i
- Parameter Value Table *
((kg/yr) - Infant 0 E-5
- Child 26 E-5 11
- Teen 42 E-5
--Adult 64 E-5 8 "
2-
, U,(kg/yr) -- Infant 0 E-5 Child 520 E-5
'j
. - Teen 630 E-5 g - Adult 520 E-5 ft (dimensionless) 1.0 E-5
} 0.76 p. 28
+ f8 (dimensionless) .
. tg (seconds- 8.6 x 104 (1 day) E-15 k th (seconds'). 5.18 x 106 (60 days) E-15
')
.Yy (kg/m2). 2.0 E-15
'j .
i.
7 ,
q-
.t t
1
.J 9
. v>
L ,
a L .l
- ~t 4
)
i N of Regulatory Guide 1.109 unless otherwise stated ll 1
j
- CLINTON-I 3-60 Rev.0-4/85 1
.f
'R.*'I '
CPS-0DCM.
TABLE 3.5-13 PATHWAY DOSE RATE FACTORS FOR INFANT - R g Nuclide R R (cow) R (goat) R R
-Rfl area /yr m2 mrem /yr' m2 mrem /yr m2 mrem /yr- m2 mrem /yr. m mrem a /yr 1Ei/m 3 pCi/sec' .pCi/sec pCi/see tCi/sec IC1/sec-Total Body Skin H-3 6.47E+02,, 0.0 0.0 2.38E+03*' 4.86E+03* N/A N/A C 2.65E+04 0.0 0.0 2.34E+09 2.33E+09 N/A N/A NA-24 1.06E+04- 1.20E+07 1.39E+07 1.55E+07 1.87E+06 N/A N/A
-P 2.03E+06- 0.0 0.0 1.60E+11 1.92E+11 N/A N/A CR-51 3.57E+02 4.65E+06 5.50E+06~ 4.70E+06 5.62E+05 N/A N/A MN-54: ~1.00E+06 1.38E+09 1.62E+09 3.90E+07 4.67E+06 N/A N/A
'MN-56~ .7.17E+04- 9.03E+05 1.07E+06. 2.84E+00 3.40E-01 N/A N/A FE-55 18.69E+04 0.0 0.0 1.35E+08 1.75E+06 N/A N/A FE-59 1.02E+06 -2.72E+08 3.20E+08 3.92E+08 5.08E+06 N/A N/A-CO-58 7.77E+05- 3.80E+08 4.45E+08 6.06E+07 7.24E+06- N/A N/A CO-60 - 4'. 51E+06 2.15E+10 2.53E+10 2.10E+08 2.51E+07 N/A N/A
.NI-63 3.39E+05 0.0 0.0 3.50E+10 4.18E+10 N/A N/A NI-65' '5.01E+04 2.97E+05 3.45E+05 3.03E+01 3.62E+00 N/A N/A'
'CU 1.50E+04- 6.05E+05 '6.86E+05 -3.78E+06 4.19E+05 N/A N/A.
ZN-65 6.47E+05 7.48E+08 8.60E+08- 1.91E+10- 2.28E+09 N/A N/A
'ZN-69 1.32E+04 0.0 0.0 2.85E-09 3.41E-10 N/A N/A BR -83 3.81E+02 ~4.87E+03' 7.07E+03 NO DATA NO DATA N/A- N/A
.BR-84 4.00E+02 2.19E+05 2.55E+05 NO DATA NO DATA N/A N/A BR-85 2.04E+01 0.0- 0.0 NO DATA NO DATA. N/A N/A RB-86 1.90E+05 8.98E+06 .1.03E+07 2.23E+10 2.66E+09- N/A N/A
'RB-88 5.57E+02 3.30E+04 3.78E+04 1.88E-44 2.25E-45 N/A N/A RB-89 <3.21E+02 1.23E+05 1.48E+05 3.42E-52 4.09E-53 N/A N/A SR '2.03E+06 2.16E+04 2.50E+04 1.26E+'O 2.64E+10 N/A N/A SR-90 4.09E+07 NO DATA NO DATA 1.22E+11 2.55E+11 N/A N/A
= SR-91 57.34E+04 2.14E+06 .2.51E+06 3.20E+05 6.69E+05 N/A N/A SR-92 ~1.40E+05 7.77E+05 8.63E+05 5.06E+01' 1.06E+02 N/A N/A
.Y-90 2.69E+05 4.50E+03 5.31E+03 9.43E+05 1.13E+05 N/A N/A CLINTON-I 3-61 Rev.0-4/85
i CPS-0DCM TABLE 3.5-13 (2ontinued)
PATHWAY DOSE RATE FACTORS FOR INFANT - R t
Nuclide Rf R R (cow) R (goat) R R -
mrem /yr m2 mrem /yr m2mrem /yr m2 mrem /yr m2 mrem /yr m2 mrem /yr T pCi/sec pCi/sec LC1/m LCi/see tC1/sec pCi/sec Total Body Skin Y-91m 2.79E+03 1.00E+05 1.loE+05 2.03E-15 2.43E-16 N/A N/A
'Y-91 2.45E+06 1.07E+06 1.21E+06 5.26E+06 6.29E+05 N/A N/A Y-92 1.26E+05 1.80E+05 2.14E+05 1.02E+01 1.22E+00 N/A N/A
-Y-93 1.67E+05 1.83E+05 2.50E+05 1.69E+04 2.02E+03 N/A N/A
-ZR-95 _1.75E+06 2.45E+08 2.84E+08 8.27E+05 9.89E+04 N/A N/A ZR-97 1.40E+05 2.96E+06 3.44E+06 4.40E+04 5.31E+03 N/A N/A NB-95 4.79E+05- 3.79E+06 4.46E+06 4.70E+06 5.62E+05 N/A N/A
'MO-99 1.35E+05 3.99E+06 4.62E+06 3.10E+08 3.71E+07 N/A N/A TC-99m 2.03E+03 1.84E+05 2.11E+05 1.64E+04 1.96E+03 N/A N/A
'iC- 101 8.44E+02 2.03E+04 2.26E+04 4.89E-57 5.85E-58 N/A N/A RU-103 5.52E+05 1.08E+08 7.20E+05 1.06E+05 1.26E+04 N/A N/A RU-105 4.84E+04 6.36E+05 7.20E+05 3.18E+00 3.81E+01 N/A N/A RU-106 1.16E-07 4.22E+08 5.06E+08 1.45E+06 1.73E+05 N/A N/A AG-110m 3.67E+06 3.44E+09 4.01E+09 1.46E+10 1.75E+09 N/A N/A TE-125m 4.47E+05 1.55E+06 2.13E+06 1.51E+08 1.80E+07 N/A N/A TE-127m 1.31E+06 9.16E+04 1.08E+05 4.22E+08 5.04E+07 N/A N/A TE-127 2.44E+04 2.99E+03 3.29E+03 1.36E+05 1.62E+04 N/A N/A TE-129m 1.68E+06 1.97E+07 2.31E+07 1.39E+09 1.67E+08 N/A N/A TE-129 2.63E+04 2.64E+04 3.12E+04 2.59E-07 3.10E-08 N/A N/A TE-131m 1.99E+05 8.02E+06 9.45E+06 2.29E+07 2.74E+06 N/A N/A TE-131 8.22E+03 2.92E+04 3.45E+07 1.41E-30 1.69E-31 N/A N/A TE-132 3.40E+05 4.24E+06 4.98E+06 6.55E+07 7.83E+06 N/A N/A I-130 1.60E+06 5.50E+06 6.68E+06 8.70E+08 1.04E+09 N/A N/A I-131 1.48E+07 1.72E+07 2.09E+07 1.05E+12 1.26E+12 N/A N/A I-132 1.69E+05 1.24E+06 1.46E+06 1.36E+02 1.64E+02 N/A N/A I-133 .3.56E+06 2.45E+06 2.98E+06 9.59E+09 1.15E+10 N/A N/A I-134 4.45E+04 4.46E+05 5.29E+05 7.86E-10 9.44E-10 N/A N/A CLINTON-I 3-62 Rev.0-4/85
CPS-0DCM TABLE 3.5-13 (continued; PATHWAY DOSE RATE FACTORS FOR INFANT - R y
'Nuclide Rg R R (cow) R (goat) R R mrem /yr 'm2mrem /yr m2 mrem /yr m2 mrem /yr m2 mrem /yr m2 mrem /yr ECi/m 3
tCi/sec pCi/sec pCi/sec pCi/sec pCi/sec Total Body Skin I-135 6.96E+05 2.53E+06 2.95E+06 2.01E+07 2.42E+07 N/A N/A CS-134 7.03E+05 6.89E+09 8.04E+06 6.81E+10 2.04E+11 N/A N/A CS-136 1.34E+05 1.51E+08 1.71E+08 5.81E+09 1.74E+10 N/A N/A CS-137 6.12E+05 1.03E+10 1.20E+10 6.03E+10 1.80E+11 N/A N/A CS-138 8.76E+02 3.58E+09 4.10E+09 1.16E+08 3.45E+08 N/A N/A BA-139 5.10E+04 1.06E+05 1.19E+05 2.72E-05 3.25E-06 N/A N/A BA-140 1.60E+06 2.05E+07 2.35E+07 2.44E+08 2.88E+07 N/A N/A BA-141 4.75E+03 4.17E+04 4.75E+04 5.08E-44 6.08E-45 N/A N/A BA-142 1.55E+03 4.48E+04 5.10E+04 9.53E-79 1.14E-79 N/A N/A LA-140 1.68E+05 1.92E+07 2.18E+07 1.88E+05 2.24E+04 N/A N/A LA-142 5.95E+04 7.60E+05 9.12E+05 1.08E-05 1.29E-06 N/A N/A CE-141 5.17E+05 1.36E+07 1.54E+07 1.37E+07 1.64E+06 N/A N/A CE-143 1.16E+05 2.31E+06 2.63E+06 1.54E+06 1.84E+05 N/A N/A CE-144 9.84E+06 6.96E+07 8.04E+07 1.34E+08 1.60E+07 N/A N/A PR-143 4.33E+05 0.0 0.0 7.84E+05 9.38E+04 N/A N/A PR-144 4.28E+03 1.84E+03 2.11E+03 1.13E-48 1.35E-49 N/A N/A ND-147 3.22E+05 8.38E+06 1.01E+07 5.74E+05 6.86E+04 N/A N/A W-187 3.96E+04 2.35E+06 2.73E+06 2.49E+06 2.97E+05 N/A N/A NP-239 5.95E+04 1.71E+06 1.98E+06 9.42E+04 1.13E+04 N/A N/A mrem /yr per.tci/m
- 0 2.65 X 10
~CLINTON-I 3-63 Rev.0-4/85
- CPS-0DCM TABLE 3.5-14 PATHWAY DOSE RATE FACTORS FOR CHILD - R f
-Nuclide R R (cow) R (goat) R R Rf <
arem/yr m7 mrem /yr m2 mrem /yr m2 mrem /yr ma mrem /yr m2 mrem /yr p C1/m 3 pCi/sec pCi/see pCi/sec p Ci/sec p Ci/sec Total Body Skin
-H-3 = 1.12E+03 0.0: 0.0 1.57E+03* 3.20E+03* 2.34E+02* 4.01E+03*
- C-14 3.59E+04** 0.0 0.0 1.20E+09 1.19E+09 3.83E+08. 8.89E+08
.NA 1.61E+04 1.20E+07 1.39E+07 8.93E+06 1.07E+06 1.78E+08 3.75E+05 P-32 2.60E+06 0.0. 0.0 7.79E+10 9.31E+10 7.43E+09 3.37E+09 CR-51 1.70E+04 4.65E+06 '5.50E+06 5.40E+06 6.46E+05 4.66E+05 6.20E+06 MN-54 1.58E+06 1.38E+09 1.62E+09 2.10E+07 2.51E+06 8.02E+06 6.65E+08
.HN-56 1.23E+05 9.03E+05 1.07E+06 1.85E+00 2.21E-01 2.26E-51 .2.71E+03 FE-55 1.11E+05 0.0 0.0 1.12E+08 1.45E+06 4.58E+08 8.01E+08 -
FE-59 1.27E+06 2.72E+08 3.20E+08 2.03E+08 2.62E+06 6.33E+08 6.69E+08 -
-C0-58~ 1.11E+06- 3.80E+08 4.45E+08 7.08E+07 8.47E+06 9.58E+07 -3.76E+08 CO-60_ - 7.07E+06 2.15E+10 2.53E+10 2.39E+08 2.86E+07 3.84E+08 2.10E+09
-NI-63 8.21E+05 0.0 0.0 2.97E+10 3.55E+09 2.91E+10 3.95E+10 NI-65. 8.40E+04- 2.97E+05. 3.45E+05 1.91E+01 2.29E+00 4.09E-51 1.21E+03 CU-64 3.67E+04: 6.05E+05 6.86E+05 3.47E+06 3.86E+05 1.30E-05 5.12E+05-
'ZN-65 9.95E+05 7.48E+08 8.60E+08 1.10E+10 1.32E+09 6.00E+06 2.16E+09 ZN-69 ' 1.02E+04 0.0 0.0 8.30E-10 9.92E-11 0.0 8.47E-04 BR 4.74E+02 4.87E+03 7.07E+03 NO DATA NO DATA NO DATA NO DATA
'BR-84 5.48E+02 2.19E+05 2.55E+05 NO DATA NO DATA NO DATA NO DATA BR-85 2.53E+01' O.0 0.0 NO DATA NO DATA NO DATA NO DATA RB-86 : 1.98E+05- 8.98E+06 1.03E+07 8.78E+09 1.05E+09 5.76E+08 4.53E+08
.RB-88 5.62E+02 3.30E+04 3.78E+04 7.17E-45 8.58E-46 0.0 4.38E-22 RB-89 3.45E+02 1.23E+05 1.48E+05 1.40E-52 1.67E-53 0.0 4.69E-26 SR-89 2.16E+06 2.16E+04 2.50E+04 6.62E+09 1.38E+10 4.81E+08 3.59E+10 SR-90 1.01E+08 PK) DATA NO DATA- 1.12E+11 2.34E+11 1.04E+10 1.24E+12 i
~SR-91 1.74E+05 2.14E+06 2.51E+06 2.86E+05 5.98E+05 4.99E-10 1.15E+06
. SR-92_ 2.42E+05 .7.77E+05 8.63E+05 4.18E+01 8.74E+01 3.80E-48 1.38E+04 L Y-90 2.68E+05 4.50E+03 5.31E+03 9.20E+05 1.10E+05 4.91E+05 6.58E+07 >
l CLINTON-I 3-64 Rev.0-4/85
,w. - . - , _.,.-.% . .,_m,_.. ,. . _ . - _ . . - - , , , _ _ . . _ ,._r. , _..._,._,.~m.,_.,..e.m.., , . , . , . . . . . .
CPS-0DCM TABLE 3.5-14 (continued)
PATHWAY DOSE RATE FACTORS FOR CHILD - R 1
Nuclide Rf R R (cow) R (goat) R R mrem /yr m2 mrem /yr m2 mrem /yr m2 mrem /yr m2 mrem /yr m2 mrem /yr pC1/m 3 pC1/sec pCi/sec PC1/sec UCi/sec PCi/sec Total Body Skin Y-91m 2.81E+03 1.00E+05 1.16E+05 5.63E-16 6.73E-17 0.0 1.81E-05 Y-91 2.63E+06 1.07E+06 1.21E+06 5.20E+06 - 6.22E+05 2.40E+08 2.48E+09 Y-92 2.39E+05 1.80E+05 2.14E+05 7.30E+00 8.73E-01 6.84E-35 4.57E+04 Y-93 3.88E+05 1.83E+05 2.50E+05 1.50E+04 1.79E+03 1.04E-07 4.35E+06 ZR-95 2.23E+06 2.45E+08 2.84E+08 8.80E+05 1.05E+05 6.11E+08 8.86E+08 ZR-97 3.51E+05 2.96E+06 3.44E+06 4.20E+04 5.02E+03 6.92E-01 1.24E+07 NB-95 6.14E+05 3.79E+06 4.46E+06 5.21E+06 6.23E+05 1.94E+02 2.35E+06 MO-99 1.35E+05 3.99E+06 4.62E+06 1.74E+08 2.08E+07 2.44E+05 1.64E+07 TC-99m 4.81E+03 1.84E+05 2.11E+05 1.47E+04 1.76E+03 6.71E-18 5.24E+03 TC-101 5.85E+02 2.03E+04 2.26E+04 1.92E-58 2.30E-59 0.0 2.41E-29 RU-103 6.62E+05 1.08E+08 1.26E+08 1.11E+05 1.32E+04 4.00E+09 3.96E+08 RU-105 9.95E+04 6.36E+0} 7.20E+05 2.48E+00 2.96E-01 5.53E-25 5.96E+04 RU-106 1.43E+07 4.22E+08 5.06E+08 1.44E+06 1.72E+05 6.90E+10 1.16E+10 AG-110m 5.48E+06 3.44E+09 4.01E+09 1.68E+10 2.01E+09 6.74E+08 2.58E+09 TE-125m 4.77E+05 1.55E+06 2.13E+06 7.39E+07 8.83E+06 5.69E+08 3.51E+08 TE-127m 1.48E+06 9.16E+04 1.08E+05 5.94E+08 7.10E+07 5.06E+09 3.77E+09 TE-127 5.62E+04 2.99E+03 3.29E+03 1.19E+05 1.42E+04 1.56E-08 3.89E+05 TE-129m 1.76E+06 1.97E+07 2.31E+07 7.97E+08 9.53E+07 5.25E+09 2.47E+09 TE-129 2.55E+04 2.64E+04 3.12E+04 9.53E-08 1.14E-08 0.0 9.00E-02 TE-131m 3.08E+05 8.02E+06 9.45E+06 2.24E+07 2.68E+06 9.77E+03 2.16E+07 TE-131 2.05E+03 2.92E+04 3.45E+07 8.64E-32 1.03E-32 0.0 1.36E-14 TE-132 3.77E+05 4.24E+06 4.98E+06 4.57E+07 5.47E+06 - 9.48E+06 3.12E+07 I-130 1.85E+06 5.50E+06 6.68E+06 3.82E+08 4.59E+08 6.49E-04 1.36E+08 I-131 1.62E+07 1.72E+07 2.09E+07 4.33E+11 5.20E+11 5.50E+09 4.75E+10 I-132 1.94E+05 1.24E+06 1.46E+06 5.89E+01 7.07E+01 8.93E-57 7.87E+03 I-133 3.85E+06 2.45E+06 2.98E+06 3.94E+09 4.73E+09 1.30E+02 8.11E+08 I-134 5.07E+04 4.46E+05 5.29E+05 3.39E-10 4.07E-10 0.0 6.40E-03 CLINTON-I 3-65 Rev.0-4/85
e ~ '
CPS-0DCIO TABLE 3.5-14 (continued)
PATHWAY DOSE RATE FACTORS FOR CHILD - R f l:
y l
Nuclide' R R (cow) R (goat) R R Rf
- mrem /yr m2 mrem /yr- m2 mrem /yr m2 mrem /yr m2 mrem /yr .m2mrem /yr p Ci/m 3- UCi/sec 4C1/see pC1/sec pCi/sec -Ifi/sec Total Body Skin- ,
I-135 7.92E+05 2.53E+06 2.95E+06 8.65E+06 1.04E+07 1.09E-14 1.00E+07 CS-134~ 1.01E+06 6.89E+09 8.04E+06 3.72E+10 #
1.11E+11 1.51E+09 2.63E+10 CS-136 1.'71E+05 1.51E+08 1.71E+08 2.78E+09 8.32E+09 4.45E+07 2.26E+08 CS-137 9.07E+05 1.03E+10 1.20E+10 3.23E+10 9.65E+10 1.33E+09 2.39E+10
'CS-138 8.40E+02 3.58E+09 4.10E+09 2.93E+07 8.76E+07 1.14E+06 1.84E+07 BA-139 '5.77E+04 1.06E+05 1.19E+05 1.16E-05 1.39E-06 0.0 2.86E+00 BA-140' 1.74E+06- 2.05E+07 2.35E+07 1.18E+08 1.40E+07 4.38E+07 2.77E+08 BA-141- 2.92E+03~ 4.17E+04 4.75E+04 1.96E-45 2.34E-46 0.0 2.04E-21 BA-142- 1.64E+03 ~4.48E+04 5.10E+04 1.10E-79 1.31E-80 0.0 9.67E-39
- LA-140 2.26E+07 1.92E+07 2.18E+07 .1.89E+05 2.'26E+04 5.41E+02 3.16E+07 I.A-142 - 7.58E+04' 7.60E+05 9.12E+05 5.21E-06 '6.23E-07 3.91E-87 2.14E+01 CE-141 5.44E+05 1.36E+07 1.54E+07' 1.36E+07 1.63E+06 1.37E+07 4.08E+08 CE-143 1.27E+05 2.31E+06 2.63E+06 -1.49E+06 1.78E+05 2.54E+02 1.36E+07 CE-144 1.20E+07 6.96E+07 8.04E+07' 1.33E+08 1.59E+07 1.89E+08 1.04E+10-l PR-143 4.33E+05 0.0 0.0 7.75E+05 9.27E+04 3.60E+07 1.57E+08 PR-144 1.56E+03 1.84E+03 2.11E+03 1.96E-50 2.35E-51 0.0 3.75E-23 ND-147 3.28E+05 8.38E+06 '1.01E+07
- 5.71E+05 6.82E+04 1.50E+07 6.96E+08 W-187 9.10E+04' 2.35E+06 2.73E+06 2.40E+06 2.88E+05 2.67E+00 5.35E+06
- 1. .
NP-239 6.40E+04 1.71E+06 1.98E+06 9.16E+04 1.10E+04 2.25E+03 1.36E+07 arem/yr per UCi/m 3 3.59 x 10 CLINTON-I 3-66 Rev.0-4/85 L
CPS-0DCl4 TABLE 3.5-15 PATHWAY DOSE RATE FACTORS FOR TEEti - R 1
Nuclide R R (cow) R (goat) R R Rf mrem /yr -m2 mrem /yr m' mrem /yr m2 mrem /yr m2 mrem /yr m2 mrem /yr pC1/m 3 pCi/sec p Ci/sec pCi/sec gCi/sec gCi/sec Total Body Skin ,
H-3 1.27E+03 0.0 0.0 9.92E+02* 2.02E+03* 1.93E+02* 2.59E+03*
C-14 2.60E+04** 0.0 0.0 4.86E+08 '
4.85E+08 2.04E+08 3.58E+08 NA-24 1.38E+04 1.20E+07 1.39E+07 4.29E+06 5.15E+05 1.12E+08 2.40E+05
- P-32 1.89E+05 0.0 0.0 3.16E+10 3.78E+10 3.94E+09 1.61E+09 CR-51 3.00E+03 4.65E+06 5.50E+06 8.39E+06 1.00E+06 9.47E+05 1.03E+07 MN-54 1.98E+06 1.38E+09 1.62E+09 2.88E+07 3.44E+06 1.44E+07 9.32E+08 MN-56 5.74E+04 9.03E+05 1.07E+06 4.82E-01 5.77E-02 7.72E-52 9.41E+02 FE-55 1.24E+05 0.0 0.0 4.46E+07 5.78E+05 2.38E+08 3.26E+08 FE-59 1.53E+06 2.72E+08 3.20E+08 2.67E+09 3.71E+06 1.17E+09 9.89E+08 t CO-58 1.34E+04 3.80E+08 4.45E+08 1.10E+08 1.31E+07 1.94E+08 6.02E+08 CO-60 8.72E+06 2.15E+10 2.53E+10 3.62E+08 4.33E+07 7.60E+08 3.24E+09 NI-63 5.80E+05 0.0 0.0 1.18E+10 1.42E+09 1.52E+10 1.61E+10 NI-65 3.67E+04 2.97E+05 3.45E+05 4.70E+00 5.62E-01 1.32E-51 3.97E+02
. CU-64 6.14E+04 6.05E+05 6.86E+05 3.26E+06 3.63E+05 1.60E-05 6.42E+05 ZN-65 1.24E+06 7.48E+08 8.60E+08 7.32E+09 8.76E+08 5.22E+06 1.47E+09 ZN-69 1.58E+03 0.0 0.0 1.30E-11 1.56E-12 0.0 1.77E-05 BR-83 3.44 E+02 4.87E+03 7.07E+03 NO DATA NO DATA NO DATA NO DATA BR-84 4.33E+02 2.19E+05 2.55E+05 NO DATA NO DATA NO DATA NO DATA BR-85 4.23E+01 0.0 0.0 NO DATA NO DATA NO DATA NO DATA RB-86 1.90E+05 8.98E+06 1.03E+07 4.73E+09 5.66E+08 4.06E+08 2.74E+08 RB-88 5.46E+02 3.30E+04 3.78E+04 3.90E-45 4.66E-46 0.0 3.17E-22 RB-89 3.52E+02 1.23E+05 1.48E+05 7.96E-53 9.52E-54 0.0 3.56E-26 SR-89 2.42E+06 2.16E+04 2.50E+04 2.68E+09 5.60E+09 2.54E+08 1.51E+10 SR-90 1.08E+08 NO DATA NO DATA 6.62E+10 1.38E+11 8.04E+09 7.50E+11 SR-91 2.59E+05 2.14E+06 2.51E+06 2.39E+05 5.01E+05 5.47E-10 1.28E+06
, SR-92 1.19E+05 7.77E+05 8.63E+05 2.30E+01 4.81E+01 2.74E-48 1.02E+04 Y-90 5.59E+05 4.50E+03 5.31E+03 1.08E+06 1.29E+05 7.52E+05 1.03E+08 i
CLINToti-I 3-67 Rev.0-4/85 l
m
CPS-0DCM.
TABLE 3.5-15 (continued)
PATilWAY DOSE RATE FACTORS FOR TEEN - R1 Nuclide R R (cou) R (goat) R R Rf mrem /yr m2 mrem /yr m2 mrem /yr m2 mrem /yr m2 mrem /yr m2 mrem /yr mci /m 3 UC1/sec UCi/sec PC1/sec p Ci/sec U Ci/sec Total Body Skin Y-91m 3.20E+03 1.00E+05 1.16E+05 5.55E-18 6.64E-19 0.0 2.38E-07 Y-91 2.94E+06 1.07E+06 1.21E+06 6.48E+06 7.75E+05 3.91E+08 3.21E+09 Y-92 1.65E+05 1.80E+05 2.14E+05 2.82E+00 '
3.38E-01 3.46E-35 2.36E+04
~
Y-93 5.79E+05 1.83E+05 2.50E+05 1.25E+04 1.49E+03 1.13E-07 4.83E+06 ZR-95 2.69E+06 2.45E+08 2.84E+08 1.20E+06 1.44E+05 1.09E+09 1.26E+09 ZR-97 6.30E+05 2.95E+06 3.44E+06 4.22E+04 5.05E+03 9.11E-01 1.67E+07
. NB-95 7.51E+05 3.79E+06 4.46E+06 7.60E+06 9.10E+05 3.70E+02 4.58E+06 MO-99 2.69E+05 3.99E+06 4.62E+06 1.02E+08 1.22E+07 1.88E+05 1.29E+07 TC-99m 6.13E+03 1.84E+05 2.11E+05 1.05E+04 1.26E+03 6.28E-18 5.00E+03 TC-101 6.67E+02 2.03E+04 2.26E+04 1.13E-58 1.35E-59 0.0 1.89E-29 RU-103 7.83E+05 1.08E+08 1.26E+08 1.51E+05 1.81E+04 7.15E+09 5.69E+08 RU-105 9.04E+04 6.36E+05 7.20E+05 1.26E+00 1.50E-01 3.67E-25 4.02E+04 RU-106 1.61E+07 4.22E+08 5.06E+08 1.80E+06 2.15E+05 1.13E+11 1.48E+10 AC-110m 6.75E+06 3.44E+09 4.01E+09 2.56E+10 3.06E+09 1.34E+09 4.03E+09 TE-125m 5.36E+05 1.55E+06 2.13E+06 8.88E+07 1.06E+07 8.95E+08 4.38E+08 TE-127m 1.66E+06 9.16E+04 1.08E+05 3.42E+08 4.09E+07 3.81E+09 2.24E+09 TE-127 8.08E+04 2.99E+03 3.29E+03 9.54E+04 1.14E+04 1.64E-08 4.17E+05 TE-129m 1.98E+06 1.97E+07 2.31E+07 4.61E+08 5.51E+07 3.97E+09 1.51E+09 TE-129 3.30E+03 2.64E+04 3.12E+04 3.39E-09 4.06E-10 0.0 4.27E-03 l TE-131m 6.21E+05 8.02E+06 9.45E+06 2.53E+07 3.02E+06 1.44E+04 3.25E+07 i TE-131 2.34E+03 2.92E+04 3.45E+07 2.93E-32 3.51E-33 0.0 6.15E-15 TE-132 4.63E+05 4.24E+06 4.98E+06 8.63E+07 1.03E+07 2.34E+07 7.84E+07 I-130 1.49E+06 5.50E+06 6.68E+06 1.73E+08 2.08E+08 3.85E-04 8.25E+07 I-131 1.46E+07 1.72E+07 2.09E+07 2.19E+11 2.63E+11 3.64E+09 3.14E+10 1-132 1.51E+05 1.24E+06 1.46E+06 2.57E+01 3.09E+01 5.10E-57 4.58E+03 I-133 2.92E+06 2.45E+06 2.98E+06 1.67E+09 2.01E+09 7.19E+01 4.58E+08 I-134 3.95E+04 4.46E+05 5.29E+05 1.48E-10 1.78E-10 0.0 3.73E-03 CLINTON-I 3-68 Rev.0-4/85 u.
CPS-0DCl!
l TABLE 3.5-15 (continued)
PATHWAY.-DOSE RATE FACTORS FOR TEEN - R f Nuclide R R (cow) R (goat) R R Rf mrem /yr m* mrem /yr m2 mrem /yr m2 mrem /yr m2 mrem /yr m2 mrem /yr pC1/m 3 pCi/sec p Ci/sec pCi/sec LC1/sec pCi/sec Total Body Skin ,
l I-135 6.21E+05 2.53E+06 2.95E+06 3.80E+06 4.56E+06 6.27E-15 5.85E+06
.CS-134 1.13E+06 6.89E+09 8.04E+06 2.31E+10 '
6.91E+10 1.23E+09 1.67E+10 CS-136 1.94E+05 1.51E+08 1.71E+08 1.76E+09 5.28E+09 3.69E+07 1.72E+08 CS-137 8.48E+05 1.03E+10 1.20E+10 1.78E+10 5.33E+10 9.63E+08 1.35E+10 CS-138 8.56E+02 3.58E+09 4.10E+09 1.67E+07 4.99E+07 8.54E+05 1.08E+07 BA-139 1.13E+03 1.06E+05 1.19E+05 7.32E-07 8.76E-08 0.0 2.40E-01 BA-140 2.03E+06 2.05E+07 2.35E+07 7.56E+07 8.96E+06 3.66E+07 2.13E+08 BA-141 3.29E+03 4.17E+04 4.75E+04 7.96E-46 9.52E-47 0.0 1.11E-21 BA-142 1.91E+03 4.48E+04 5.10E+04 4.55E-80 5.44E-81 0.0 5.34E-39 LA-140 4.87E+05 1.92E+07 2.18E+07 2.29E+05 2.73E+04 8.56E+02 5.09E+07 LA-142 1.20E+04 7.60E+05 9.12E+05 4.62E-07 5.52E-08 4.54E-88 2.53E+00 CE-141 6.14E+05 1.36E+07 1.54E+07 1.70E+07 2.03E+06 2.24E+07 5.40E+08 CE-143 2.55E+05 2.31E+06 2.63E+06 1.67E+06 2.00E+05 3.72E+02 2.04E+07 l CE-144 1.34E+07 6.96E+07 8.04E+07 1.66E+08 1.98E+07 3.09E+08 1.33E+10 i
PR-143 4.83E+05 0.0 0.0 9.55E+05 1.14E+05 5.80E+07 2.30E+08 PR-144 1.75E+03 1.84E+03 2.11E+03 1.19E-53 1.42E-54 0.0 3.04E-26 ND-147 3.72E+05 8.38E+06 1.01E+07 7.11E+05 8.50E+04 2.44E+07 1.42E+08 W-187 1.77E+05 2.35E+06 2.73E+06 2.63E+06 3.15E+05 3.82E+00 7.80E+06 NP-239 1.32E+05 1.71E+06 1.98E+06 1.06E+05 1.27E+04 3.41E+03 2.10E+07 l
-
- 3
! mrem /yr per pCi/m
'#* 4 2.60 X 10 CLINTON-I 3-69 Rev.0-4/85 L_
CPS-0DChi 1NiBLE 3.5-16 PATHWAY DOSE RATE FACTORS FOR ADULT - R f
Nuclide R R (cow) R (goat) R R Rf mrem /yr m2 mrem /yr m2 mrem /yr m2 mrem /yr m? mrem /yr m2 mrem /yr PC1/m 3 PC1/sec PC1/sec LCi/sec p C1/sec p C1/sec Total ,_
Body Skin H-3 1.26E+03 0.0 0.0 7.62E+02* '
1.55E+03* 3.24E+02* 2.26E+03*
C-14 1.82E+04** 0.0 0.0 2.64E+08 2.63E+08 2.41E+08 2.28E+08 NA-24 1.02E+04 1.20E+07 1.39E+07 2.46E+06 2.95E+05 1.40E+08 2.71E+05 P-32 1.32E+06 0.0 0.0 1.71E+10 2.05E+10 4.66E+09 1.40E+09 CR-51 1.44 E+04 4.65E+06 5.50E+06 7.19E+06 8.60E+05 1.77E+06 1.16E+07 MN-54 1.40E+06 1.38E+09 1.62E+09 2.58E+07 3.08E+06 2.81E+07 9.58E+08 MN-56 2.02E+04 9.03E+05 1.07E+06 1.32E-01 1.58E-02 4.61E-52 5.06E+02 FE-55 7.21E+04 0.0 0.0 2.51E+07 3.26E+05 2.94E+08 2.10E+08 FE-59 1.02E+06 2.72E+08 3.20E+08 2.33E+08 3.02E+06 2.08E+09 9.87E+08 CO-58 9.28E+05 3.80E+08 4.45E+08 9.57E+07 1.14E+07 3.70E+08 6.24E+08 CO-60 5.97E+06 2.15E+10 2.53E+10 3.08E+08 3.69E+07 1.41E+09 3.14E+09 NI-63 4.32E+05 0.0 0.0 6.74E+09 8.05E+08 1.89E+10 1.04E+10 NI-65 5.60E+03 2.97E+05 3.45E+05 1.22E+00 1.46E-01 7.46E-52 2.03E+02 CU-64 4.90E+04 6.05Es35 6.86E+05 2.01E+06 2.24E+05 2.15E-05 7.79E+05 ZN-65 8.64E+05 7.48E+08 8.60E+08 4.37E+09 5.22E+08 6.80E+06 1.01E+09 ZN-69 9.20E+02 0.0 0.0 3.85E-12 4.60E-13 0.0 1.03-05 BR-83 2.41E+02 4.87E+03 7.07E+03 NO DATA NO DATA NO DATA NO DATA BR-84 3.13E+02 2.19E+05 2.55E+05 NO DATA NO DATA NO DATA NO DATA BR-85 1.28E+01 0.0 0.0 NO DATA NO DATA NO DATA NO DATA RB-86 1.35E+05 8.98E+06 1.03E+07 2.60E+09 3.10E+08 4.87E+08 2.19E+08 RB-88 3.87E+02 3.30E+04 3.78E+04 2.15E-45 2.57E-46 0.0 3.43E-22 RB-89 2.56E+02 1.23E+05 1.48E+05 4.50E-53 5.38E-54 0.0 3.96E-26 SR-89 1.40E+06 2.16E+04 2.50E+04 1.45E+09 3.04E+09 3.01E+08 9.95E+09 SR-90 9.92E+07 UO DATA NO DATA 4.68E+10 9.80E+10 1.24E+10 '6.04E+11 SR-91 1.91E+05 2.14E+06 2.51E+06 1.37E+05 2.86E+05 6.82E-10 1.44E+06 SR-92 4.30E+04 7.77E+05 8.63E+05 9.77E+00 2.04E+01 2.54E-48 8.49E+03 Y-90 5.06E+05 4.50E+03 5.31E+03 7.53E+05 9.00E+04 1.15E+06 1.41E+08 CLINTON-I 3-70 Rev.0-4/85
CPS-0DCM TABLE 3.5-l'6 (continued)
PATHWAY DOSE RATE FACTORS FOR ADULT - R t
Nuclide Rf R R (cow) R (goat) R R mrem /yr m2 mrem /yr m2 mrem /yr m2 mrem /yr m2 mrem /yr m2 mrem /yr pCi/m3 PCi/sec pC1/sec UC1/sec PCi/sec UC1/sec Total _
Body Skin Y-91m 1.92E+03 1.00E+05 1.16E+05 1.89E-19 - 2.26E-20 0.0 1.59E-08 Y-91 1.70E+06 1.07E+06 1.21E+06 4.73E+06 5.66E+05 6.23E+08 2.82E+09 Y-92 7.35E+04 1.80E+05 2.14E+05 9.76E-01 1.17E-01 2.61E-35 1.60E+04 Y-93 4.22E+05 1.83E+05 2.50E+05 7.03E+03 8.41E+02 1.39E-07 5.35E+06
.R-95 1.77E+06 2.45E+08 2.84E+08 9.60E+05 1.15E+05 1.90E+09 1.20E+09 ZR-97 5.23E+05 2.96E+06 3.44E+06 2.70E+04 3.23E+03 1.27E+00 2.10E+07 NB-95 5.05E+05 3.79E+06 4.46E+06 6.35E+06 7.59E+05 6.75E+02 7.51E+06 MO-99 2.48E+05 3.99E+06 4.62E+06 5.74E+07 6.86E+06 2.30E+05 1.42E+07 TC-99m 4.16E+03 1.84E+05 2.11E+05 5.54E+03 6.62E+02 7.22E-18 5.18E+03 TC-101 3.99E+02 2.03E+04 2.26E+04 6.23E-59 7.45E-60 0.0 2.05E-29 RU-103 5.05E+05 1.08E+08 1.26E+08 1.19E+05 1.4 2E+04 1.23E+10 5.57E+08 RU-105 4.82E+04 6.36E+05 7.20E+05 5.21E-01 6.23E-02 3.32E-25 3.28E+04 RU-106 9.36E+06 4.22E+08 5.06E+08 1.32E+06 1.58E+05 1.81E+11 1.25E+10 AG-110m 4.63E+06 3.44E+09 4.01E+09 2.20E+10 2.63E+09 2.52E+09 3.98E+09 TE-125m 3.14E+05 1.55E+06 2.13E+06 6.64E+07 7.93E+06 1.46E+09 3.93E+08 TE-127m 9.6E+05 9.16E+04 1.08E+05 1.86E+08 2.22E+07 4.53E+09 1.42E+09 TE-127 5.74E+04 2.99E+03 3.29E+03 5.26E+04 6.29E+03 1.97E-08 4.52E+05 TE-129m 1.16E+06 1.97E+07 2.31E+07 3.03E+08 3.63E+07 5.70E+09 1.26E+09 TE-129 1.94E+03 2.64E+04 3.12E+04 1.42E-09 1.69E-10 0.0 3.51E-03 TE-131m 5.56E+05 8.02E+06 9.45E+06 1.75E+07 2.10E+06 2.18E+04 4.43E+07 TE-131 1.39E+03 2.92E+04 3.45E+07 1.61E-32 1.92E-33 0.0 6.63E-15 TE-132 5.10E+05 4.24E+06 4.98E+06 7.36E+07 8.80E+06 4.36E+07 1.32E+08 I-130 1.14E+06 5.50E+06 6.68E+06 1.04E+08 1.25E+08 5.06E-04 9.77E+07 I-131 1.19E+07 1.72E+07 2.09E+07 1.39E+11 1.66E+11 5.03E+09 3.78E+10 I-132 1.14E+05 1.24E+06 1.46E+06 1.54E+01 1.85E+01 6.67E-57 5.40E+03 I-133 2.15E+06 2.45E+06 2.98E+06 9.88E+08 1.18E+09 9.28E+01 5.33E+08 I-134 2.98E+04 4.46E+05 5.29E+05 8.88E-11 1.07E-10 0.0 4.39E-03 CLINTON-I 3-71 Rev.0-4/85
CPS-0DCM TABLE 3.5-16 (continued)
PATHWAY DOSE RATE FACTORS FOR ADULT - R.
1 Nuclide Rf R R (cow) R (goat) R R mrem /yr m2 mrem /yr m2 mrem /yr m2 mrem /yr m2 mrem /yr m mrem /yr pC1/m 3 pC1/sec pC1/sec pCi/sec pCi/sec pCi/sec Total ,_
Body Skin I-135 4.48E+05 2.53E+06 2.95E+06 2.23E+06 2.68E+06 8.04E-15 6.75E+06 CS-134 8.48E+05 6.89E+09 8.04E+06 1.35E+10 4.02E+10 1.56E+09 1.11E+10 CS-136 1.46E+05 1.51E+08 1.71E+08 1.04E+09 3.11E+09 4.75E+07 1.68E+08 CS-137 6.21E+05 1.03E+10 1.20E+10 1.01E+10 3.02E+10 1.19E+09 8.70E+09 CS-138 6.21E+02 3.58E+09 4.10E+09 9.46E+06 2.03E+07 1.06E+06 7.02E+06 BA-139 3.76E+03 1.06E+05 1.19E+05 7.87E-08 9.41E-09 0.0 5.07E-02 BA-140 1.27E+06 2.05E+07 2.35E+07 5.59E+07 6.63E+06 5.92E+07 2.65E+08 BA-141 a.94E+03 4.17E+04 4.75E+04 4.33E-46 5.18E-47 0.0 1.18E-21 BA-142 1.19E+03 4.48E+04 5.10E+04 2.51E-80 3.00E-81 0.0 5.80E-39 LA-140 4.58E+05 1.92E+07 2.18E+07 1.67E+05 2.00E+04 1.36E+03 7.31E+07 LA-142 6.33E+03 7.60E+05 9.12E+05 6.28E-08 7.51E-09 1.35E-88 6.77E-01 CE-141 3.62E+05 1.36E+07 1.54E+07 1.25E+07 1.50E+06 3.61E+07 5.09E+08 CE-143 2.26E+05 2.31E+06 2.63E+06 1.15E+06 1.38E+05 5.59E+02 2.76E+07 CE-144 7.78E+06 6.96E+07 8.04E+07 1.21E+08 1.45E+07 4.93E+08 1.11E+10 PR-143 2.81E+05 0.0 0.0 6.92E+05 8.28E+04 9.17E+07 2.74E+08 PR-144 1.02E+03 1.84E+03 2.11E+03 6.46E-54 7.72E-55 0.0 3.24E-26 ND-147 2.21E+05 8.38E+06 1.01E+07 5.23E+05 6.25E+04 3.92E+07 1.85E+08 W-187 1.55E+05 2.35E+06 2.73E+06 1.78E+06 2.13E+05 5.65E+00 5.20E+06 NP-239 1.19E+05 1.71E+06 1.98E+06 7.40E+04 8.85E+03 5.19E+03 2.88E+07 mrem /yr per PC1/m 1.82 X 10 4 CLINTON-I 3-72 Rev.0-4/85
CPS-0DCM 4.0 COMPLIANCE WITH 40CFR190 CPS RETS 3.11.4 specifies that when the calculated doses associated with the effluent releases exceed twice the limits of CPS RETS 3.11.1.2, 3.11.2.2 or 3.11.2.3, a Special Report shall be prepared and submitted to the Commission. In
- - - - - ~ ~ - - -
addition, suisequent releases shall be limited such that the dose or dose commitment to a real individual from all uranium fuel cycle sources is limited to 25 mrem to the total body
~ ~ - - - ~ ~ - - -
- or any organ (75 mrem to the thyroid) over 12 consecutive months. This Special Report is to include an analysis which demonstrates that radiation exposures to all real individuals from all uranium fuel cycle sources (including all liquid and gaseous effluent pathways and direct radiation) are less than the standards in 40CFR190, ENVIRONMENTAL RADIATION PROTECTION STANDARDS FOR NUCLEAR POWER OPERATIONS. If analysis indicates that releases resulting in doses that exceed the
- ~ - -- -- - 40CFR190 standard could have occurred, and if the release condition resulting in violation of 40CFR190 has not been corrected, then a variance from the Commission to permit such releases will be requested.
The Special Report shall contain:
- 1. A determination of which uranium fuel cycle facilities or operations, in addition to CPS, contribute to the annual dose to the maximum exposed individual. Fuel cycle facilities located beyond the 5 mile radius from CPS need not be considered in this determination.
- 2. A determination of the maximum exposed individual.
- 3. A determination of the total annual dose to the maximum exposed individual from all existing pathways and sources of radioactivity and radiation (including direct radiation from N-16, the plant and storage facilities) using methodologies described in the CPS-0DCM. The direct radiation dose may be either calculated using NUREG-0133 methodology or measured.
The total body and organ doses resulting from liquid f
effluents will be summed with the doses resulting from gaseous effluents (including non-noble gases) and the doses to the maximum exposed individual from other operations of the uranium fuel cycle. The effluent doses'will be based upon releases from CPS during the previous three quarters and from the quarter in which CPS RETS 3.11.4 was exceeded.
CLINTON-I 4-1 Rev.0-4/85
CPS-0DCM'
\
5.0 RADIOLOGICAL ENVIRONMENTAL MONITORING The CPS Radiological Environmental Monitoring Program (REMP)
'a, is defined in Table 5.0-1 and Figures 5.0-1, 5.0-2 and 5.0-3.
The REMP is based on the latest land use census. All deviations from the sampling program described in Table 5.0-1 shall be documented and reported in the annual report of the
, _ . . _ . . _ . - radiological environmental monitoring program.
f
.p -. -
4 i
1 4
p . . - - . . . .
l1 I
1 I
l l
i e
CLINTON-I 5-1 Rev 0-4/85
. CPS-0DCM j l
Table 5.0-1 CPS REMP SAMPLING LOCATIONS AND FREQUENCY FREQUENCY OF COLLECTION Semi- Semi- Once every Location / Type (1) Description (2) Weekly Monthly Monthly Ouarterly Annually three years
~~~ ~~ CL-1 ' ~ ~ (I) 1.8 mile W AP,AI( )( ) TLD TS (I)
~ ' ~ ' '
CL-2 0.7 mile NNE AP,AI TLD TS (I) TS
~ ~ ~
~CL-3' 0.6 mile NE AP,AI TLD CL-4 (I) 0.8 mile WSW AP,AI TLD TS
. -. ~ '~ ~ 'CL -5 ~ (I)~~ 0.7 mile NNE TLD CL-6 (I) 0.7 mile SW AP AI TLD TS
~ ' ~
^CL-7A' (I) 2.3 mile SE AP AI TLD TS CL-75 (I) 2.1 mile SE SS (I) 1.3 mile SE
~ ~ ~ ' '~
CL-7C BS.SL CL-7D (I) 1.4 mile SE SS CL-7E (I) 2.4 mile ESE W 2.2 mile E TS CL-8 (I) AP.AI TLD CL-9 (I) 2.7 mile ESE SW( }
CL-10 (I) 5.0 mile ENE SW(5) BS SS,SL CL-11 (C) 16.0 mile S AP.AI MorG TLD CL-12 (I) 1.6 mile E CL-13 (I) 3.6 mile SW SW($} BS CL-14 (I) Station DW CL-15A (I) (6) MorG( )
CL-15B (I) (6) VE(5)
MorG('}
CL-16 (I) (6)
CL-17 (I) (6) MorG( }
CL-18 (I) (6) VE(5) ,
CLINTON-I 5-2 Rev.0-4/85
CPS-0DCM 1;
Table 5.0-1 CPS REMP SAMPLING LOCATIONS AND FREQUENCY FREQUENCT OF COLLECTION Semi- Semi- Once every Location / Type (I) Description I) Weekly Monthly Monthly Quarterly Annually three years CL-19 (I) 3.4 mile E F BS, ,
! CL-21 (I) 0.9 mile NNE TLD CL-22 (I) 0.6 mile NE TLD CL-23 (I) 0.5 mile ENE TLD
- CL-24 (I) 0.5 mile E TLD CL-25 (I) 0.4 mile ESE TLD CL-26 (I) 0.3 mile SE TLD CL-85 (I) 0.7 mile E TLD CL-86 (I) 0.8 mile ESE TLD CL-87 (I) 0.7 mile SE ,
TLD CL-27 -(I) 0.6 mile SSE TLD CL-28 (I) 0.5 mile S TLD CL-29 (I) 0.6 mile $$W TLD CL-30 (I) 0.9 mile SW TLD
'CL-31 (I) 0.8 mile WSW TLD CL-32 (I) 0.7 mile WSW TLD CL-82 (I) 1.1 mile W TLD CL-34 (I) 0.8 mile WNW TLD CL-35 (I) 0.7 mile NW TLD CL-83 (I) 0.6 mile NNW TLD CL-36 (1) 0.6 mile N TLD i
l L
i-CLINTON-I 5-3 Rev.0-4/85 L_
CPS-0DCM ;
I.
Table 5.0-1 {
CPS REMP SAMPLING LOCATIONS AND FREQUENCY :
1-1 FREQUENCY OF COLLECTION Semi- Semi- Once every i g) Weekly Monthly Monthly Quarterly Annually three years Location / Type (g) Description {
i TLp CL-77 ~(I)- 4.4 mile NNE ;
TLD .
CL-78 (I)' 4.6 mile NE I
TLD CL-79 (I) 4.5 mile ENE.
5.1 mile ENE TLD CL-113 (I) ,
4.3 mile E TLD CL-53 (I) e TLD
'CL-54 (I) 4.6 mile ESE
4.6 mile 5 TLD CL-57 (I)
TLD CL-58 -(I) 4.3 mile S8W TLD CL-60 (I) 4.5 mile SW 4.5 mile WSW TLD CL-61 (1)
TLD CL-80 (I) 4.1 mile W TLD CL-81 (I) 4.5 mile WNW TLD CL-51 (I) 4.4 mile NW TLD CL-52 (I) 4.3 mile NNW 4.6 mile N TLD CL-76 (I) 4.6 mile N TLD CL-112 (I)
TLD CL-38 (I) 3.6 mile NNE TLD CL-39 (I) 3.8 mile NE TLD CL-40 (I) 3.5 mile NE 5-4 Rev.0-4/85 CLINTON-I
- - . . . . - . . . ~ . - - . . . - -
. = . . - - . , . = - . - . .- -.-
s CPS-0DCM-Table 5.0-1 .
i CPS REMP SAMPLING LOCATIONS AND FREQUENCY b
FREQUENCT OF COLLECTION Semi- Semi- Once every
- Location / Type I Description I Weekly Monthly Monthly Quarterly Annually three years CL-65 (I) 2.5 mile INE TLD
, CL-41 (I). 2.4 mile E TLD CL-42 (I) 2.8 mile ESE TLD ,
CL-43 (I) 2.8 mile SE TLD L CL-44 (I)- 2.3 mile SSE TLD l
CL-45 ~(I) 2.8 mile S TLD CL-46 (I) 2.8 mile SSW TLD
'CL-59 (I) 3.3 mile SSW TLD CL-47 (1) 3.3 mile SW TLD CL-48 (I) 2.3 mile WSW TLD .
'CL-49 (I) 3.5 mile W TLD CL-50 (I) 3.2 mile WNW TLD t
CL-37 (I) 3.4 mile N TLD f CL-62 (I) 1.9 mile NW TLD l
CL-63 (I) 1.3 mile NNW TLD CL-64 (I) 2.1 mile WNW TLD CL-74 (I) 1.9 mile W TLD CL-75 (I) 1.0 mile N TLD ;
I CL-20 (C) 12 miles ENE TLD j CL-33 (C) 11.1 miles SSW TLD CL-88 (I) 2.5 mile SE SS [
i-I- CL-89A (C) 3.6 mile NNE SW( ) 3 CL-898 (I) 4.5 mile NNE BS,SS
- l. CLINTON-I S-5 Rev.0-4/85
?
I l
V .
CPS-0DCM Table 5.0-1 CPS REMP SAMPLING LOCATIONS AND FREQUENCY FREQUENCY OF COLLECTION Semi- Semi- Once every Location / Type ( } Description ( Weekly Monthly Monthly Quarterly Annually three years CL-90 (I) 0.4 mile ESE SW CL-92 (I) 0.1 mile NW SW CL-94 (I) 0.5 mile E AP, AI ,
TS CL-95 (I) 0.4 mile ESE AP, AI TS CL-105 (C) 41 miles S F.BS, (Lake SS,SL Shelbyville)
CL-114 (C). 13 miles SSE VE( }
CLINTON-I 5-6 Rev.0-4/85
CPS-ODCM Notes for. Table 5.0-1 ,
(1) Type of monitoring location - I = Indicator C = Control (2) As measured from the HVAC stack
~
(3) Sample codes AP = Airborne Particulate AI = Airborne Radioiodine TLD = Thermoluminescent Dosimeter for Direct Gamma Radiation >
M = Milk DW = Drinking Water SW = Surface Water WW = Well Water VE = Broad leafy and/or Tuberous Vegetables G = Grass in lieu of milk F = Fish SL = Slime or Aquatic. Vegetation (Periphyton)
BS = Lakebottom or Creekbottom Sediments SS = Shoreline Sedimants TS = Terrestrial Soil (4) Grass (when available) in lieu of milk (5) When available grab sample, not composite (6) ~ Determined by Annual Census Sample Code Type of Analyses Frequency of analysis (7)
AP gross beta following filter change (weekly) gamma isbtopic quarterly composite AI I-131 analysis of charcoal weekly TLD gamma exposure quarterly M I-131 semi-monthly when animals gamma isotopic are on pastures monthly at other times CLINTON-I 5-7 ,
Rev.0-4/85
- CPS-0DCM Notes for Table 5.0-1 (continued)
Sample Code Type of Analyses Frequency of analysis t
DW I-131 analysis on each composite over two week [,
composite when the dose period if I-131 analysis is -
performed, monthly calculated for the consumption of the water composite otherwise ,
is greater than 1 mrem per year. Composite for gross beta and gamma isotopic ;
analyses. Composite for l-tritium analysis quarterly SW gamma isotopic of composite sample over one ,
composite sample monthly. month period. .
Composite for tritium '
analysis quarterly. ;
WW gamma itotopic and quarterly critium ;
VE gamma isotopic and monthly when available I-131 analysis G gamma isotopic semi-monthly when animals #
I-131 are on pastures monthly at !
other times when available [
F gamma isotopic on semi-annually !
edible portions ',
SL gamma isotopic semi-annually BS SS gamma isotopic semi-annually TS gamma isotopic once every three years ,
J l
CLINTON-I 5-8 Rev.0-4/85 F - -
,-,----,-,,-,y, -. .---.._-.-...y--..,..-._..--.-.,-v
- - , - - . - . . - . - - . _ . . - . ~ . - - - - - - , - - < ~ - - - . - - . . , . -
CPS-0DCM FIGURE 5.0-1 REMP LOCATIONS WITHIN 2 MILES OF CPS i
s
.- .s e _ >.3-.... 2 - .,,,--- ,, . . ,
Nl i
W w ; cs &a s p ;s. g.s%,; e.s:
. UE K :. ,
[
'7~
,'tM 2 'r '
,y A ~- "
..c p-wty 9.> .-
- u, f.r. .... ., . .
-- ->; -- a p* '44,,3L , .; -
=- .
- y. '
1 : ~ -f =
[ . . ., .Y, 'Z. . .,. ;
..#M.,,{ >.J.l . ,' ~ c) Dy*M t
i . 3
, d.%'. p h K..c ,w ..4C9.w%
~pt: /'~k;2."Q/
- f-a -
iL';n.,4 ' , ?l5'!'/f 7 /_ /Ni.3 s:
. m..t. T y, * *- ..siyi % W _./ ,. . . e ...,.
5- .. sr 'g
,h
..f. kf hr..n .;,, %': . %.
u .,
nr 1: . $$',%DiA lh * '. * * '
.\.
g.
C ,j _kik .* Q;.'. - .";) .j.c t .3.@ 1.T,,
f _
~
d
~
M -
? ! k.Q' L,hs:.%..g
- .. .... - ~?~w.
>3. g .
i $W $ $ 5 & W bT+ W 95l$. & $ f W _
Mi~,:R G i,'. %hb _.e "h};j . ? ' /7 M
~ f } }uMdf
_ " 27'.[e.j W [ j *
.w n -%.x g.l. ,*, b. y- nCM&,, h%g gyy.8's M -
.,.. - c . . ., u : _ . /.::SE
]
a WW.T*'.".."-lCgyg*'g@ggQ-qfQTTg 7 ., . ..: .: . . .. ~ .< 3 t T -
N&'(yh.iklW;_hhl:;hh%$h,,.
I ~
~
j
' ': 3
%' , , W <.
- %y . -=fy
' '., ' :. ' Q,it,P:.s.l4_f G
- ' t.t;.' , k. . ,
...f-
, ' '. ~
}> iI gy,W b.m ;u x).cn.ss.;l, '- N ~& : - .cc ns3 t . s
- str # .;a.
. .~. r-
'li'.'.: .
\ *
/f , ~ .:.:;, " . .
, ~ ,. . . , y ! n r= n n .:
- cy... .. .,f.. ..Am.m s n/. . ...,.-y..a
~v=
. m . , ;,.. g .,... . :. , , .. . ,. e.. , . ._ , , . y. . ,
e
. a.a . .. . . . .. . .
,s.
i \ ,r o
CLINTON-I 5-9 Rev 0-4/85 i
s i
- . CPS-0DCM 1
FIGURE 5.0-2 REMP LOCATIONS WITHIN 5 MILES OF CPS (N)
A(0)
(M) R , i , # ,s '.o h a (NNt)
.. I m u .<., . .
g)iE3 4 *M i .r ... .. : =
c 3,3
~
4!difMW Mn k % -
/i. *.v. .
- ..n,L w n ': N.
(
~V
- . e .v "'
'" % /\/.MLK ' Y ' MI ' ' . .
- % r W;-
. T] 7 / ih r h F ~ ,. c4 ".' ' ' .. ?- .o L,','l f
',YlW4 '3,1 #." '1 ", 9 gfn-[T.! . p. .. 1 r+Tn <!_ ._
M.$ in V E <g.
(m r(ts ) ,
.' N . 414*"7. eV ys.y y -
-l
- l3 (SW) L (225) %- } ,., l\ ji, ',
G(135) (sg3
'." L ?
,@[EI
'>W
(SsW) K H (333)
J(180)
DISTANCE SET'.!EEN (5)
CIRCLES =0 .SttIt.ES I
CLINTON-I 5-10 Rev.0-4/85 ,
t
CPS-ODCM
- ., t, i l
FIGURE 5.0-3 REMP LOCATIONS WITH 50 MILES OF CPS k
I(0) (N)
(NNW)R -
.. B II
- s. c > 50' 6 : e
. ,.-.w
' -Q ~$. \.
..-. '""L-MilF
_~
- yj' ~.. .m (NW) Q(3 t S) , i . / C (45) (ug) 4 '
- ..& ;- 4"" t..
,a g? .
tu ,
.g:.
,e ..=~ "E h2.
en ; Y i"' :.. - %_ %T '-
i.
. "%-X ;; A.. . . '. ' ,*h-: . .
- , - ~
- i; s g.
. 4. . ..h ,.i.-) : ...
.r f.
I (WNW)P . .
.- . N == '
. g- s
.r& e' ' m! L. sy .! i.s. ;. ._ ._t. * '"."._" O ( ENE )
.il:z,. ' w :.::.!:
W , ., ' _
hh_&'
f~fi ~-:, 4!. ' W. .'WMMM. r __
.x .,,
(u, n g) %r-.,g ,(., g ;fy 1 .-.m . a 9 . r . :. t <+
tp,/+8 Nh-t, e 7. , e j(go) e (E>
Gv -- s. .. w. .;, ,., e v w ', v -
....,n ;1. ,
m,i sk;. .y , j. .; ;w .g s 1+/g l- --
.y ... a x, .
pgg; t =auwx s '
xy.
-l (WSW) M -
- r. 't p ',
_ ,L . .g . z G4 -
- 9. U , ,.,_ m F (ESE) l . -
%".:Tl. w'sM).y -
- e. r s-
\' ~ r 3' ' p
}. .j. t ,,j- -
.: y .
].. ,,,~~~ A7,, y ,,
(SW) L(225) ' 'i~ ,-
'~ /fi.'.~ .~ -y 1
j ;e . f, 'r y:
- %j{RT.- ~1 77W' .
, j' G(135) (SE)
(SSW) K .T <'--
H (SSE)
O! STANCE SETWEEN J(180) 1 CIRCLES-S.0 MILES I3) r CLINTON-I 5-11 Rev.0-4/85
CPS-0DCM l s i
'n Consistent with the NRC Commissioners' opinion on 10CFR50 Appendix I dated April 30, 1975, CPS will use environs
- - monitoring data to improve dose calculational models and to request CPS RETS changes on the basis of such operating experience data. Such adjustments are recognized as being especially important for the radioiodine-milk pathway where conservative regulatory guide assumptions have been made. By using environs monitoring data, all the uncertainties associated with plume behavior, radiciodine chemical form, deposition and retention on forages, and milk consumption 1' _ __ _ _ patterns are circumvented or reduced.
- l
.] .
i l .
i
}
j .
I h
i 1
)
I 1
CLINTON-I 6-1 Rev.0-4/85
I- LICENSING PROOFREADING CHECKLIST .,
. Correct File #' '
-Correct Format <
Letter Not Dated //
Letter Number Provided [
Address Correct
- Dr./Mr.
State Spelled Out Correct Headings NRC Letter " Subject" Paragraphs Indented Non-NRC Letter - the word " Subject" is not used. "
Subject Lines Centered -
Paragraphs Indented '
Dear Mr./Dr.
Proof read for Typos Correct Closing - Sincerely yours, Should have author (s) initials and typist - No diskette number Attachment Specified, Verified Joint Stipulation Yes/No N -
cc's Correct -
NRC Res! dent Office Regional Administrator, Region III,USNRC Author's Name not Repeated on CC List Check bec List for Completeness ,[
and Correct Mail Codes V CPS Central File, T-31 (File Code - Retention - Safety or Non-safety)
Background Information Provided Gayle Buckley - Licensing __ Id 678-CAB /ws i
A. -
f